[
  {
    "id": "Medical-422500d5",
    "source": "Medical",
    "question": "Which anatomical locations are most commonly affected by basal cell carcinoma?",
    "answer": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCC most commonly develops in sun-exposed areas.",
      "Common sun-exposed areas for BCC include the face.",
      "Common sun-exposed areas for BCC include the head.",
      "Common sun-exposed areas for BCC include the neck."
    ],
    "evidence_relations": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck"
  },
  {
    "id": "Medical-5ad931db",
    "source": "Medical",
    "question": "How does fair skin affect the risk of developing BCC?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fair skin increases the risk of BCC."
    ],
    "evidence_relations": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-88c0b2ba",
    "source": "Medical",
    "question": "Which diagnostic methods are used for BCC?",
    "answer": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of BCC involves medical history.",
      "Diagnosis of BCC involves family history.",
      "Diagnosis of BCC involves a physical exam.",
      "Diagnosis of BCC involves a skin exam.",
      "Diagnosis of BCC involves a biopsy.",
      "Diagnosis of BCC may involve imaging."
    ],
    "evidence_relations": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-ec7d8801",
    "source": "Medical",
    "question": "When might radiation therapy be used in BCC?",
    "answer": "Radiation therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy may be used in some cases of basal cell carcinoma."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-9797af69",
    "source": "Medical",
    "question": "What is recurrence in the context of BCC?",
    "answer": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Recurrence refers to basal cell carcinoma returning to the original site.",
      "Recurrence refers to basal cell carcinoma spreading to lymph nodes.",
      "Recurrence refers to basal cell carcinoma spreading to distant sites."
    ],
    "evidence_relations": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-6884d3fa",
    "source": "Medical",
    "question": "What does follow-up for BCC typically include?",
    "answer": "Follow-up includes full skin exams with a doctor at least once a year.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for basal cell carcinoma includes full skin exams with a doctor.",
      "Follow-up for basal cell carcinoma occurs at least once a year."
    ],
    "evidence_relations": "Follow-up includes full skin exams with a doctor at least once a year"
  },
  {
    "id": "Medical-df1408f4",
    "source": "Medical",
    "question": "What hair and eye colors are associated with increased BCC risk?",
    "answer": "Red hair, blond hair, and light eye color increase the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Red hair increases the risk of basal cell carcinoma.",
      "Blond hair increases the risk of basal cell carcinoma.",
      "Light eye color increases the risk of basal cell carcinoma."
    ],
    "evidence_relations": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-5f2cb8a5",
    "source": "Medical",
    "question": "Which systemic therapy may be considered for BCC?",
    "answer": "Systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Systemic therapy may be used in some cases of BCC."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-0429f83c",
    "source": "Medical",
    "question": "What is included in the management of BCC recurrence?",
    "answer": "Management of recurrence involves treatment options based on risk and recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Management of BCC recurrence involves treatment options.",
      "Treatment options for BCC recurrence are based on risk and recurrence."
    ],
    "evidence_relations": "Management: Treatment options based on risk and recurrence"
  },
  {
    "id": "Medical-e3923e5f",
    "source": "Medical",
    "question": "Can BCC spread to lymph nodes?",
    "answer": "BCC recurrence can involve spread to lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCC recurrence can involve spread to lymph nodes."
    ],
    "evidence_relations": "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites"
  },
  {
    "id": "Medical-5c30dd24",
    "source": "Medical",
    "question": "What is the role of imaging in BCC diagnosis?",
    "answer": "Imaging may be used in the diagnosis of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging may be used in the diagnosis of BCC."
    ],
    "evidence_relations": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-acec9fa2",
    "source": "Medical",
    "question": "How does fair skin affect the risk of basal cell carcinoma?",
    "answer": "Fair skin increases the risk of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fair skin increases the risk of BCC."
    ],
    "evidence_relations": "Fair skin, light hair, and light eye color increase the risk of BCC"
  },
  {
    "id": "Medical-4061f8c4",
    "source": "Medical",
    "question": "Is immune suppression a risk factor for basal cell carcinoma?",
    "answer": "Immune suppression is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immune suppression is a risk factor for BCC."
    ],
    "evidence_relations": "Radiation therapy and immune suppression are risk factors for BCC"
  },
  {
    "id": "Medical-bc412bb6",
    "source": "Medical",
    "question": "When might radiation therapy or systemic therapy be used for BCC?",
    "answer": "Radiation therapy or systemic therapy may be used in some cases of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy may be used in some cases of BCC.",
      "Systemic therapy may be used in some cases of BCC."
    ],
    "evidence_relations": "Radiation therapy or systemic therapy may be used in some cases of BCC"
  },
  {
    "id": "Medical-ae28e711",
    "source": "Medical",
    "question": "Is sun exposure a risk factor for BCC?",
    "answer": "Sun exposure is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Sun exposure is a risk factor for BCC."
    ],
    "evidence_relations": "Sun exposure"
  },
  {
    "id": "Medical-4f1779a5",
    "source": "Medical",
    "question": "Is autoimmune disease a risk factor for BCC?",
    "answer": "Autoimmune disease is a risk factor for BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Autoimmune disease is a risk factor for BCC."
    ],
    "evidence_relations": "Autoimmune disease"
  },
  {
    "id": "Medical-f8b6c41e",
    "source": "Medical",
    "question": "What is the significance of a brown or glossy black bump with rolled border?",
    "answer": "A brown or glossy black bump with rolled border is a symptom of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A brown or glossy black bump with rolled border is a symptom of BCC."
    ],
    "evidence_relations": "Brown or glossy black bump with rolled border"
  },
  {
    "id": "Medical-04249246",
    "source": "Medical",
    "question": "Is imaging sometimes used in the diagnosis of BCC?",
    "answer": "Imaging may be used in the diagnosis of BCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging may be used in the diagnosis of BCC."
    ],
    "evidence_relations": "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy, and sometimes imaging"
  },
  {
    "id": "Medical-a296a86b",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this context?",
    "answer": "Primary CNS lymphoma is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary CNS lymphoma is the primary cancer type."
    ],
    "evidence_relations": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system"
  },
  {
    "id": "Medical-b3c430ef",
    "source": "Medical",
    "question": "Name a cancer subtype of primary CNS lymphoma that affects the eyes.",
    "answer": "Vitreoretinal lymphoma is a subtype that affects the eyes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Vitreoretinal lymphoma is a subtype of primary CNS lymphoma.",
      "Vitreoretinal lymphoma affects the eyes."
    ],
    "evidence_relations": "Vitreoretinal lymphoma is a cancer subtype of primary CNS lymphoma that affects the eyes, retina, and vitreous"
  },
  {
    "id": "Medical-e306413c",
    "source": "Medical",
    "question": "Which laboratory test is commonly used during the diagnosis of primary CNS lymphoma?",
    "answer": "Complete blood count (CBC) is commonly used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complete blood count (CBC) is commonly used during the diagnosis of primary CNS lymphoma."
    ],
    "evidence_relations": "Laboratory Tests include Complete blood count (CBC)"
  },
  {
    "id": "Medical-e05d0922",
    "source": "Medical",
    "question": "Which procedure is performed if cancer cells are found in the cerebrospinal fluid?",
    "answer": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid."
    ],
    "evidence_relations": "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid"
  },
  {
    "id": "Medical-1c1492e7",
    "source": "Medical",
    "question": "What specialized treatment is given if the eyes are involved in primary CNS lymphoma?",
    "answer": "Intraocular chemotherapy or radiation may be used if the eyes are involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intraocular chemotherapy or radiation may be used if the eyes are involved in primary CNS lymphoma."
    ],
    "evidence_relations": "Intraocular chemotherapy or radiation may be used if the eyes are involved"
  },
  {
    "id": "Medical-f5fc9016",
    "source": "Medical",
    "question": "Which immunotherapy drug is primarily used in the treatment of primary CNS lymphoma?",
    "answer": "Rituximab is the main immunotherapy drug used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Rituximab is the main immunotherapy drug used in the treatment of primary CNS lymphoma."
    ],
    "evidence_relations": "Rituximab is the main immunotherapy drug used for primary CNS lymphoma"
  },
  {
    "id": "Medical-a4081e18",
    "source": "Medical",
    "question": "Which performance measure is evaluated to guide treatment decisions in primary CNS lymphoma?",
    "answer": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is evaluated to guide treatment decisions.",
      "Performance status is evaluated to determine eligibility for clinical trials."
    ],
    "evidence_relations": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials"
  },
  {
    "id": "Medical-c99256ce",
    "source": "Medical",
    "question": "Name three neurological symptoms commonly caused by primary CNS lymphoma.",
    "answer": "Leg weakness, confusion, and seizures are common neurological symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Leg weakness is a common neurological symptom caused by primary CNS lymphoma.",
      "Confusion is a common neurological symptom caused by primary CNS lymphoma.",
      "Seizures are a common neurological symptom caused by primary CNS lymphoma."
    ],
    "evidence_relations": "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes"
  },
  {
    "id": "Medical-7b5a8ac6",
    "source": "Medical",
    "question": "Which diagnostic method is used to assess eye involvement in primary CNS lymphoma?",
    "answer": "Eye exam is used to assess eye involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Eye exam is used to assess eye involvement in primary CNS lymphoma."
    ],
    "evidence_relations": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture"
  },
  {
    "id": "Medical-26033837",
    "source": "Medical",
    "question": "What follow-up method is recommended for surveillance after treatment of primary CNS lymphoma?",
    "answer": "Repeat MRI is recommended for follow-up surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Repeat MRI is recommended for follow-up surveillance after treatment of primary CNS lymphoma."
    ],
    "evidence_relations": "Follow-up/Surveillance includes Repeat MRI"
  },
  {
    "id": "Medical-f619b6ea",
    "source": "Medical",
    "question": "What is the role of corticosteroids in the treatment of primary CNS lymphoma?",
    "answer": "Corticosteroids are one of the treatment options for primary CNS lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Corticosteroids are one of the treatment options for primary CNS lymphoma."
    ],
    "evidence_relations": "Treatment options for primary CNS lymphoma include corticosteroids, chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell rescue, and supportive care"
  },
  {
    "id": "Medical-9474c5bb",
    "source": "Medical",
    "question": "Which chemotherapy drugs, besides methotrexate, can be used in induction therapy for primary CNS lymphoma?",
    "answer": "Temozolomide, vincristine, procarbazine, cytarabine, pemetrexed, pomalidomide, lenalidomide, and ibrutinib can be used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Temozolomide can be used in induction therapy for primary CNS lymphoma.",
      "Vincristine can be used in induction therapy for primary CNS lymphoma.",
      "Procarbazine can be used in induction therapy for primary CNS lymphoma.",
      "Cytarabine can be used in induction therapy for primary CNS lymphoma.",
      "Pemetrexed can be used in induction therapy for primary CNS lymphoma.",
      "Pomalidomide can be used in induction therapy for primary CNS lymphoma.",
      "Lenalidomide can be used in induction therapy for primary CNS lymphoma.",
      "Ibrutinib can be used in induction therapy for primary CNS lymphoma."
    ],
    "evidence_relations": "Induction phase includes High-dose methotrexate, Rituximab, Temozolomide, Vincristine, Procarbazine, Cytarabine, Pemetrexed, Pomalidomide, Lenalidomide, Ibrutinib, Clinical trial"
  },
  {
    "id": "Medical-5825991f",
    "source": "Medical",
    "question": "Which procedure is included in laboratory tests for diagnosing primary CNS lymphoma?",
    "answer": "Lactate dehydrogenase (LDH) testing is included in laboratory tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lactate dehydrogenase (LDH) testing is included in laboratory tests for diagnosing primary CNS lymphoma."
    ],
    "evidence_relations": "Laboratory Tests include Lactate dehydrogenase (LDH)"
  },
  {
    "id": "Medical-a4dcffa3",
    "source": "Medical",
    "question": "What is a potential site of relapse for primary CNS lymphoma?",
    "answer": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary CNS lymphoma can relapse in the brain.",
      "Primary CNS lymphoma can relapse in the spinal cord.",
      "Primary CNS lymphoma can relapse in the eyes."
    ],
    "evidence_relations": "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes"
  },
  {
    "id": "Medical-d1e50927",
    "source": "Medical",
    "question": "Which cancer subtype is classified as a type of nonmelanoma skin cancer?",
    "answer": "CSCC is a type of nonmelanoma skin cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CSCC is a type of nonmelanoma skin cancer."
    ],
    "evidence_relations": "CSCC is a type of nonmelanoma skin cancer"
  },
  {
    "id": "Medical-9536f8e7",
    "source": "Medical",
    "question": "What are the main stages of cutaneous squamous cell carcinoma (CSCC)?",
    "answer": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CSCC is staged as local.",
      "CSCC is staged as regional.",
      "CSCC is staged as metastatic."
    ],
    "evidence_relations": "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)"
  },
  {
    "id": "Medical-1f290988",
    "source": "Medical",
    "question": "What is a precancerous lesion that can progress to CSCC?",
    "answer": "Actinic keratosis is a precancerous lesion that can progress to CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC."
    ],
    "evidence_relations": "Actinic keratosis is a precancerous lesion that can progress to CSCC"
  },
  {
    "id": "Medical-3d21bfb3",
    "source": "Medical",
    "question": "Which risk factors are major contributors to CSCC development?",
    "answer": "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chronic sun exposure is a major risk factor for CSCC.",
      "Indoor tanning is a major risk factor for CSCC.",
      "Environmental toxins are a major risk factor for CSCC.",
      "Actinic keratoses are a major risk factor for CSCC.",
      "Genetic syndromes are a major risk factor for CSCC.",
      "A weakened immune system is a major risk factor for CSCC.",
      "Chronic wounds or scars are a major risk factor for CSCC."
    ],
    "evidence_relations": "Major risk factors for CSCC include chronic sun exposure, indoor tanning, environmental toxins, actinic keratoses, genetic syndromes, weakened immune system, and chronic wounds or scars"
  },
  {
    "id": "Medical-a2555661",
    "source": "Medical",
    "question": "Which genetic syndromes increase the risk for CSCC?",
    "answer": "Xeroderma pigmentosum and RDEB increase risk for CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Xeroderma pigmentosum increases the risk for CSCC.",
      "RDEB increases the risk for CSCC."
    ],
    "evidence_relations": "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC"
  },
  {
    "id": "Medical-8866282b",
    "source": "Medical",
    "question": "What are common symptoms of CSCC?",
    "answer": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of CSCC include scaly patches.",
      "Common symptoms of CSCC include solid or misshapen skin lesions.",
      "Common symptoms of CSCC include lesions in areas of chronic damage."
    ],
    "evidence_relations": "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage"
  },
  {
    "id": "Medical-d9522675",
    "source": "Medical",
    "question": "What biopsy types are used in the diagnosis of CSCC?",
    "answer": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biopsy types for diagnosis of CSCC include shave biopsy.",
      "Biopsy types for diagnosis of CSCC include punch biopsy.",
      "Biopsy types for diagnosis of CSCC include excision biopsy."
    ],
    "evidence_relations": "Biopsy types for diagnosis include shave biopsy, punch biopsy, and excision biopsy"
  },
  {
    "id": "Medical-0d21d2d6",
    "source": "Medical",
    "question": "Which systemic therapies are used for advanced CSCC?",
    "answer": "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Systemic therapy options for advanced CSCC include platinum-based chemotherapy.",
      "Systemic therapy options for advanced CSCC include EGFR inhibitors.",
      "Cetuximab is an EGFR inhibitor used for advanced CSCC.",
      "Systemic therapy options for advanced CSCC include PD-1 inhibitors.",
      "Cemiplimab is a PD-1 inhibitor used for advanced CSCC.",
      "Pembrolizumab is a PD-1 inhibitor used for advanced CSCC."
    ],
    "evidence_relations": "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)"
  },
  {
    "id": "Medical-6a38af6d",
    "source": "Medical",
    "question": "What is a key biomarker used in risk assessment for CSCC?",
    "answer": "Perineural invasion is a key biomarker for CSCC risk assessment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perineural invasion is a key biomarker for CSCC risk assessment."
    ],
    "evidence_relations": "Perineural invasion is listed as a biomarker in the ontology for CSCC"
  },
  {
    "id": "Medical-eac1c791",
    "source": "Medical",
    "question": "Which environmental toxins are risk factors for CSCC?",
    "answer": "Environmental toxins such as arsenic and tobacco smoke are risk factors for CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Arsenic is an environmental toxin that is a risk factor for CSCC.",
      "Tobacco smoke is an environmental toxin that is a risk factor for CSCC."
    ],
    "evidence_relations": "Environmental toxins (arsenic, tobacco smoke) are listed as risk factors for CSCC"
  },
  {
    "id": "Medical-8bf3a99b",
    "source": "Medical",
    "question": "How is risk assessment for CSCC performed?",
    "answer": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk assessment for CSCC is based on tumor location.",
      "Risk assessment for CSCC is based on tumor size.",
      "Risk assessment for CSCC is based on border definition.",
      "Risk assessment for CSCC is based on recurrence.",
      "Risk assessment for CSCC is based on depth.",
      "Risk assessment for CSCC is based on perineural invasion.",
      "Risk assessment for CSCC is based on lymphovascular invasion.",
      "Risk assessment for CSCC is based on tumor grade.",
      "Risk assessment for CSCC is based on patient immune status."
    ],
    "evidence_relations": "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status"
  },
  {
    "id": "Medical-c8c9c0ee",
    "source": "Medical",
    "question": "Which imaging modalities are used for staging and surveillance in CSCC?",
    "answer": "Imaging (CT, MRI, PET/CT) is used for staging and surveillance in regional and high-risk cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CT is an imaging modality used for staging and surveillance in CSCC.",
      "MRI is an imaging modality used for staging and surveillance in CSCC.",
      "PET/CT is an imaging modality used for staging and surveillance in CSCC.",
      "Imaging is used for staging and surveillance in regional and high-risk cases of CSCC."
    ],
    "evidence_relations": "Imaging is used for staging and surveillance in regional and high-risk cases"
  },
  {
    "id": "Medical-b1ab4938",
    "source": "Medical",
    "question": "What follow-up schedule is recommended for high-risk local CSCC after treatment?",
    "answer": "Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Skin and lymph node exams are recommended every 3-6 months for 2 years after treatment for high-risk local CSCC.",
      "Skin and lymph node exams are recommended every 6 months for 3 years after treatment for high-risk local CSCC.",
      "Skin and lymph node exams are recommended every 6-12 months after the initial follow-up period for high-risk local CSCC."
    ],
    "evidence_relations": "Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months"
  },
  {
    "id": "Medical-9a719269",
    "source": "Medical",
    "question": "Which patients are recommended to consider clinical trials in CSCC management?",
    "answer": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are an option for systemic therapy in CSCC management.",
      "Clinical trials are especially recommended for advanced CSCC.",
      "Clinical trials are especially recommended for refractory CSCC."
    ],
    "evidence_relations": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC"
  },
  {
    "id": "Medical-d8a3772b",
    "source": "Medical",
    "question": "Which immunotherapy agents are used for metastatic CSCC?",
    "answer": "PD-1 inhibitors such as cemiplimab and pembrolizumab are used for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-1 inhibitors are used for metastatic CSCC.",
      "Cemiplimab is a PD-1 inhibitor used for metastatic CSCC.",
      "Pembrolizumab is a PD-1 inhibitor used for metastatic CSCC."
    ],
    "evidence_relations": "PD-1 inhibitors (cemiplimab, pembrolizumab) are listed as systemic therapy options for metastatic CSCC"
  },
  {
    "id": "Medical-ff41533a",
    "source": "Medical",
    "question": "What is the preferred systemic therapy for metastatic CSCC?",
    "answer": "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC."
    ],
    "evidence_relations": "Systemic therapy (PD-1 inhibitor preferred) is listed for metastatic CSCC"
  },
  {
    "id": "Medical-c87c6baf",
    "source": "Medical",
    "question": "Which factors are included in clinical management risk assessment for CSCC?",
    "answer": "Risk assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, and immunosuppression.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk assessment for CSCC includes tumor location.",
      "Risk assessment for CSCC includes tumor size.",
      "Risk assessment for CSCC includes tumor border definition.",
      "Risk assessment for CSCC includes recurrence.",
      "Risk assessment for CSCC includes depth of invasion.",
      "Risk assessment for CSCC includes perineural invasion.",
      "Risk assessment for CSCC includes lymphovascular invasion.",
      "Risk assessment for CSCC includes tumor grade.",
      "Risk assessment for CSCC includes immunosuppression."
    ],
    "evidence_relations": "Risk Assessment includes tumor location and size, tumor border definition, recurrence, depth of invasion, perineural invasion, lymphovascular invasion, tumor grade, immunosuppression"
  },
  {
    "id": "Medical-3e2b82f5",
    "source": "Medical",
    "question": "Which clinical management strategy is used for surveillance in high-risk or regional CSCC?",
    "answer": "Surveillance involves regular skin and lymph node exams and imaging for high-risk or regional disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance for high-risk or regional CSCC involves regular skin exams.",
      "Surveillance for high-risk or regional CSCC involves regular lymph node exams.",
      "Surveillance for high-risk or regional CSCC involves imaging."
    ],
    "evidence_relations": "Surveillance: Regular skin and lymph node exams, imaging for high-risk or regional disease"
  },
  {
    "id": "Medical-9b293f2c",
    "source": "Medical",
    "question": "What genetic alteration causes chronic myeloid leukemia?",
    "answer": "CML is caused by the BCR::ABL1 fusion gene.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene."
    ],
    "evidence_relations": "CML is caused by the BCR::ABL1 fusion gene"
  },
  {
    "id": "Medical-e49be454",
    "source": "Medical",
    "question": "Which chromosomal translocation results in the BCR::ABL1 gene?",
    "answer": "A translocation between chromosome 9 and chromosome 22 creates the BCR::ABL1 gene.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A translocation between chromosome 9 and chromosome 22 creates the BCR::ABL1 gene."
    ],
    "evidence_relations": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
  },
  {
    "id": "Medical-c97b2e2b",
    "source": "Medical",
    "question": "What is the Philadelphia chromosome?",
    "answer": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from the translocation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The Philadelphia chromosome (Ph) is an abnormal chromosome.",
      "The Philadelphia chromosome (Ph) is chromosome 22.",
      "The Philadelphia chromosome (Ph) results from a translocation."
    ],
    "evidence_relations": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
  },
  {
    "id": "Medical-e5676a79",
    "source": "Medical",
    "question": "What is required for a diagnosis of CML?",
    "answer": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Presence of the Ph chromosome is required for CML diagnosis.",
      "Presence of the BCR::ABL1 gene is required for CML diagnosis."
    ],
    "evidence_relations": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
  },
  {
    "id": "Medical-77457615",
    "source": "Medical",
    "question": "What are the two main diagnostic methods for CML?",
    "answer": "Blood tests and bone marrow tests are used to diagnose CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used to diagnose CML.",
      "Bone marrow tests are used to diagnose CML."
    ],
    "evidence_relations": "Blood tests and bone marrow tests are used to diagnose CML"
  },
  {
    "id": "Medical-72a77731",
    "source": "Medical",
    "question": "What is the primary treatment goal for CML?",
    "answer": "Treatment for CML aims to inhibit BCR::ABL1 protein activity.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary treatment goal for CML is to inhibit BCR::ABL1 protein activity."
    ],
    "evidence_relations": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-62a9b979",
    "source": "Medical",
    "question": "Which blood cell type is produced in increased numbers in CML?",
    "answer": "Myeloid progenitor cells are produced in increased numbers in CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Myeloid progenitor cells are produced in increased numbers in CML."
    ],
    "evidence_relations": "CML arises from blood stem cells producing increased myeloid progenitor cells"
  },
  {
    "id": "Medical-61ec9250",
    "source": "Medical",
    "question": "Which treatment strategy targets the abnormal protein in CML?",
    "answer": "BCR::ABL1 protein inhibition is the treatment strategy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1 protein inhibition is the treatment strategy for CML."
    ],
    "evidence_relations": "Treatment: BCR::ABL1 protein inhibition"
  },
  {
    "id": "Medical-ea3d4859",
    "source": "Medical",
    "question": "Which chromosomes are specifically mentioned as being involved in CML pathogenesis?",
    "answer": "Chromosome 9 and chromosome 22 are involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chromosome 9 is involved in CML pathogenesis.",
      "Chromosome 22 is involved in CML pathogenesis."
    ],
    "evidence_relations": "Chromosomal Abnormality: chromosome 9, chromosome 22"
  },
  {
    "id": "Medical-8109c3aa",
    "source": "Medical",
    "question": "What is the function of BCR::ABL1 protein inhibition in CML treatment?",
    "answer": "It is the primary treatment approach for CML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1 protein inhibition is the primary treatment approach for CML."
    ],
    "evidence_relations": "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
  },
  {
    "id": "Medical-8be16d47",
    "source": "Medical",
    "question": "Which cells do squamous cell carcinoma originate from?",
    "answer": "Squamous cell carcinoma forms from cells that line the bronchi.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma forms from cells that line the bronchi."
    ],
    "evidence_relations": "Squamous cell carcinoma forms from cells that line the bronchi"
  },
  {
    "id": "Medical-9e7500a0",
    "source": "Medical",
    "question": "What is the origin of large cell carcinoma in NSCLC?",
    "answer": "Large cell carcinoma forms from large cells found throughout the airways.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Large cell carcinoma forms from large cells.",
      "Large cells are found throughout the airways."
    ],
    "evidence_relations": "Large cell carcinoma forms from large cells found throughout the airways"
  },
  {
    "id": "Medical-a61abd42",
    "source": "Medical",
    "question": "How is Stage 1 NSCLC classified?",
    "answer": "Stage 1 NSCLC is considered early stage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage 1 NSCLC is considered early stage."
    ],
    "evidence_relations": "Stage 1 NSCLC is considered early stage"
  },
  {
    "id": "Medical-e1aa3f36",
    "source": "Medical",
    "question": "What is the primary treatment for early or locally advanced NSCLC when possible?",
    "answer": "Surgery is a primary treatment for early or locally advanced NSCLC when possible.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgery is a primary treatment for early NSCLC when possible.",
      "Surgery is a primary treatment for locally advanced NSCLC when possible."
    ],
    "evidence_relations": "Surgery is a primary treatment for early or locally advanced NSCLC when possible"
  },
  {
    "id": "Medical-83b8a631",
    "source": "Medical",
    "question": "Which treatment is used for some early NSCLC cases?",
    "answer": "Radiation therapy is used for some early NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Radiation therapy is used for some early NSCLC cases."
    ],
    "evidence_relations": "Radiation therapy is used for some early NSCLC cases"
  },
  {
    "id": "Medical-2c702150",
    "source": "Medical",
    "question": "What treatment is used for some locally advanced NSCLC cases?",
    "answer": "Chemoradiation is used for some locally advanced NSCLC cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemoradiation is used for some locally advanced NSCLC cases."
    ],
    "evidence_relations": "Chemoradiation is used for some locally advanced NSCLC cases"
  },
  {
    "id": "Medical-5bae1c96",
    "source": "Medical",
    "question": "What type of care extends and enhances life for people with lung cancer?",
    "answer": "Supportive care extends and enhances life for people with lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care extends life for people with lung cancer.",
      "Supportive care enhances life for people with lung cancer."
    ],
    "evidence_relations": "Supportive care extends and enhances life for people with lung cancer"
  },
  {
    "id": "Medical-64042235",
    "source": "Medical",
    "question": "List environmental risk factors for lung cancer besides tobacco.",
    "answer": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Exposure to radon is a risk factor for lung cancer.",
      "Exposure to asbestos is a risk factor for lung cancer.",
      "Exposure to arsenic is a risk factor for lung cancer.",
      "Exposure to beryllium is a risk factor for lung cancer.",
      "Exposure to cadmium is a risk factor for lung cancer.",
      "Exposure to chromium is a risk factor for lung cancer.",
      "Exposure to nickel is a risk factor for lung cancer.",
      "Exposure to coal smoke is a risk factor for lung cancer.",
      "Exposure to soot is a risk factor for lung cancer.",
      "Exposure to silica is a risk factor for lung cancer.",
      "Exposure to diesel fumes is a risk factor for lung cancer.",
      "Air pollution is a risk factor for lung cancer."
    ],
    "evidence_relations": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer"
  },
  {
    "id": "Medical-1b7a0e02",
    "source": "Medical",
    "question": "How are lung nodules assessed for malignancy?",
    "answer": "Lung nodules are assessed by biopsy and lung cancer screening.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lung nodules are assessed by biopsy.",
      "Lung nodules are assessed by lung cancer screening."
    ],
    "evidence_relations": "Lung nodules may be detected by imaging and require further assessment to determine malignancy"
  },
  {
    "id": "Medical-b77be62e",
    "source": "Medical",
    "question": "What is the indication for lung cancer screening?",
    "answer": "Lung cancer screening is indicated for high risk individuals.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lung cancer screening is indicated for high risk individuals."
    ],
    "evidence_relations": "Lung cancer screening is recommended for people at high risk"
  },
  {
    "id": "Medical-d2746bf8",
    "source": "Medical",
    "question": "What is the most common subtype of nasopharyngeal cancer?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer."
    ],
    "evidence_relations": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer"
  },
  {
    "id": "Medical-75f181e8",
    "source": "Medical",
    "question": "Which anatomical site is affected by nasopharyngeal carcinoma?",
    "answer": "Nasopharyngeal carcinoma affects the nasopharynx.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nasopharyngeal carcinoma affects the nasopharynx."
    ],
    "evidence_relations": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx"
  },
  {
    "id": "Medical-c5bc82ff",
    "source": "Medical",
    "question": "What are two common symptoms of nasopharyngeal carcinoma?",
    "answer": "Enlarged lymph nodes and hearing loss are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Enlarged lymph nodes are a common symptom of nasopharyngeal carcinoma.",
      "Hearing loss is a common symptom of nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Symptom: [\"Enlarged lymph nodes\", \"Hearing loss\", \"Symptoms may be absent until advanced stage\"]"
  },
  {
    "id": "Medical-8f64cf43",
    "source": "Medical",
    "question": "Which biomarker tests are recommended for nasopharyngeal carcinoma?",
    "answer": "EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden are recommended biomarker tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA is a recommended biomarker test for nasopharyngeal carcinoma.",
      "MSI-H/dMMR is a recommended biomarker test for nasopharyngeal carcinoma.",
      "PD-L1 is a recommended biomarker test for nasopharyngeal carcinoma.",
      "HPV is a recommended biomarker test for nasopharyngeal carcinoma.",
      "Tumor mutational burden is a recommended biomarker test for nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden"
  },
  {
    "id": "Medical-49ff508e",
    "source": "Medical",
    "question": "Which performance measure is considered in NPC treatment planning?",
    "answer": "Performance status is considered in NPC treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is considered in nasopharyngeal carcinoma treatment planning."
    ],
    "evidence_relations": "Performance status is considered in NPC treatment planning"
  },
  {
    "id": "Medical-debec9f1",
    "source": "Medical",
    "question": "What are the possible classifications of nasopharyngeal carcinoma based on extent of disease?",
    "answer": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nasopharyngeal carcinoma can be classified as resectable.",
      "Nasopharyngeal carcinoma can be classified as unresectable.",
      "Nasopharyngeal carcinoma can be classified as locoregional.",
      "Nasopharyngeal carcinoma can be classified as locally advanced.",
      "Nasopharyngeal carcinoma can be classified as metastatic."
    ],
    "evidence_relations": "NPC can be classified as resectable, unresectable, locoregional, locally advanced, or metastatic based on extent of disease"
  },
  {
    "id": "Medical-2f8ada62",
    "source": "Medical",
    "question": "Which organs are common sites for metastasis from nasopharyngeal carcinoma?",
    "answer": "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nasopharyngeal carcinoma commonly spreads to lymph nodes in the neck.",
      "Nasopharyngeal carcinoma less frequently spreads to the lungs."
    ],
    "evidence_relations": "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs"
  },
  {
    "id": "Medical-b696a6b5",
    "source": "Medical",
    "question": "What is the purpose of EBV DNA testing in NPC?",
    "answer": "EBV DNA testing is performed before and after treatment for NPC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA testing is performed before treatment for nasopharyngeal carcinoma.",
      "EBV DNA testing is performed after treatment for nasopharyngeal carcinoma."
    ],
    "evidence_relations": "EBV DNA testing is performed before and after treatment for NPC"
  },
  {
    "id": "Medical-41723902",
    "source": "Medical",
    "question": "How is the cancer subtype determined in NPC?",
    "answer": "Biopsy determines cancer subtype in NPC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biopsy determines cancer subtype in nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Biopsy confirms diagnosis and determines cancer subtype"
  },
  {
    "id": "Medical-558d306b",
    "source": "Medical",
    "question": "Which imaging tests are used for surveillance of NPC?",
    "answer": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CT is used for surveillance of nasopharyngeal carcinoma.",
      "MRI is used for surveillance of nasopharyngeal carcinoma.",
      "PET/CT is used for surveillance of nasopharyngeal carcinoma.",
      "Ultrasound is used for surveillance of nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance"
  },
  {
    "id": "Medical-806207e1",
    "source": "Medical",
    "question": "What are the different types of biopsy used for NPC diagnosis?",
    "answer": "Fine-needle aspiration (FNA), fine-needle biopsy (FNB), and core needle biopsy (CNB) are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fine-needle aspiration (FNA) is used for nasopharyngeal carcinoma diagnosis.",
      "Fine-needle biopsy (FNB) is used for nasopharyngeal carcinoma diagnosis.",
      "Core needle biopsy (CNB) is used for nasopharyngeal carcinoma diagnosis."
    ],
    "evidence_relations": "Diagnostic Method: [\"Biopsy\", [\"Fine-needle aspiration (FNA)\", \"Fine-needle biopsy (FNB)\", \"Core needle biopsy (CNB)\"]]"
  },
  {
    "id": "Medical-0155c059",
    "source": "Medical",
    "question": "Which factors are considered prognostic in NPC?",
    "answer": "EBV DNA level and performance status are prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA level is a prognostic factor in nasopharyngeal carcinoma.",
      "Performance status is a prognostic factor in nasopharyngeal carcinoma."
    ],
    "evidence_relations": "Prognostic Factor: [\"EBV DNA level\", \"Performance status\"]"
  },
  {
    "id": "Medical-4482bd32",
    "source": "Medical",
    "question": "Which assessments are recommended before starting NPC treatment?",
    "answer": "Dental exam, nutrition assessment, and speech and swallowing assessment are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Dental exam is recommended before starting nasopharyngeal carcinoma treatment.",
      "Nutrition assessment is recommended before starting nasopharyngeal carcinoma treatment.",
      "Speech and swallowing assessment is recommended before starting nasopharyngeal carcinoma treatment."
    ],
    "evidence_relations": "Diagnostic Method: [\"Dental exam\", \"Nutrition assessment\", \"Speech and swallowing assessment\"]"
  },
  {
    "id": "Medical-6b0b36c7",
    "source": "Medical",
    "question": "Which populations are at increased risk for NPC due to geographic origin?",
    "answer": "People from Asia, Native America, and North Africa are at increased risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "People from Asia are at increased risk for NPC.",
      "Native Americans are at increased risk for NPC.",
      "People from North Africa are at increased risk for NPC."
    ],
    "evidence_relations": "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
  },
  {
    "id": "Medical-5d011928",
    "source": "Medical",
    "question": "What is the significance of symptoms being absent until advanced stage in NPC?",
    "answer": "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of NPC may be absent until the advanced stage.",
      "Symptoms of NPC can be similar to other conditions."
    ],
    "evidence_relations": "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions"
  },
  {
    "id": "Medical-07e567d4",
    "source": "Medical",
    "question": "Which biomarker is tested both before and after NPC treatment?",
    "answer": "EBV DNA is tested both before and after NPC treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EBV DNA is tested before NPC treatment.",
      "EBV DNA is tested after NPC treatment."
    ],
    "evidence_relations": "EBV DNA testing is performed before and after treatment for NPC"
  },
  {
    "id": "Medical-77578361",
    "source": "Medical",
    "question": "What is the most common subtype of colon cancer?",
    "answer": "Adenocarcinoma is the most common subtype of colon cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenocarcinoma is the most common subtype of colon cancer."
    ],
    "evidence_relations": "Adenocarcinoma is the most common subtype of colon cancer"
  },
  {
    "id": "Medical-04a90969",
    "source": "Medical",
    "question": "Which types of polyps rarely become cancerous in the colon?",
    "answer": "Hyperplastic and inflammatory polyps rarely become cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hyperplastic polyps rarely become cancerous in the colon.",
      "Inflammatory polyps rarely become cancerous in the colon."
    ],
    "evidence_relations": "Hyperplastic and inflammatory polyps rarely become cancer"
  },
  {
    "id": "Medical-d3fcc0fe",
    "source": "Medical",
    "question": "What procedure is used to remove polyps during colonoscopy?",
    "answer": "Polypectomy removes polyps during colonoscopy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Polypectomy removes polyps during colonoscopy."
    ],
    "evidence_relations": "Polypectomy removes polyps during colonoscopy"
  },
  {
    "id": "Medical-2360f9dd",
    "source": "Medical",
    "question": "What defines Stage 0 colon cancer?",
    "answer": "Stage 0 colon cancer is carcinoma in situ.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage 0 colon cancer is carcinoma in situ."
    ],
    "evidence_relations": "Stage 0 colon cancer is carcinoma in situ"
  },
  {
    "id": "Medical-879889ee",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for all colon cancers?",
    "answer": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All colon cancers should be tested for mismatch repair deficiency (dMMR).",
      "All colon cancers should be tested for microsatellite instability-high (MSI-H)."
    ],
    "evidence_relations": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)"
  },
  {
    "id": "Medical-a77dafa9",
    "source": "Medical",
    "question": "Which biomarker guides immunotherapy in colon cancer?",
    "answer": "dMMR/MSI-H is a biomarker guiding immunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "dMMR/MSI-H is a biomarker that guides immunotherapy in colon cancer."
    ],
    "evidence_relations": "dMMR/MSI-H is a biomarker guiding immunotherapy"
  },
  {
    "id": "Medical-973bc3d0",
    "source": "Medical",
    "question": "How are pMMR/MSS colon cancers generally treated?",
    "answer": "pMMR/MSS cancers are treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "pMMR/MSS colon cancers are generally treated with chemotherapy."
    ],
    "evidence_relations": "pMMR/MSS cancers are treated with chemotherapy"
  },
  {
    "id": "Medical-a43ea44f",
    "source": "Medical",
    "question": "Is family history a risk factor for colon cancer?",
    "answer": "Family history of colorectal cancer is a risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history of colorectal cancer is a risk factor for colon cancer."
    ],
    "evidence_relations": "Family history of colorectal cancer is a risk factor"
  },
  {
    "id": "Medical-13fbbea3",
    "source": "Medical",
    "question": "What blood tests are recommended for initial evaluation of colon cancer?",
    "answer": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests recommended for initial evaluation of colon cancer include CBC.",
      "Blood tests recommended for initial evaluation of colon cancer include chemistry profile.",
      "Blood tests recommended for initial evaluation of colon cancer include CEA."
    ],
    "evidence_relations": "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing"
  },
  {
    "id": "Medical-6f2d6386",
    "source": "Medical",
    "question": "When is MRI used in the evaluation of colon cancer?",
    "answer": "MRI may be used for further evaluation of liver or rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MRI may be used for further evaluation of the liver in colon cancer.",
      "MRI may be used for further evaluation of the rectum in colon cancer."
    ],
    "evidence_relations": "MRI may be used for further evaluation of liver or rectum"
  },
  {
    "id": "Medical-80328029",
    "source": "Medical",
    "question": "What is the current role of ctDNA testing in colon cancer?",
    "answer": "ctDNA testing is investigational and recommended only in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ctDNA testing is investigational in colon cancer.",
      "ctDNA testing is recommended only in clinical trials for colon cancer."
    ],
    "evidence_relations": "ctDNA testing is investigational and recommended only in clinical trials"
  },
  {
    "id": "Medical-5f9dfcb6",
    "source": "Medical",
    "question": "What is the preferred treatment for dMMR/MSI-H colon cancers?",
    "answer": "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H colon cancers."
    ],
    "evidence_relations": "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers"
  },
  {
    "id": "Medical-d4f3ad82",
    "source": "Medical",
    "question": "What are the components of surveillance after colon cancer treatment?",
    "answer": "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance after colon cancer treatment includes colonoscopy.",
      "Surveillance after colon cancer treatment includes CEA testing.",
      "Surveillance after colon cancer treatment includes CT scans."
    ],
    "evidence_relations": "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans"
  },
  {
    "id": "Medical-babf4510",
    "source": "Medical",
    "question": "What chemotherapy regimens are commonly used for colon cancer?",
    "answer": "Capecitabine, 5-fluorouracil (5-FU), leucovorin, FOLFOX, and CAPEOX are chemotherapy regimens used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Capecitabine is a chemotherapy regimen used for colon cancer.",
      "5-fluorouracil (5-FU) is a chemotherapy regimen used for colon cancer.",
      "Leucovorin is a chemotherapy regimen used for colon cancer.",
      "FOLFOX is a chemotherapy regimen used for colon cancer.",
      "CAPEOX is a chemotherapy regimen used for colon cancer."
    ],
    "evidence_relations": "Capecitabine, 5-fluorouracil (5-FU), Leucovorin, FOLFOX, CAPEOX"
  },
  {
    "id": "Medical-6c255c33",
    "source": "Medical",
    "question": "What is the primary cancer type affecting the esophagus?",
    "answer": "Esophageal cancer is the primary type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Esophageal cancer is the primary cancer type affecting the esophagus."
    ],
    "evidence_relations": "Esophageal cancer starts in the inner lining of the esophagus"
  },
  {
    "id": "Medical-04e27815",
    "source": "Medical",
    "question": "Which anatomical sites are included for esophageal cancer in general?",
    "answer": "Esophagus and esophagogastric junction are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Esophagus is included as an anatomical site for esophageal cancer.",
      "Esophagogastric junction is included as an anatomical site for esophageal cancer."
    ],
    "evidence_relations": "Anatomical Location: Esophagus, Esophagogastric junction"
  },
  {
    "id": "Medical-bb0fe530",
    "source": "Medical",
    "question": "What is a precancerous condition for esophageal adenocarcinoma?",
    "answer": "Barrett esophagus is a precancerous condition.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Barrett esophagus is a precancerous condition."
    ],
    "evidence_relations": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-08144fc9",
    "source": "Medical",
    "question": "Which risk factor increases the likelihood of developing esophageal adenocarcinoma?",
    "answer": "Barrett esophagus increases the risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Barrett esophagus increases the risk of developing esophageal adenocarcinoma."
    ],
    "evidence_relations": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma"
  },
  {
    "id": "Medical-fdfcf977",
    "source": "Medical",
    "question": "Which diagnostic methods are involved in esophageal cancer diagnosis?",
    "answer": "Blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used in esophageal cancer diagnosis.",
      "Imaging tests are used in esophageal cancer diagnosis.",
      "Endoscopy is used in esophageal cancer diagnosis.",
      "Biopsy is used in esophageal cancer diagnosis.",
      "Biomarker testing is used in esophageal cancer diagnosis.",
      "Genetic risk testing is used in esophageal cancer diagnosis."
    ],
    "evidence_relations": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-c06a99a5",
    "source": "Medical",
    "question": "What additional assessments are included in esophageal cancer diagnosis beyond imaging and biopsy?",
    "answer": "Nutritional assessment and performance status are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nutritional assessment is included in esophageal cancer diagnosis.",
      "Performance status is included in esophageal cancer diagnosis."
    ],
    "evidence_relations": "Diagnostic Method: Nutritional assessment, Performance status"
  },
  {
    "id": "Medical-5c1a382a",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for esophageal cancer?",
    "answer": "Cancer type, location, stage, and Siewert types (for EGJ tumors) are considered.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cancer type is considered in treatment planning for esophageal cancer.",
      "Location is considered in treatment planning for esophageal cancer.",
      "Stage is considered in treatment planning for esophageal cancer.",
      "Siewert types are considered in treatment planning for esophageal cancer for EGJ tumors."
    ],
    "evidence_relations": "Treatment planning is based on cancer type, location, and stage"
  },
  {
    "id": "Medical-0f576b9d",
    "source": "Medical",
    "question": "Which genetic assessments are part of esophageal cancer diagnosis?",
    "answer": "Biomarker testing and genetic risk testing are part of the diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing is part of the diagnosis for esophageal cancer.",
      "Genetic risk testing is part of the diagnosis for esophageal cancer."
    ],
    "evidence_relations": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-6b811802",
    "source": "Medical",
    "question": "What are the main stages of esophageal cancer described in the ontology?",
    "answer": "Early-stage, locoregional, and metastatic are the main stages.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Early-stage is one of the main stages of esophageal cancer.",
      "Locoregional is one of the main stages of esophageal cancer.",
      "Metastatic is one of the main stages of esophageal cancer."
    ],
    "evidence_relations": "Disease Stage: Early-stage, Locoregional, Metastatic"
  },
  {
    "id": "Medical-21c7cd3c",
    "source": "Medical",
    "question": "How are tumors at the esophagogastric junction staged?",
    "answer": "They are staged using Siewert types.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumors at the esophagogastric junction are staged using Siewert types."
    ],
    "evidence_relations": "Siewert types are used to stage tumors at the esophagogastric junction"
  },
  {
    "id": "Medical-9ba19145",
    "source": "Medical",
    "question": "Which assessments help determine performance status in esophageal cancer patients?",
    "answer": "Performance status assessment is used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status assessment is used to determine performance status in esophageal cancer patients."
    ],
    "evidence_relations": "Diagnostic Method: Performance status"
  },
  {
    "id": "Medical-465ca672",
    "source": "Medical",
    "question": "What is a key factor in planning treatment for esophageal cancer located at the esophagogastric junction?",
    "answer": "Siewert types are a key factor for EGJ tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Siewert types are a key factor in planning treatment for esophageal cancer located at the esophagogastric junction."
    ],
    "evidence_relations": "Treatment Planning: Based on: Siewert types (for EGJ tumors)"
  },
  {
    "id": "Medical-ad0123e9",
    "source": "Medical",
    "question": "What is the main cancer type discussed in this dataset?",
    "answer": "Gray zone lymphoma is the main cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gray zone lymphoma is the main cancer type discussed in this dataset."
    ],
    "evidence_relations": "Gray zone lymphoma is listed as a Cancer Type in the ontology."
  },
  {
    "id": "Medical-87d7f30f",
    "source": "Medical",
    "question": "What are the overlapping features of gray zone lymphomas?",
    "answer": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL).",
      "Gray zone lymphomas have overlapping features of Hodgkin lymphoma (HL)."
    ],
    "evidence_relations": "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-cf8b52e2",
    "source": "Medical",
    "question": "Which histopathological feature is characteristic of MGZL?",
    "answer": "Reed-Sternberg cells are characteristic histopathological features in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Reed-Sternberg cells are characteristic histopathological features in MGZL."
    ],
    "evidence_relations": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-e875d9cd",
    "source": "Medical",
    "question": "What is the recommended initial treatment for MGZL?",
    "answer": "MGZL is usually treated with chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL is usually treated with chemotherapy."
    ],
    "evidence_relations": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-afb11f97",
    "source": "Medical",
    "question": "What type of radiation therapy may be used in localized MGZL?",
    "answer": "Involved-site radiation therapy (ISRT) may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL."
    ],
    "evidence_relations": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-0cbbd549",
    "source": "Medical",
    "question": "What diagnostic method is required for MGZL?",
    "answer": "Diagnosis of MGZL requires expert hematopathologist review.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of MGZL requires expert hematopathologist review."
    ],
    "evidence_relations": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-aed3f61c",
    "source": "Medical",
    "question": "Which age group is most commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals aged 20 to 40 years.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL commonly affects individuals aged 20 to 40 years."
    ],
    "evidence_relations": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-3c1265b5",
    "source": "Medical",
    "question": "Which sex assigned at birth is more commonly affected by MGZL?",
    "answer": "MGZL commonly affects individuals assigned male at birth.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MGZL commonly affects individuals assigned male at birth."
    ],
    "evidence_relations": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
  },
  {
    "id": "Medical-30e1cf9c",
    "source": "Medical",
    "question": "What is a common presenting symptom of MGZL?",
    "answer": "A large mediastinal mass is a common presenting symptom of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A large mediastinal mass is a common presenting symptom of MGZL."
    ],
    "evidence_relations": "MGZL is characterized by a large mediastinal mass"
  },
  {
    "id": "Medical-8a80ec5c",
    "source": "Medical",
    "question": "What is a distinguishing feature of non-mediastinal gray zone lymphomas compared to MGZL?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons.",
      "Non-mediastinal gray zone lymphomas have higher rates of bone marrow involvement.",
      "Non-mediastinal gray zone lymphomas have higher rates of extranodal involvement."
    ],
    "evidence_relations": "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
  },
  {
    "id": "Medical-e9a8741e",
    "source": "Medical",
    "question": "Which sites are more commonly involved in non-mediastinal gray zone lymphomas?",
    "answer": "Bone marrow and extranodal disease are more commonly involved in non-mediastinal gray zone lymphomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone marrow disease is more commonly involved in non-mediastinal gray zone lymphomas.",
      "Extranodal disease is more commonly involved in non-mediastinal gray zone lymphomas."
    ],
    "evidence_relations": "Sites of involvement for non-mediastinal gray zone lymphoma include Bone marrow involvement and Extranodal disease"
  },
  {
    "id": "Medical-60151004",
    "source": "Medical",
    "question": "Which professional is required for the diagnosis of MGZL?",
    "answer": "Expert hematopathologist review is required for diagnosis of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "An expert hematopathologist review is required for the diagnosis of MGZL."
    ],
    "evidence_relations": "Diagnosis of MGZL requires expert hematopathologist review"
  },
  {
    "id": "Medical-1b949b50",
    "source": "Medical",
    "question": "Name two related entities to gray zone lymphoma.",
    "answer": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) are related entities.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary mediastinal B-cell lymphoma (PMBL) is a related entity to gray zone lymphoma.",
      "Hodgkin lymphoma (HL) is a related entity to gray zone lymphoma."
    ],
    "evidence_relations": "Related Entities: Primary mediastinal B-cell lymphoma (PMBL), Hodgkin lymphoma (HL)"
  },
  {
    "id": "Medical-f83e84a2",
    "source": "Medical",
    "question": "What kind of therapy may be considered for MGZL in addition to chemotherapy?",
    "answer": "Chemoimmunotherapy and radiation therapy may be considered for MGZL in addition to chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemoimmunotherapy may be considered for MGZL in addition to chemotherapy.",
      "Radiation therapy may be considered for MGZL in addition to chemotherapy."
    ],
    "evidence_relations": "Treatment for MGZL includes Chemotherapy, Chemoimmunotherapy (Rituximab), and Radiation Therapy (ISRT)"
  },
  {
    "id": "Medical-e84ba674",
    "source": "Medical",
    "question": "Which cells are a histopathological hallmark of MGZL?",
    "answer": "Reed-Sternberg cells are a histopathological hallmark of MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Reed-Sternberg cells are a histopathological hallmark of MGZL."
    ],
    "evidence_relations": "Reed-Sternberg cells are characteristic histopathological features in MGZL"
  },
  {
    "id": "Medical-e7b5ec54",
    "source": "Medical",
    "question": "Which lymphoma is a subtype of gray zone lymphomas?",
    "answer": "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas."
    ],
    "evidence_relations": "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas"
  },
  {
    "id": "Medical-47995a35",
    "source": "Medical",
    "question": "What is the epidemiological profile of non-mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons."
    ],
    "evidence_relations": "Non-mediastinal gray zone lymphomas occur in older persons"
  },
  {
    "id": "Medical-4dcf4539",
    "source": "Medical",
    "question": "Which lymphoma is diagnosed if gray zone lymphoma presents with extra-mediastinal disease?",
    "answer": "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if there is extra-mediastinal disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if gray zone lymphoma presents with extra-mediastinal disease."
    ],
    "evidence_relations": "If extra-mediastinal disease: Diagnose as DLBCL-NOS"
  },
  {
    "id": "Medical-efc035f3",
    "source": "Medical",
    "question": "What is the purpose of involved-site radiation therapy (ISRT) in MGZL?",
    "answer": "ISRT may be added in localized MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL."
    ],
    "evidence_relations": "Involved-site radiation therapy (ISRT) may be added in localized MGZL"
  },
  {
    "id": "Medical-b6d5f2ae",
    "source": "Medical",
    "question": "Which lymph nodes are typically involved in MGZL?",
    "answer": "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL."
    ],
    "evidence_relations": "Sites of involvement for MGZL include Lymph nodes above the collar bone (supraclavicular)"
  },
  {
    "id": "Medical-5f5a35d2",
    "source": "Medical",
    "question": "What is the main diagnostic method for gray zone lymphoma?",
    "answer": "Expert hematopathologist review is the main diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Expert hematopathologist review is the main diagnostic method for gray zone lymphoma."
    ],
    "evidence_relations": "Diagnostic Method for MGZL: Expert hematopathologist review"
  },
  {
    "id": "Medical-5a4056c3",
    "source": "Medical",
    "question": "Name two cancer types related to gray zone lymphoma.",
    "answer": "Classical Hodgkin lymphoma (CHL) and Non-Hodgkin lymphoma are related to gray zone lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Classical Hodgkin lymphoma (CHL) is related to gray zone lymphoma.",
      "Non-Hodgkin lymphoma is related to gray zone lymphoma."
    ],
    "evidence_relations": "Related Entities: Classical Hodgkin lymphoma (CHL), Non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-b4916c72",
    "source": "Medical",
    "question": "What is the standard chemotherapy regimen for MGZL?",
    "answer": "Chemotherapy is the standard treatment for MGZL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy is the standard treatment for MGZL."
    ],
    "evidence_relations": "MGZL is usually treated with chemotherapy"
  },
  {
    "id": "Medical-14497bbd",
    "source": "Medical",
    "question": "What is the primary diagnostic method for cervical cancer?",
    "answer": "Cervical biopsy is the primary diagnostic method.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cervical biopsy is the primary diagnostic method for cervical cancer."
    ],
    "evidence_relations": "Cervical biopsy is the primary diagnostic method for cervical cancer"
  },
  {
    "id": "Medical-29a726a3",
    "source": "Medical",
    "question": "What system is used to stage cervical cancer?",
    "answer": "The FIGO system is used to stage cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The FIGO system is used to stage cervical cancer."
    ],
    "evidence_relations": "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages)"
  },
  {
    "id": "Medical-4262873a",
    "source": "Medical",
    "question": "Which surgical procedure can be both diagnostic and therapeutic for early-stage cervical cancer?",
    "answer": "Cone biopsy can be both diagnostic and therapeutic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cone biopsy can be both diagnostic for early-stage cervical cancer.",
      "Cone biopsy can be therapeutic for early-stage cervical cancer."
    ],
    "evidence_relations": "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer"
  },
  {
    "id": "Medical-bb870733",
    "source": "Medical",
    "question": "Which fertility-sparing surgical option is available for selected early-stage cervical cancer cases?",
    "answer": "Trachelectomy is an option for selected early-stage cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Trachelectomy is a fertility-sparing surgical option.",
      "Trachelectomy is available for selected early-stage cervical cancer cases."
    ],
    "evidence_relations": "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases"
  },
  {
    "id": "Medical-e8a07389",
    "source": "Medical",
    "question": "Which radiation therapies are used for local control in cervical cancer?",
    "answer": "External beam radiation therapy (EBRT) and brachytherapy are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "External beam radiation therapy (EBRT) is used for local control in cervical cancer.",
      "Brachytherapy is used for local control in cervical cancer."
    ],
    "evidence_relations": "External beam radiation therapy (EBRT) and brachytherapy are used for local control"
  },
  {
    "id": "Medical-a41f7cdf",
    "source": "Medical",
    "question": "Which systemic therapy options are available for cervical cancer?",
    "answer": "Platinum-based chemotherapy, targeted therapy, and immunotherapy are options.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Platinum-based chemotherapy is an option for cervical cancer.",
      "Targeted therapy is an option for cervical cancer.",
      "Immunotherapy is an option for cervical cancer."
    ],
    "evidence_relations": "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy"
  },
  {
    "id": "Medical-e3419109",
    "source": "Medical",
    "question": "Which biomarker testing is recommended for recurrent or metastatic cervical cancer?",
    "answer": "Biomarker testing for PD-L1, MSI, TMB, MMR, HER2, RET, and NTRK is recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing for PD-L1 is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for MSI is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for TMB is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for MMR is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for HER2 is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for RET is recommended for recurrent or metastatic cervical cancer.",
      "Biomarker testing for NTRK is recommended for recurrent or metastatic cervical cancer."
    ],
    "evidence_relations": "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer"
  },
  {
    "id": "Medical-bc97fb7b",
    "source": "Medical",
    "question": "What biomarker guides the use of pembrolizumab in cervical cancer?",
    "answer": "PD-L1 positivity guides the use of pembrolizumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-L1 positivity guides the use of pembrolizumab in cervical cancer."
    ],
    "evidence_relations": "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)"
  },
  {
    "id": "Medical-5c0cc4b2",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy for metastatic cervical cancer?",
    "answer": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bevacizumab may be added to chemotherapy for metastatic cervical cancer."
    ],
    "evidence_relations": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer"
  },
  {
    "id": "Medical-2bbad791",
    "source": "Medical",
    "question": "Which factors increase the risk of cervical cancer?",
    "answer": "HPV infection, smoking, immunosuppression, and HIV increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV infection increases the risk of cervical cancer.",
      "Smoking increases the risk of cervical cancer.",
      "Immunosuppression increases the risk of cervical cancer.",
      "HIV increases the risk of cervical cancer."
    ],
    "evidence_relations": "Risk factors include HPV infection, smoking, immunosuppression (e.g., HIV infection)"
  },
  {
    "id": "Medical-15dda38d",
    "source": "Medical",
    "question": "How does smoking affect cervical cancer risk?",
    "answer": "Smoking increases the risk of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Smoking increases the risk of cervical cancer."
    ],
    "evidence_relations": "Smoking increases the risk of cervical cancer"
  },
  {
    "id": "Medical-788a228f",
    "source": "Medical",
    "question": "How does immunosuppression, such as HIV infection, affect cervical cancer risk?",
    "answer": "Immunosuppression increases the risk of cervical cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunosuppression increases the risk of cervical cancer."
    ],
    "evidence_relations": "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer"
  },
  {
    "id": "Medical-c6f1ea93",
    "source": "Medical",
    "question": "What is the main purpose of surveillance after cervical cancer treatment?",
    "answer": "Surveillance includes regular physical exams and imaging as indicated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance includes regular physical exams.",
      "Surveillance includes imaging as indicated."
    ],
    "evidence_relations": "Surveillance after treatment includes regular physical exams and imaging as indicated"
  },
  {
    "id": "Medical-d6b9a73e",
    "source": "Medical",
    "question": "What effect does smoking cessation have on treatment outcomes in cervical cancer?",
    "answer": "Smoking cessation improves treatment outcomes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Smoking cessation improves treatment outcomes in cervical cancer."
    ],
    "evidence_relations": "Smoking cessation improves treatment outcomes"
  },
  {
    "id": "Medical-5eeca870",
    "source": "Medical",
    "question": "Which physical examination methods are included in the diagnostic process for cervical cancer?",
    "answer": "Physical exam, cystoscopy, and proctoscopy are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Physical examination methods for cervical cancer include physical exam.",
      "Physical examination methods for cervical cancer include cystoscopy.",
      "Physical examination methods for cervical cancer include proctoscopy."
    ],
    "evidence_relations": "Other diagnostic methods include cystoscopy, proctoscopy, and physical exam"
  },
  {
    "id": "Medical-c6e9519c",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in cervical cancer for biomarker testing?",
    "answer": "Relevant genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, and NTRK fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Relevant genetic alterations for cervical cancer biomarker testing include PD-L1 positivity.",
      "Relevant genetic alterations for cervical cancer biomarker testing include MSI-H.",
      "Relevant genetic alterations for cervical cancer biomarker testing include dMMR.",
      "Relevant genetic alterations for cervical cancer biomarker testing include TMB-H.",
      "Relevant genetic alterations for cervical cancer biomarker testing include HER2 amplification.",
      "Relevant genetic alterations for cervical cancer biomarker testing include RET fusion.",
      "Relevant genetic alterations for cervical cancer biomarker testing include NTRK fusion."
    ],
    "evidence_relations": "Genetic alterations include PD-L1 positivity, MSI-H, dMMR, TMB-H, HER2 amplification, RET fusion, NTRK fusion"
  },
  {
    "id": "Medical-bc603db5",
    "source": "Medical",
    "question": "What is a rare subtype of Hodgkin lymphoma?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma."
    ],
    "evidence_relations": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma"
  },
  {
    "id": "Medical-d81ad4db",
    "source": "Medical",
    "question": "Which cell type is characteristic of NLPHL?",
    "answer": "NLPHL is characterized by popcorn-shaped cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is characterized by popcorn-shaped cells."
    ],
    "evidence_relations": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-41eb01ac",
    "source": "Medical",
    "question": "Into which disease can NLPHL transform?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-620a1582",
    "source": "Medical",
    "question": "What is the primary diagnostic method for Hodgkin lymphoma?",
    "answer": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary diagnostic method for Hodgkin lymphoma is excisional lymph node biopsy."
    ],
    "evidence_relations": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy"
  },
  {
    "id": "Medical-45b14e2d",
    "source": "Medical",
    "question": "Which biopsy method may be used for Hodgkin lymphoma diagnosis in some cases?",
    "answer": "Core needle biopsy may be used for diagnosis in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Core needle biopsy may be used for Hodgkin lymphoma diagnosis in some cases."
    ],
    "evidence_relations": "Core needle biopsy may be used for diagnosis in some cases"
  },
  {
    "id": "Medical-d3a58aef",
    "source": "Medical",
    "question": "Which diagnostic procedures are part of the initial workup for Hodgkin lymphoma?",
    "answer": "Health history and physical exam are part of the diagnostic process.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Health history is part of the diagnostic process for Hodgkin lymphoma.",
      "Physical exam is part of the diagnostic process for Hodgkin lymphoma."
    ],
    "evidence_relations": "Health history and physical exam are part of the diagnostic process"
  },
  {
    "id": "Medical-49e5ee6e",
    "source": "Medical",
    "question": "What laboratory and imaging tests are used in the diagnostic workup for Hodgkin lymphoma?",
    "answer": "Blood tests and imaging tests are used in the diagnostic workup.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used in the diagnostic workup for Hodgkin lymphoma.",
      "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-9b5a2b0a",
    "source": "Medical",
    "question": "Which two biopsy methods are listed for diagnosing CHL?",
    "answer": "Excisional lymph node biopsy and core needle biopsy are listed for CHL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Excisional lymph node biopsy is listed for diagnosing CHL.",
      "Core needle biopsy is listed for diagnosing CHL."
    ],
    "evidence_relations": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy"
  },
  {
    "id": "Medical-8f34d47a",
    "source": "Medical",
    "question": "What cell type is associated with NLPHL according to the ontology?",
    "answer": "Popcorn-shaped cells are associated with NLPHL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Popcorn-shaped cells are associated with NLPHL."
    ],
    "evidence_relations": "Cell Type: popcorn-shaped cells"
  },
  {
    "id": "Medical-54f18ca7",
    "source": "Medical",
    "question": "Which diagnostic methods are common to both CHL and NLPHL?",
    "answer": "Excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests are common to both.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Excisional lymph node biopsy is a common diagnostic method for both CHL and NLPHL.",
      "Core needle biopsy is a common diagnostic method for both CHL and NLPHL.",
      "Health history is a common diagnostic method for both CHL and NLPHL.",
      "Physical exam is a common diagnostic method for both CHL and NLPHL.",
      "Blood tests are a common diagnostic method for both CHL and NLPHL.",
      "Imaging tests are a common diagnostic method for both CHL and NLPHL."
    ],
    "evidence_relations": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests"
  },
  {
    "id": "Medical-e9c535e5",
    "source": "Medical",
    "question": "What disease transformation is noted for NLPHL?",
    "answer": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "Disease Transformation: diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-9d5ac399",
    "source": "Medical",
    "question": "What is the main cell type that distinguishes NLPHL from CHL?",
    "answer": "Popcorn-shaped cells distinguish NLPHL from CHL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Popcorn-shaped cells distinguish NLPHL from CHL."
    ],
    "evidence_relations": "NLPHL is characterized by popcorn-shaped cells"
  },
  {
    "id": "Medical-1b774745",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is rare according to the relations?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is rare.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype."
    ],
    "evidence_relations": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma"
  },
  {
    "id": "Medical-3306e2b6",
    "source": "Medical",
    "question": "What is the role of blood tests in Hodgkin lymphoma diagnosis?",
    "answer": "Blood tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-15c48832",
    "source": "Medical",
    "question": "Which imaging techniques are part of the diagnostic methods for Hodgkin lymphoma?",
    "answer": "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are used in the diagnostic workup for Hodgkin lymphoma."
    ],
    "evidence_relations": "Blood tests and imaging tests are used in the diagnostic workup"
  },
  {
    "id": "Medical-c8e42c69",
    "source": "Medical",
    "question": "What are the main cancer types associated with the gallbladder and bile ducts?",
    "answer": "Intrahepatic bile duct cancer is a main cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intrahepatic bile duct cancer is a main cancer type associated with the gallbladder and bile ducts."
    ],
    "evidence_relations": "intrahepatic bile duct cancer"
  },
  {
    "id": "Medical-0e5e7e44",
    "source": "Medical",
    "question": "Which anatomical structures are covered by a thin, moist epithelial layer?",
    "answer": "The gallbladder and bile ducts are covered by a thin, moist epithelial layer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The gallbladder is covered by a thin, moist epithelial layer.",
      "The bile ducts are covered by a thin, moist epithelial layer."
    ],
    "evidence_relations": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer"
  },
  {
    "id": "Medical-a0ee92b3",
    "source": "Medical",
    "question": "What is the outermost membrane covering the gallbladder and bile ducts?",
    "answer": "Serosa is the outer membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Serosa is the outer membrane covering the gallbladder.",
      "Serosa is the outer membrane covering the bile ducts."
    ],
    "evidence_relations": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-aa283616",
    "source": "Medical",
    "question": "What histological layers are found in the bile duct wall?",
    "answer": "The bile duct wall contains epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The bile duct wall contains epithelium.",
      "The bile duct wall contains lamina propria.",
      "The bile duct wall contains muscularis.",
      "The bile duct wall contains perimuscular fibrous tissue.",
      "The bile duct wall contains serosa."
    ],
    "evidence_relations": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-7d67a49f",
    "source": "Medical",
    "question": "What is the function of the muscularis layer in the bile duct wall?",
    "answer": "Muscularis is a soft tissue layer in the bile duct wall.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Muscularis is a soft tissue layer in the bile duct wall."
    ],
    "evidence_relations": "Muscularis is a soft tissue layer in the bile duct wall"
  },
  {
    "id": "Medical-0535a6b1",
    "source": "Medical",
    "question": "What tissue surrounds the muscle layer in the bile duct and gallbladder?",
    "answer": "Perimuscular fibrous tissue surrounds the muscle layer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perimuscular fibrous tissue surrounds the muscle layer in the bile duct.",
      "Perimuscular fibrous tissue surrounds the muscle layer in the gallbladder."
    ],
    "evidence_relations": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-ebc2ff97",
    "source": "Medical",
    "question": "Which structures can bile duct cancer invade as it progresses?",
    "answer": "Cancer can invade nearby blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bile duct cancer can invade nearby blood vessels.",
      "Bile duct cancer can invade the liver.",
      "Bile duct cancer can invade structures outside the liver."
    ],
    "evidence_relations": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-5c7974c9",
    "source": "Medical",
    "question": "Which layer directly covers the muscularis in the gallbladder and bile duct?",
    "answer": "Perimuscular fibrous tissue directly covers the muscularis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Perimuscular fibrous tissue directly covers the muscularis in the gallbladder.",
      "Perimuscular fibrous tissue directly covers the muscularis in the bile duct."
    ],
    "evidence_relations": "Perimuscular fibrous tissue surrounds the muscle layer"
  },
  {
    "id": "Medical-d8aa135d",
    "source": "Medical",
    "question": "What is the primary tumor characteristic used for staging bile duct cancer?",
    "answer": "Primary tumor size and extent of spread are used for staging.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary tumor size is used for staging bile duct cancer.",
      "Extent of spread is used for staging bile duct cancer."
    ],
    "evidence_relations": "Bile duct cancer staging is based on tumor size and extent of spread"
  },
  {
    "id": "Medical-d465de28",
    "source": "Medical",
    "question": "Which layer is the innermost lining of the gallbladder and bile ducts?",
    "answer": "The epithelium is the innermost lining.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The epithelium is the innermost lining of the gallbladder.",
      "The epithelium is the innermost lining of the bile ducts."
    ],
    "evidence_relations": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer"
  },
  {
    "id": "Medical-651ea4b6",
    "source": "Medical",
    "question": "What is the relationship between lamina propria and the epithelium in these cancers?",
    "answer": "Lamina propria is a connective tissue found under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lamina propria is a connective tissue.",
      "Lamina propria is found under the epithelium."
    ],
    "evidence_relations": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-340cdb40",
    "source": "Medical",
    "question": "What are examples of tumor spread in intrahepatic bile duct cancer?",
    "answer": "Tumor can spread to blood vessels, liver, or structures outside the liver.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor can spread to blood vessels.",
      "Tumor can spread to the liver.",
      "Tumor can spread to structures outside the liver."
    ],
    "evidence_relations": "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
  },
  {
    "id": "Medical-d70b14a4",
    "source": "Medical",
    "question": "Which anatomical structures are included in the ontology for intrahepatic bile duct cancer?",
    "answer": "Bile duct and gallbladder are included as anatomical structures.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bile duct is included as an anatomical structure for intrahepatic bile duct cancer.",
      "Gallbladder is included as an anatomical structure for intrahepatic bile duct cancer."
    ],
    "evidence_relations": "Anatomical Structure: bile duct, gallbladder"
  },
  {
    "id": "Medical-2ebac5e5",
    "source": "Medical",
    "question": "Which tumor characteristic involves the measurement in centimeters or millimeters?",
    "answer": "Primary tumor size (cm or mm) is a tumor characteristic.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary tumor size is a tumor characteristic.",
      "Primary tumor size is measured in centimeters or millimeters."
    ],
    "evidence_relations": "Tumor Characteristic: primary tumor size (cm or mm)"
  },
  {
    "id": "Medical-c663d954",
    "source": "Medical",
    "question": "Which histological layer provides structural support under the epithelium?",
    "answer": "Lamina propria provides structural support under the epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lamina propria provides structural support under the epithelium."
    ],
    "evidence_relations": "Lamina propria is a connective tissue found under the epithelium"
  },
  {
    "id": "Medical-af5dbcb0",
    "source": "Medical",
    "question": "What anatomical layers must a tumor penetrate to reach the serosa in the bile duct?",
    "answer": "A tumor must penetrate the epithelium, lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A tumor must penetrate the epithelium to reach the serosa.",
      "A tumor must penetrate the lamina propria to reach the serosa.",
      "A tumor must penetrate the muscularis to reach the serosa.",
      "A tumor must penetrate the perimuscular fibrous tissue to reach the serosa."
    ],
    "evidence_relations": "bile duct has Histological Layer: epithelium, lamina propria, muscularis, perimuscular fibrous tissue, serosa"
  },
  {
    "id": "Medical-e79c55d4",
    "source": "Medical",
    "question": "Which layer is described as a membrane in the anatomical structure of the gallbladder and bile ducts?",
    "answer": "Serosa is described as a membrane covering the gallbladder and bile ducts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Serosa is described as a membrane.",
      "Serosa covers the gallbladder.",
      "Serosa covers the bile ducts."
    ],
    "evidence_relations": "Serosa is the outer membrane covering the gallbladder and bile ducts"
  },
  {
    "id": "Medical-e4d47909",
    "source": "Medical",
    "question": "What type of lymphoma is follicular lymphoma (FL)?",
    "answer": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma."
    ],
    "evidence_relations": "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma"
  },
  {
    "id": "Medical-49d93af8",
    "source": "Medical",
    "question": "How is follicular lymphoma (FL) graded?",
    "answer": "FL is graded based on the proportion of centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follicular lymphoma (FL) is graded based on the proportion of centrocytes.",
      "Follicular lymphoma (FL) is graded based on the proportion of centroblasts."
    ],
    "evidence_relations": "FL is graded based on the proportion of centrocytes and centroblasts"
  },
  {
    "id": "Medical-7ed82690",
    "source": "Medical",
    "question": "How is grade 3B follicular lymphoma treated?",
    "answer": "Grade 3B FL is treated as diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Grade 3B follicular lymphoma is treated as diffuse large B-cell lymphoma."
    ],
    "evidence_relations": "Grade 3B FL is treated as DLBCL"
  },
  {
    "id": "Medical-4be4d916",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in uncommon FL (uFL)?",
    "answer": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is t(14;18)-negative.",
      "Uncommon follicular lymphoma has uncommon pathologic features."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features"
  },
  {
    "id": "Medical-2e05b3f3",
    "source": "Medical",
    "question": "How is uncommon FL (uFL) treated?",
    "answer": "Uncommon FL (uFL) is treated as classic FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is treated as classic follicular lymphoma."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL"
  },
  {
    "id": "Medical-f3e4ed65",
    "source": "Medical",
    "question": "What is the typical presentation of pediatric-type follicular lymphoma (PTFL)?",
    "answer": "PTFL usually presents with a single enlarged lymph node in the head and neck and minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pediatric-type follicular lymphoma usually presents with a single enlarged lymph node.",
      "The single enlarged lymph node in pediatric-type follicular lymphoma is located in the head and neck.",
      "Pediatric-type follicular lymphoma usually presents with minimal symptoms."
    ],
    "evidence_relations": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-0ab293c2",
    "source": "Medical",
    "question": "Which diagnostic methods are used for follicular lymphoma (FL)?",
    "answer": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of follicular lymphoma involves blood tests.",
      "Diagnosis of follicular lymphoma involves bone marrow aspirate and biopsy.",
      "Diagnosis of follicular lymphoma involves imaging studies.",
      "Diagnosis of follicular lymphoma involves immunophenotyping."
    ],
    "evidence_relations": "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping"
  },
  {
    "id": "Medical-2d90241b",
    "source": "Medical",
    "question": "What are common symptoms of follicular lymphoma (FL)?",
    "answer": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of follicular lymphoma include swollen lymph nodes.",
      "Common symptoms of follicular lymphoma include enlarged spleen.",
      "Common symptoms of follicular lymphoma include fever.",
      "Common symptoms of follicular lymphoma include night sweats.",
      "Common symptoms of follicular lymphoma include fatigue.",
      "Common symptoms of follicular lymphoma include weight loss."
    ],
    "evidence_relations": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-44af5ecf",
    "source": "Medical",
    "question": "What guides treatment decisions in follicular lymphoma (FL)?",
    "answer": "The type of cells in FL determines the grade, which guides treatment decisions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The type of cells in follicular lymphoma determines the grade.",
      "The grade of follicular lymphoma guides treatment decisions."
    ],
    "evidence_relations": "The type of cells in FL determines the grade, which guides treatment decisions"
  },
  {
    "id": "Medical-9b28edf9",
    "source": "Medical",
    "question": "What are the main cell types found in follicular lymphoma (FL)?",
    "answer": "The main cell types in FL are centrocytes and centroblasts.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The main cell types in follicular lymphoma are centrocytes.",
      "The main cell types in follicular lymphoma are centroblasts."
    ],
    "evidence_relations": "FL is graded based on the proportion of centrocytes and centroblasts"
  },
  {
    "id": "Medical-bf9805af",
    "source": "Medical",
    "question": "What genetic alteration is associated with FL besides t(14;18)?",
    "answer": "Chromosome translocation is associated with FL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chromosome translocation is associated with follicular lymphoma."
    ],
    "evidence_relations": "Genetic Alteration: chromosome translocation"
  },
  {
    "id": "Medical-9410dd14",
    "source": "Medical",
    "question": "Which FL subtype is defined by t(14;18)-negativity?",
    "answer": "Uncommon FL (uFL) is defined by t(14;18)-negativity.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Uncommon follicular lymphoma is defined by t(14;18)-negativity."
    ],
    "evidence_relations": "Uncommon FL (uFL) is t(14;18)-negative"
  },
  {
    "id": "Medical-2876eea3",
    "source": "Medical",
    "question": "What is the classification of grade 3A FL?",
    "answer": "Grade 3A FL may be classified as classic FL or as DLBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Grade 3A follicular lymphoma may be classified as classic follicular lymphoma.",
      "Grade 3A follicular lymphoma may be classified as DLBCL."
    ],
    "evidence_relations": "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)"
  },
  {
    "id": "Medical-43e5c06b",
    "source": "Medical",
    "question": "Which FL subtype is associated with minimal symptoms?",
    "answer": "Pediatric-type FL (PTFL) is associated with minimal symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pediatric-type follicular lymphoma is associated with minimal symptoms."
    ],
    "evidence_relations": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms"
  },
  {
    "id": "Medical-08098847",
    "source": "Medical",
    "question": "What is the main clinical management consideration for FL?",
    "answer": "Not all patients with FL require immediate treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Not all patients with FL require immediate treatment."
    ],
    "evidence_relations": "Not all patients with FL require immediate treatment"
  },
  {
    "id": "Medical-3fb59b05",
    "source": "Medical",
    "question": "What is the disease site for extranodal FL?",
    "answer": "Extranodal FL occurs in tissues outside the lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Extranodal FL occurs in tissues outside the lymph nodes."
    ],
    "evidence_relations": "FL can present as nodal or extranodal disease"
  },
  {
    "id": "Medical-cd57cf13",
    "source": "Medical",
    "question": "Which lymphoma subtype can FL transform into?",
    "answer": "FL can transform into diffuse large B-cell lymphoma (DLBCL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "FL can transform into diffuse large B-cell lymphoma (DLBCL)."
    ],
    "evidence_relations": "FL can transform into DLBCL, a more aggressive lymphoma"
  },
  {
    "id": "Medical-ffc96616",
    "source": "Medical",
    "question": "Which organ is commonly enlarged in FL patients?",
    "answer": "The spleen is commonly enlarged in FL patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The spleen is commonly enlarged in FL patients."
    ],
    "evidence_relations": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
  },
  {
    "id": "Medical-33eeb504",
    "source": "Medical",
    "question": "How does chronic hepatitis C infection affect liver cancer risk?",
    "answer": "Chronic hepatitis C infection increases the risk of liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chronic hepatitis C infection increases the risk of liver cancer."
    ],
    "evidence_relations": "Chronic hepatitis C infection increases the risk of liver cancer"
  },
  {
    "id": "Medical-b73b866c",
    "source": "Medical",
    "question": "Who should undergo screening for liver cancer?",
    "answer": "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Screening for liver cancer is recommended for individuals with cirrhosis.",
      "Screening for liver cancer is recommended for individuals with chronic hepatitis B."
    ],
    "evidence_relations": "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B"
  },
  {
    "id": "Medical-0c921721",
    "source": "Medical",
    "question": "What screening methods are used for liver cancer?",
    "answer": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Liver cancer screening includes ultrasound.",
      "Liver cancer screening includes alpha-fetoprotein (AFP) test.",
      "Liver cancer screening is done every 6 months."
    ],
    "evidence_relations": "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
  },
  {
    "id": "Medical-7e444f04",
    "source": "Medical",
    "question": "Which biomarker may indicate primary liver cancer?",
    "answer": "Elevated alpha-fetoprotein (AFP) may indicate primary liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Elevated alpha-fetoprotein (AFP) may indicate primary liver cancer."
    ],
    "evidence_relations": "Elevated AFP may indicate primary liver cancer"
  },
  {
    "id": "Medical-4329a9ca",
    "source": "Medical",
    "question": "What tests are usually used to confirm the diagnosis of liver cancer?",
    "answer": "Diagnosis of liver cancer is usually confirmed with imaging tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of liver cancer is usually confirmed with imaging tests."
    ],
    "evidence_relations": "Diagnosis of liver cancer is usually confirmed with imaging tests"
  },
  {
    "id": "Medical-aece5feb",
    "source": "Medical",
    "question": "Which genetic alteration is a risk factor for liver cancer?",
    "answer": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic hemochromatosis is a risk factor for cirrhosis.",
      "Genetic hemochromatosis is a risk factor for liver cancer."
    ],
    "evidence_relations": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer"
  },
  {
    "id": "Medical-3c025533",
    "source": "Medical",
    "question": "Which diagnostic methods are listed for liver cancer in the ontology?",
    "answer": "Imaging tests and biopsy are diagnostic methods for liver cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are diagnostic methods for liver cancer.",
      "Biopsy is a diagnostic method for liver cancer."
    ],
    "evidence_relations": "Diagnosis of liver cancer is usually confirmed with imaging tests; Biopsy may be needed to confirm liver cancer"
  },
  {
    "id": "Medical-9671d373",
    "source": "Medical",
    "question": "What is another name for oncocytic carcinoma?",
    "answer": "Oncocytic carcinoma is also known as Hrthle cell carcinoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Oncocytic carcinoma is also known as Hrthle cell carcinoma."
    ],
    "evidence_relations": "Oncocytic carcinoma is also known as Hrthle cell carcinoma"
  },
  {
    "id": "Medical-63709f72",
    "source": "Medical",
    "question": "Which thyroid cancer subtype is the rarest and most aggressive?",
    "answer": "Anaplastic thyroid cancer is the most aggressive and rarest subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Anaplastic thyroid cancer is the rarest subtype of thyroid cancer.",
      "Anaplastic thyroid cancer is the most aggressive subtype of thyroid cancer."
    ],
    "evidence_relations": "Anaplastic thyroid cancer is the most aggressive and rarest subtype"
  },
  {
    "id": "Medical-1068c5b7",
    "source": "Medical",
    "question": "Which inherited syndromes are linked to increased thyroid cancer risk?",
    "answer": "FAP, Carney complex, Cowden syndrome, and MEN are inherited syndromes linked to increased thyroid cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "FAP is an inherited syndrome linked to increased thyroid cancer risk.",
      "Carney complex is an inherited syndrome linked to increased thyroid cancer risk.",
      "Cowden syndrome is an inherited syndrome linked to increased thyroid cancer risk.",
      "MEN is an inherited syndrome linked to increased thyroid cancer risk."
    ],
    "evidence_relations": "Family history and inherited syndromes (FAP, Carney complex, Cowden syndrome, MEN) increase risk"
  },
  {
    "id": "Medical-bedfa4d0",
    "source": "Medical",
    "question": "What is the main treatment for most thyroid cancers?",
    "answer": "Surgery is the main treatment for most thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgery is the main treatment for most thyroid cancers."
    ],
    "evidence_relations": "Surgery is the main treatment for most thyroid cancers"
  },
  {
    "id": "Medical-06892ea0",
    "source": "Medical",
    "question": "When is lobectomy considered for thyroid cancer?",
    "answer": "Lobectomy is an option for small, low-risk differentiated thyroid cancers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lobectomy is considered for small, low-risk differentiated thyroid cancers."
    ],
    "evidence_relations": "Lobectomy is an option for small, low-risk differentiated thyroid cancers"
  },
  {
    "id": "Medical-d5a2a39b",
    "source": "Medical",
    "question": "What additional surgical procedure is performed if lymph nodes are involved in thyroid cancer?",
    "answer": "Neck dissection is performed if lymph nodes are involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Neck dissection is performed if lymph nodes are involved in thyroid cancer."
    ],
    "evidence_relations": "Neck dissection is performed if lymph nodes are involved"
  },
  {
    "id": "Medical-5a111bc2",
    "source": "Medical",
    "question": "What therapy is required after total thyroidectomy?",
    "answer": "Thyroid hormone replacement therapy is required after total thyroidectomy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Thyroid hormone replacement therapy is required after total thyroidectomy."
    ],
    "evidence_relations": "Thyroid hormone replacement therapy is required after total thyroidectomy"
  },
  {
    "id": "Medical-2e96fdbb",
    "source": "Medical",
    "question": "What is the standard medication for thyroid hormone replacement?",
    "answer": "Levothyroxine is the standard thyroid hormone replacement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Levothyroxine is the standard thyroid hormone replacement."
    ],
    "evidence_relations": "Levothyroxine is the standard thyroid hormone replacement"
  },
  {
    "id": "Medical-130e07e9",
    "source": "Medical",
    "question": "When is targeted therapy indicated in thyroid cancer?",
    "answer": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Targeted therapy is used for thyroid cancers not responsive to surgery.",
      "Targeted therapy is used for thyroid cancers not responsive to RAI.",
      "Targeted therapy is used for thyroid cancers with metastasis."
    ],
    "evidence_relations": "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis"
  },
  {
    "id": "Medical-7e564d1e",
    "source": "Medical",
    "question": "Which targeted therapies are used for progressive, unresectable, or metastatic thyroid cancer?",
    "answer": "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lenvatinib is a targeted therapy for progressive thyroid cancer.",
      "Sorafenib is a targeted therapy for unresectable thyroid cancer.",
      "Cabozantinib is a targeted therapy for metastatic thyroid cancer."
    ],
    "evidence_relations": "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer"
  },
  {
    "id": "Medical-dc537cd7",
    "source": "Medical",
    "question": "What is the role of chemotherapy in thyroid cancer?",
    "answer": "Chemotherapy is rarely effective and mainly used for anaplastic thyroid cancer with radiation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy is rarely effective in thyroid cancer.",
      "Chemotherapy is mainly used for anaplastic thyroid cancer with radiation."
    ],
    "evidence_relations": "Chemotherapy is rarely effective, mainly used for anaplastic thyroid cancer with radiation"
  },
  {
    "id": "Medical-8a22c205",
    "source": "Medical",
    "question": "What follow-up is recommended after total thyroidectomy?",
    "answer": "Follow-up after total thyroidectomy includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up after total thyroidectomy includes a physical exam.",
      "Follow-up after total thyroidectomy includes blood tests for TSH.",
      "Follow-up after total thyroidectomy includes blood tests for Tg.",
      "Follow-up after total thyroidectomy includes blood tests for Tg ab.",
      "Follow-up after total thyroidectomy includes a neck ultrasound."
    ],
    "evidence_relations": "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound"
  },
  {
    "id": "Medical-0ad1bc85",
    "source": "Medical",
    "question": "What may rising thyroglobulin after thyroidectomy indicate?",
    "answer": "Rising thyroglobulin after thyroidectomy may indicate recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Rising thyroglobulin after thyroidectomy may indicate recurrence."
    ],
    "evidence_relations": "Rising thyroglobulin after thyroidectomy may indicate recurrence"
  },
  {
    "id": "Medical-880faffb",
    "source": "Medical",
    "question": "What laboratory tests are included in the follow-up of thyroid cancer?",
    "answer": "Laboratory tests include TSH, thyroglobulin (Tg), and anti-thyroglobulin antibodies (Tg ab).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Laboratory tests include TSH.",
      "Laboratory tests include thyroglobulin (Tg).",
      "Laboratory tests include anti-thyroglobulin antibodies (Tg ab)."
    ],
    "evidence_relations": "Laboratory: [\"TSH test\", \"Thyroglobulin (Tg)\", \"Anti-thyroglobulin antibodies (Tg ab)\"]"
  },
  {
    "id": "Medical-f944ae15",
    "source": "Medical",
    "question": "Which imaging methods are used for thyroid cancer diagnosis?",
    "answer": "Imaging methods include ultrasound, neck ultrasound, CT scan, MRI, and whole-body RAI scan.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging methods include ultrasound.",
      "Imaging methods include neck ultrasound.",
      "Imaging methods include CT scan.",
      "Imaging methods include MRI.",
      "Imaging methods include whole-body RAI scan."
    ],
    "evidence_relations": "Imaging: [\"Ultrasound\", \"Neck ultrasound\", \"CT scan\", \"MRI\", \"Whole-body RAI scan\"]"
  },
  {
    "id": "Medical-666afa8e",
    "source": "Medical",
    "question": "What is the purpose of molecular tests in thyroid cancer diagnosis?",
    "answer": "Molecular tests can help determine malignancy and need for surgery.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Molecular tests can help determine malignancy.",
      "Molecular tests can help determine the need for surgery."
    ],
    "evidence_relations": "Molecular tests can help determine malignancy and need for surgery"
  },
  {
    "id": "Medical-35f5fbd3",
    "source": "Medical",
    "question": "Which gene mutations are considered actionable biomarkers in thyroid cancer?",
    "answer": "Actionable biomarkers include BRAF gene mutation, RET gene fusion, ALK gene fusion, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Actionable biomarkers in thyroid cancer include BRAF gene mutation.",
      "Actionable biomarkers in thyroid cancer include RET gene fusion.",
      "Actionable biomarkers in thyroid cancer include ALK gene fusion.",
      "Actionable biomarkers in thyroid cancer include NTRK gene fusion."
    ],
    "evidence_relations": "Biomarker: [\"BRAF gene mutation\", \"RET gene fusion\", \"ALK gene fusion\", \"NTRK gene fusion\"]"
  },
  {
    "id": "Medical-f8d40959",
    "source": "Medical",
    "question": "What is the primary method for detecting recurrence in thyroid cancer?",
    "answer": "Detection of recurrence is primarily by rising thyroglobulin, neck ultrasound, and imaging (CT, MRI).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary method for detecting recurrence in thyroid cancer is rising thyroglobulin.",
      "Neck ultrasound is a method for detecting recurrence in thyroid cancer.",
      "Imaging methods such as CT and MRI are used to detect recurrence in thyroid cancer."
    ],
    "evidence_relations": "Recurrence: {\"Detection\": [\"Rising thyroglobulin\", \"Neck ultrasound\", \"Imaging (CT, MRI)\"]}"
  },
  {
    "id": "Medical-0cac50ed",
    "source": "Medical",
    "question": "What is the characteristic genetic alteration in Ewing sarcoma?",
    "answer": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions.",
      "The most common gene fusion in Ewing sarcoma is EWSR1-FLI1."
    ],
    "evidence_relations": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1"
  },
  {
    "id": "Medical-122b1d5d",
    "source": "Medical",
    "question": "Which bone cancer subtype starts in cartilage-forming cells?",
    "answer": "Chondrosarcoma starts in cartilage-forming cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chondrosarcoma starts in cartilage-forming cells."
    ],
    "evidence_relations": "Chondrosarcoma starts in cartilage-forming cells"
  },
  {
    "id": "Medical-c39b1031",
    "source": "Medical",
    "question": "How is the diagnosis of bone cancer confirmed?",
    "answer": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of bone cancer is confirmed by core needle biopsy.",
      "Diagnosis of bone cancer is confirmed by surgical biopsy."
    ],
    "evidence_relations": "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy"
  },
  {
    "id": "Medical-38953b85",
    "source": "Medical",
    "question": "What blood tests are used in the evaluation of bone cancer?",
    "answer": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests used in the evaluation of bone cancer include alkaline phosphatase.",
      "Blood tests used in the evaluation of bone cancer include CBC.",
      "Blood tests used in the evaluation of bone cancer include CMP.",
      "Blood tests used in the evaluation of bone cancer include LDH."
    ],
    "evidence_relations": "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation"
  },
  {
    "id": "Medical-0fcdee63",
    "source": "Medical",
    "question": "What is the purpose of genetic cancer risk testing in bone cancer?",
    "answer": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic cancer risk testing identifies germline mutations.",
      "Germline mutations are associated with increased cancer risk."
    ],
    "evidence_relations": "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk"
  },
  {
    "id": "Medical-856e9c5c",
    "source": "Medical",
    "question": "What does biomarker testing in bone cancer include?",
    "answer": "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing includes identification of gene mutations.",
      "Biomarker testing includes protein expression.",
      "Biomarker testing includes tumor mutational burden."
    ],
    "evidence_relations": "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden"
  },
  {
    "id": "Medical-7dd6e939",
    "source": "Medical",
    "question": "What treatments are available for tumor mutational burden-high (TMB-H) bone cancers?",
    "answer": "TMB-H may be treated with pembrolizumab, nivolumab, or ipilimumab.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "TMB-H may be treated with pembrolizumab.",
      "TMB-H may be treated with nivolumab.",
      "TMB-H may be treated with ipilimumab."
    ],
    "evidence_relations": "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab"
  },
  {
    "id": "Medical-142025a5",
    "source": "Medical",
    "question": "What system is used for staging bone cancer?",
    "answer": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Staging of bone cancer uses the TNM system.",
      "The TNM system includes T for tumor size/location.",
      "The TNM system includes N for lymph node involvement.",
      "The TNM system includes M for metastasis."
    ],
    "evidence_relations": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)"
  },
  {
    "id": "Medical-0b0c4cf9",
    "source": "Medical",
    "question": "How is tumor grade described in bone cancer?",
    "answer": "Tumor grade describes histologic differentiation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor grade describes histologic differentiation."
    ],
    "evidence_relations": "Tumor grade (G) describes histologic differentiation"
  },
  {
    "id": "Medical-8f43b36b",
    "source": "Medical",
    "question": "How is the stage of bone cancer determined?",
    "answer": "Stage is determined by combining T, N, M, and G scores.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage of bone cancer is determined by combining T scores.",
      "Stage of bone cancer is determined by combining N scores.",
      "Stage of bone cancer is determined by combining M scores.",
      "Stage of bone cancer is determined by combining G scores."
    ],
    "evidence_relations": "Stage is determined by combining T, N, M, and G scores"
  },
  {
    "id": "Medical-712b02a6",
    "source": "Medical",
    "question": "Which performance status scales are used in bone cancer treatment planning?",
    "answer": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ECOG performance status is used in bone cancer treatment planning.",
      "Karnofsky Performance Status (KPS) is used in bone cancer treatment planning."
    ],
    "evidence_relations": "Performance status (ECOG or KPS) is considered in treatment planning"
  },
  {
    "id": "Medical-7ced180c",
    "source": "Medical",
    "question": "What metabolic complication can bone cancer cause?",
    "answer": "Bone cancer can cause hypercalcemia due to bone destruction.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone cancer can cause hypercalcemia.",
      "Hypercalcemia is due to bone destruction."
    ],
    "evidence_relations": "Bone cancer can cause hypercalcemia due to bone destruction"
  },
  {
    "id": "Medical-45b7e7da",
    "source": "Medical",
    "question": "Where can bone cancer spread?",
    "answer": "Bone cancer can spread to lungs, other bones, or distant organs.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone cancer can spread to the lungs.",
      "Bone cancer can spread to other bones.",
      "Bone cancer can spread to distant organs."
    ],
    "evidence_relations": "Bone cancer can spread to lungs, other bones, or distant organs"
  },
  {
    "id": "Medical-4a90fe75",
    "source": "Medical",
    "question": "Which gene fusions are biomarkers for Ewing sarcoma?",
    "answer": "EWSR1-FLI1 fusion and EWSR1-ERG fusion are biomarkers for Ewing sarcoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "EWSR1-FLI1 fusion is a biomarker for Ewing sarcoma.",
      "EWSR1-ERG fusion is a biomarker for Ewing sarcoma."
    ],
    "evidence_relations": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1"
  },
  {
    "id": "Medical-9418792b",
    "source": "Medical",
    "question": "Which diagnostic methods are used for bone sarcomas?",
    "answer": "Diagnostic methods for bone sarcomas include X-ray, bone scan, CT scan, MRI, PET scan, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "X-ray is a diagnostic method for bone sarcomas.",
      "Bone scan is a diagnostic method for bone sarcomas.",
      "CT scan is a diagnostic method for bone sarcomas.",
      "MRI is a diagnostic method for bone sarcomas.",
      "PET scan is a diagnostic method for bone sarcomas.",
      "Biopsy is a diagnostic method for bone sarcomas."
    ],
    "evidence_relations": "Osteosarcoma: Diagnostic Method: [X-ray, Bone scan, CT scan, MRI, PET scan, Biopsy]"
  },
  {
    "id": "Medical-6b20ca96",
    "source": "Medical",
    "question": "Which genetic alteration is associated with Ewing sarcoma?",
    "answer": "Ewing sarcoma is associated with the t(11;22) translocation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ewing sarcoma is associated with the t(11;22) translocation."
    ],
    "evidence_relations": "Ewing sarcoma: Genetic Alteration: [t(11;22) translocation]"
  },
  {
    "id": "Medical-7a495600",
    "source": "Medical",
    "question": "What are the main risk factors for bone cancer?",
    "answer": "Family history of cancer and germline mutations are risk factors for bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history of cancer is a risk factor for bone cancer.",
      "Germline mutations are a risk factor for bone cancer."
    ],
    "evidence_relations": "Risk Factor: [Family history of cancer, Germline mutations]"
  },
  {
    "id": "Medical-a9564c89",
    "source": "Medical",
    "question": "What are common symptoms of bone cancer?",
    "answer": "Bone pain and hypercalcemia are symptoms of bone cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bone pain is a symptom of bone cancer.",
      "Hypercalcemia is a symptom of bone cancer."
    ],
    "evidence_relations": "Symptom: [Bone pain, Hypercalcemia]"
  },
  {
    "id": "Medical-bb448a1f",
    "source": "Medical",
    "question": "Which anatomic sites can be affected by mouth cancer?",
    "answer": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mouth cancer can develop in the lips.",
      "Mouth cancer can develop in the gums.",
      "Mouth cancer can develop in the buccal mucosa.",
      "Mouth cancer can develop in the tongue.",
      "Mouth cancer can develop in the hard palate.",
      "Mouth cancer can develop in the alveolar ridge.",
      "Mouth cancer can develop in the floor of mouth.",
      "Mouth cancer can develop in the retromolar trigone."
    ],
    "evidence_relations": "Mouth cancer can develop in the lips, gums, buccal mucosa, tongue, hard palate, alveolar ridge, floor of mouth, and retromolar trigone"
  },
  {
    "id": "Medical-dbfb3406",
    "source": "Medical",
    "question": "How is T2 defined in mouth cancer TNM classification?",
    "answer": "T2 is a tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T2 is a tumor 2 cm with DOI >5 mm.",
      "T2 is a tumor 24 cm with DOI 10 mm."
    ],
    "evidence_relations": "T2: Tumor 2 cm with DOI >5 mm or 24 cm with DOI 10 mm"
  },
  {
    "id": "Medical-97502e67",
    "source": "Medical",
    "question": "What characterizes a T3 tumor in mouth cancer?",
    "answer": "T3 is a 24 cm tumor with DOI >10 mm or >4 cm tumor with DOI 10 mm.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A T3 tumor in mouth cancer is 24 cm in size.",
      "A T3 tumor in mouth cancer has a depth of invasion (DOI) greater than 10 mm.",
      "A T3 tumor in mouth cancer can also be greater than 4 cm in size with a DOI of 10 mm or less."
    ],
    "evidence_relations": "T3: 24 cm with DOI >10 mm or >4 cm with DOI 10 mm"
  },
  {
    "id": "Medical-4cb0599c",
    "source": "Medical",
    "question": "What does T4a indicate in mouth cancer staging?",
    "answer": "T4a indicates moderately advanced local disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T4a indicates moderately advanced local disease in mouth cancer."
    ],
    "evidence_relations": "T4a: Moderately advanced local disease"
  },
  {
    "id": "Medical-2c20babc",
    "source": "Medical",
    "question": "What does T4b represent in the TNM classification for mouth cancer?",
    "answer": "T4b represents very advanced local disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T4b represents very advanced local disease in mouth cancer."
    ],
    "evidence_relations": "T4b: Very advanced local disease"
  },
  {
    "id": "Medical-4eefc14f",
    "source": "Medical",
    "question": "Which diagnostic methods may be used for mouth cancer besides imaging?",
    "answer": "Diagnostic methods include panoramic dental x-ray (Panorex), fine-needle aspiration (FNA), core needle biopsy (CNB), dental exam, speech and swallowing assessment, and nutrition assessment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Panoramic dental x-ray (Panorex) may be used as a diagnostic method for mouth cancer.",
      "Fine-needle aspiration (FNA) may be used as a diagnostic method for mouth cancer.",
      "Core needle biopsy (CNB) may be used as a diagnostic method for mouth cancer.",
      "A dental exam may be used as a diagnostic method for mouth cancer.",
      "Speech and swallowing assessment may be used as a diagnostic method for mouth cancer.",
      "Nutrition assessment may be used as a diagnostic method for mouth cancer."
    ],
    "evidence_relations": "Diagnostic Method: [CT scan, MRI, PET/CT, Ultrasound, Panoramic dental x-ray (Panorex), Biopsy, Fine-needle aspiration (FNA), Core needle biopsy (CNB), Dental exam, Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-6f5dcba9",
    "source": "Medical",
    "question": "What biomarkers may be tested in mouth cancer?",
    "answer": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing in mouth cancer may include PD-L1.",
      "Biomarker testing in mouth cancer may include MSI-H/dMMR.",
      "Biomarker testing in mouth cancer may include tumor mutational burden (TMB)."
    ],
    "evidence_relations": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-bb899a92",
    "source": "Medical",
    "question": "What factors are considered in treatment planning for mouth cancer?",
    "answer": "Treatment planning is based on tumor location and stage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment planning for mouth cancer is based on tumor location.",
      "Treatment planning for mouth cancer is based on tumor stage."
    ],
    "evidence_relations": "Treatment planning is based on tumor location and stage"
  },
  {
    "id": "Medical-9e29cae8",
    "source": "Medical",
    "question": "Which clinical assessment is important for treatment selection in mouth cancer?",
    "answer": "Performance status (ECOG) is considered in treatment selection.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status (ECOG) is considered in treatment selection for mouth cancer."
    ],
    "evidence_relations": "Performance status (ECOG) is considered in treatment selection"
  },
  {
    "id": "Medical-ab04c717",
    "source": "Medical",
    "question": "What symptoms may indicate mouth cancer?",
    "answer": "Symptoms may include changes in the mouth, tongue, or neck area.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of mouth cancer may include changes in the mouth.",
      "Symptoms of mouth cancer may include changes in the tongue.",
      "Symptoms of mouth cancer may include changes in the neck area."
    ],
    "evidence_relations": "Symptoms may include changes in the mouth, tongue, or neck area"
  },
  {
    "id": "Medical-7f529715",
    "source": "Medical",
    "question": "Which assessments are included in the clinical evaluation of mouth cancer patients?",
    "answer": "Speech and swallowing assessment and nutrition assessment are included in clinical evaluation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Speech and swallowing assessment is included in the clinical evaluation of mouth cancer patients.",
      "Nutrition assessment is included in the clinical evaluation of mouth cancer patients."
    ],
    "evidence_relations": "Diagnostic Method: [Speech and swallowing assessment, Nutrition assessment]"
  },
  {
    "id": "Medical-25024e4e",
    "source": "Medical",
    "question": "What is the significance of performance status (ECOG) in mouth cancer?",
    "answer": "Performance status (ECOG) is used as a clinical assessment in mouth cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status (ECOG) is used as a clinical assessment in mouth cancer."
    ],
    "evidence_relations": "Clinical Assessment: [Performance status (ECOG)]"
  },
  {
    "id": "Medical-f2c54ca8",
    "source": "Medical",
    "question": "Which genetic alterations may be evaluated in mouth cancer biomarker testing?",
    "answer": "MSI-H/dMMR and tumor mutational burden (TMB) may be evaluated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MSI-H/dMMR may be evaluated in mouth cancer biomarker testing.",
      "Tumor mutational burden (TMB) may be evaluated in mouth cancer biomarker testing."
    ],
    "evidence_relations": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)"
  },
  {
    "id": "Medical-50852ffa",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma consists of scattered cells and is less common?",
    "answer": "Diffuse type adenocarcinoma consists of scattered cells and is less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diffuse type adenocarcinoma consists of scattered cells.",
      "Diffuse type adenocarcinoma is less common."
    ],
    "evidence_relations": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-442b042c",
    "source": "Medical",
    "question": "To which organs can stomach cancer spread?",
    "answer": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stomach cancer can spread to lymph nodes.",
      "Stomach cancer can spread to veins.",
      "Stomach cancer can spread to arteries.",
      "Stomach cancer can spread to the liver.",
      "Stomach cancer can spread to the pancreas.",
      "Stomach cancer can spread to the spleen."
    ],
    "evidence_relations": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen"
  },
  {
    "id": "Medical-d8dd3085",
    "source": "Medical",
    "question": "What is a risk factor for stomach cancer related to infection?",
    "answer": "H. pylori infection is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer."
    ],
    "evidence_relations": "H. pylori infection is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-e77a80c7",
    "source": "Medical",
    "question": "Is family history a risk factor for stomach cancer?",
    "answer": "Family history is a risk factor for stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history is a risk factor for stomach cancer."
    ],
    "evidence_relations": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5778d49d",
    "source": "Medical",
    "question": "What symptoms can stomach cancer cause?",
    "answer": "Symptoms can include ulcer or mass formation in the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stomach cancer can cause ulcer formation in the stomach.",
      "Stomach cancer can cause mass formation in the stomach."
    ],
    "evidence_relations": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-b59fdb33",
    "source": "Medical",
    "question": "Which diagnostic method is used to visually examine the stomach?",
    "answer": "Endoscopy is used to visually examine the stomach.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Endoscopy is used to visually examine the stomach."
    ],
    "evidence_relations": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-fc8c1f25",
    "source": "Medical",
    "question": "What genetic risk factor is listed for stomach cancer?",
    "answer": "Family history is listed as a genetic risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history is listed as a genetic risk factor for stomach cancer."
    ],
    "evidence_relations": "Family history is a risk factor for stomach cancer"
  },
  {
    "id": "Medical-5470aded",
    "source": "Medical",
    "question": "Which stomach cancer subtype is less common?",
    "answer": "Diffuse type adenocarcinoma is less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diffuse type adenocarcinoma is a less common subtype of stomach cancer."
    ],
    "evidence_relations": "Diffuse type adenocarcinoma consists of scattered cells and is less common"
  },
  {
    "id": "Medical-4c68753b",
    "source": "Medical",
    "question": "Which stomach wall layer is the initial site for early-stage stomach cancer?",
    "answer": "The mucosa is the initial site for early-stage stomach cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The mucosa is the initial site for early-stage stomach cancer."
    ],
    "evidence_relations": "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes"
  },
  {
    "id": "Medical-e18d2c7f",
    "source": "Medical",
    "question": "Which subtype of stomach adenocarcinoma is more likely to benefit from targeted therapy?",
    "answer": "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy."
    ],
    "evidence_relations": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy"
  },
  {
    "id": "Medical-cdf0477d",
    "source": "Medical",
    "question": "Which organs are commonly involved in metastatic stomach cancer?",
    "answer": "The liver, peritoneum, and distant lymph nodes are commonly involved.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The liver is commonly involved in metastatic stomach cancer.",
      "The peritoneum is commonly involved in metastatic stomach cancer.",
      "Distant lymph nodes are commonly involved in metastatic stomach cancer."
    ],
    "evidence_relations": "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
  },
  {
    "id": "Medical-e542c70c",
    "source": "Medical",
    "question": "What are two main symptoms of stomach cancer listed in the ontology?",
    "answer": "Ulcer and mass are two main symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ulcer is a main symptom of stomach cancer.",
      "Mass is a main symptom of stomach cancer."
    ],
    "evidence_relations": "Symptoms can include ulcer or mass formation in the stomach"
  },
  {
    "id": "Medical-5724612b",
    "source": "Medical",
    "question": "What are the most common subtypes of glioma?",
    "answer": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Astrocytoma is a common subtype of glioma.",
      "Oligodendroglioma is a common subtype of glioma.",
      "Glioblastoma is a common subtype of glioma."
    ],
    "evidence_relations": "Astrocytoma, oligodendroglioma, and glioblastoma are the most common subtypes of glioma"
  },
  {
    "id": "Medical-e84e4ea0",
    "source": "Medical",
    "question": "Which glioma subtype is the most aggressive?",
    "answer": "Glioblastoma is the most aggressive subtype of glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Glioblastoma is the most aggressive subtype of glioma."
    ],
    "evidence_relations": "Glioblastoma is the most aggressive subtype of glioma"
  },
  {
    "id": "Medical-9884a4b5",
    "source": "Medical",
    "question": "How are gliomas classified?",
    "answer": "Gliomas are classified by histology, grade, and biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gliomas are classified by histology.",
      "Gliomas are classified by grade.",
      "Gliomas are classified by biomarkers."
    ],
    "evidence_relations": "Gliomas are classified by histology, grade, and biomarkers"
  },
  {
    "id": "Medical-d272b033",
    "source": "Medical",
    "question": "What biomarker is used to classify gliomas?",
    "answer": "IDH mutation is a biomarker used to classify gliomas.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "IDH mutation is a biomarker used to classify gliomas."
    ],
    "evidence_relations": "IDH mutation is a biomarker used to classify gliomas"
  },
  {
    "id": "Medical-de960459",
    "source": "Medical",
    "question": "What are common symptoms of glioma?",
    "answer": "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of glioma include headache.",
      "Common symptoms of glioma include seizures.",
      "Common symptoms of glioma include fatigue.",
      "Common symptoms of glioma include nausea.",
      "Common symptoms of glioma include vomiting.",
      "Common symptoms of glioma include cognitive changes.",
      "Common symptoms of glioma include weakness.",
      "Common symptoms of glioma include personality changes.",
      "Common symptoms of glioma include vision problems."
    ],
    "evidence_relations": "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems"
  },
  {
    "id": "Medical-7959a3b5",
    "source": "Medical",
    "question": "What additional therapy is required for high-grade gliomas after surgery?",
    "answer": "High-grade gliomas require additional therapy after surgery.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "High-grade gliomas require additional therapy after surgery."
    ],
    "evidence_relations": "High-grade gliomas require additional therapy after surgery"
  },
  {
    "id": "Medical-981edc6b",
    "source": "Medical",
    "question": "What is recommended for follow-up after glioma treatment?",
    "answer": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Periodic imaging (MRI) is recommended for follow-up after glioma treatment.",
      "The purpose of follow-up imaging is to monitor for recurrence."
    ],
    "evidence_relations": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence"
  },
  {
    "id": "Medical-28389677",
    "source": "Medical",
    "question": "What is assessed to determine treatment eligibility for glioma?",
    "answer": "Performance status is assessed to determine treatment eligibility.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is assessed to determine treatment eligibility for glioma."
    ],
    "evidence_relations": "Performance status is assessed to determine treatment eligibility"
  },
  {
    "id": "Medical-7b37919a",
    "source": "Medical",
    "question": "In which age group are gliomas more common?",
    "answer": "Gliomas are more common in adults than children.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gliomas are more common in adults than in children."
    ],
    "evidence_relations": "Gliomas are more common in adults than children"
  },
  {
    "id": "Medical-3c7e7363",
    "source": "Medical",
    "question": "What performance status assessment is used in glioma diagnosis?",
    "answer": "Performance status is assessed as part of the clinical evaluation for glioma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is assessed as part of the clinical evaluation for glioma."
    ],
    "evidence_relations": "Clinical evaluation for glioma includes performance status assessment"
  },
  {
    "id": "Medical-bf9e60be",
    "source": "Medical",
    "question": "Which imaging methods are used for glioma diagnosis according to the ontology?",
    "answer": "MRI and CT scan are imaging methods used for glioma diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MRI is an imaging method used for glioma diagnosis.",
      "CT scan is an imaging method used for glioma diagnosis."
    ],
    "evidence_relations": "Imaging for glioma diagnosis includes MRI and CT scan"
  },
  {
    "id": "Medical-86e59474",
    "source": "Medical",
    "question": "What laboratory tests are conducted for glioma diagnosis?",
    "answer": "Laboratory testing for glioma includes molecular testing and histology.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Laboratory testing for glioma includes molecular testing.",
      "Laboratory testing for glioma includes histology."
    ],
    "evidence_relations": "Laboratory testing for glioma includes molecular testing and histology"
  },
  {
    "id": "Medical-2db59cde",
    "source": "Medical",
    "question": "What are the risk factors for glioma?",
    "answer": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for glioma include age.",
      "Glioma is more common in adults.",
      "Risk factors for glioma include non-hereditary mutation."
    ],
    "evidence_relations": "Risk factors for glioma include age (more common in adults) and non-hereditary mutation"
  },
  {
    "id": "Medical-78c160d3",
    "source": "Medical",
    "question": "How is AML diagnosed?",
    "answer": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AML is diagnosed by the presence of 20% myeloblasts in bone marrow.",
      "AML is diagnosed by the presence of 20% myeloblasts in blood."
    ],
    "evidence_relations": "AML is diagnosed by the presence of 20% myeloblasts in bone marrow or blood"
  },
  {
    "id": "Medical-44f40835",
    "source": "Medical",
    "question": "What is Blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
    "answer": "BPDCN is an aggressive subtype of AML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of acute myeloid leukemia (AML)."
    ],
    "evidence_relations": "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML"
  },
  {
    "id": "Medical-93bdac1d",
    "source": "Medical",
    "question": "What causes low counts of healthy blood cells in AML?",
    "answer": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute myeloid leukemia (AML) causes a buildup of blasts in bone marrow.",
      "Acute myeloid leukemia (AML) causes a buildup of blasts in blood.",
      "The buildup of blasts in AML leads to low counts of healthy red blood cells.",
      "The buildup of blasts in AML leads to low counts of healthy platelets.",
      "The buildup of blasts in AML leads to low counts of healthy white blood cells."
    ],
    "evidence_relations": "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells"
  },
  {
    "id": "Medical-98aa1f14",
    "source": "Medical",
    "question": "Which laboratory tests are used for AML diagnosis?",
    "answer": "Complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complete blood count (CBC) is used for AML diagnosis.",
      "Comprehensive metabolic panel (CMP) is used for AML diagnosis.",
      "Lactate dehydrogenase (LDH) is used for AML diagnosis.",
      "Blood clotting tests are used for AML diagnosis."
    ],
    "evidence_relations": "Laboratory tests used for AML diagnosis include complete blood count (CBC), comprehensive metabolic panel (CMP), lactate dehydrogenase (LDH), and blood clotting tests"
  },
  {
    "id": "Medical-722f609c",
    "source": "Medical",
    "question": "What molecular and cytogenetic tests are used in AML workup?",
    "answer": "Karyotype, FISH, next-generation sequencing (NGS), and PCR are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Karyotype testing is used in AML workup.",
      "FISH testing is used in AML workup.",
      "Next-generation sequencing (NGS) is used in AML workup.",
      "PCR testing is used in AML workup."
    ],
    "evidence_relations": "Molecular and cytogenetic testing for AML includes karyotype, FISH, next-generation sequencing (NGS), and PCR"
  },
  {
    "id": "Medical-1345f015",
    "source": "Medical",
    "question": "Which chemotherapy agents are commonly used in AML?",
    "answer": "Chemotherapy regimens may include cytarabine, daunorubicin, idarubicin, and hypomethylating agents such as azacitidine and decitabine.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy regimens for AML may include cytarabine.",
      "Chemotherapy regimens for AML may include daunorubicin.",
      "Chemotherapy regimens for AML may include idarubicin.",
      "Chemotherapy regimens for AML may include hypomethylating agents such as azacitidine.",
      "Chemotherapy regimens for AML may include hypomethylating agents such as decitabine."
    ],
    "evidence_relations": "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine)"
  },
  {
    "id": "Medical-5cd1d09f",
    "source": "Medical",
    "question": "What are common genetic alterations found in AML?",
    "answer": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common genetic alterations in AML include FLT3-ITD.",
      "Common genetic alterations in AML include FLT3-TKD.",
      "Common genetic alterations in AML include inv(16).",
      "Common genetic alterations in AML include inv(3).",
      "Common genetic alterations in AML include t(8;21).",
      "Common genetic alterations in AML include del(5q).",
      "Common genetic alterations in AML include PML::RARA."
    ],
    "evidence_relations": "Common genetic alterations in AML include FLT3-ITD, FLT3-TKD, inv(16), inv(3), t(8;21), del(5q), and PML::RARA"
  },
  {
    "id": "Medical-514e9bd7",
    "source": "Medical",
    "question": "When is hematopoietic cell transplant considered in AML?",
    "answer": "Hematopoietic cell transplant is considered for eligible patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hematopoietic cell transplant is considered for eligible patients."
    ],
    "evidence_relations": "Hematopoietic cell transplant is considered for eligible patients"
  },
  {
    "id": "Medical-8ee2e2c7",
    "source": "Medical",
    "question": "What factors influence AML treatment selection?",
    "answer": "Performance status and general health influence treatment selection.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status influences AML treatment selection.",
      "General health influences AML treatment selection."
    ],
    "evidence_relations": "Performance status and general health influence treatment selection"
  },
  {
    "id": "Medical-70d75840",
    "source": "Medical",
    "question": "What are risk factors for developing AML?",
    "answer": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Family history of leukemia is a risk factor for developing AML.",
      "Hereditary predisposition syndromes are risk factors for developing AML."
    ],
    "evidence_relations": "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML"
  },
  {
    "id": "Medical-4811934e",
    "source": "Medical",
    "question": "Which tests are used for immunophenotyping in AML diagnosis?",
    "answer": "Flow cytometry and immunophenotyping are used for immunophenotyping in AML diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Flow cytometry is used for immunophenotyping in AML diagnosis.",
      "Immunophenotyping is used for immunophenotyping in AML diagnosis."
    ],
    "evidence_relations": "Flow cytometry and immunophenotyping are used for immunophenotyping in AML diagnosis"
  },
  {
    "id": "Medical-67b8e0a9",
    "source": "Medical",
    "question": "What fertility preservation options are recommended in AML?",
    "answer": "Fertility preservation counseling and referral to a reproductive specialist are recommended.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation counseling is recommended in AML.",
      "Referral to a reproductive specialist is recommended in AML."
    ],
    "evidence_relations": "Fertility Preservation in AML includes fertility preservation counseling and referral to reproductive specialist"
  },
  {
    "id": "Medical-78cecf8c",
    "source": "Medical",
    "question": "What is the most common type of ovarian cancer?",
    "answer": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Ovarian cancer is most commonly an epithelial cancer.",
      "Epithelial cancer arises from the ovary surface epithelium."
    ],
    "evidence_relations": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium"
  },
  {
    "id": "Medical-17badae3",
    "source": "Medical",
    "question": "Which subtypes are most common in epithelial ovarian cancer?",
    "answer": "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "High-grade serous carcinoma is a common subtype of epithelial ovarian cancer.",
      "High-grade endometrioid carcinoma is a common subtype of epithelial ovarian cancer."
    ],
    "evidence_relations": "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes of epithelial ovarian cancer"
  },
  {
    "id": "Medical-ceb6a99b",
    "source": "Medical",
    "question": "Which cancers are managed similarly to ovarian cancer?",
    "answer": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary peritoneal cancer is managed similarly to ovarian cancer.",
      "Fallopian tube cancer is managed similarly to ovarian cancer."
    ],
    "evidence_relations": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer"
  },
  {
    "id": "Medical-1a736b11",
    "source": "Medical",
    "question": "What are the common symptoms of ovarian cancer?",
    "answer": "Common symptoms include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of ovarian cancer include bloating.",
      "Common symptoms of ovarian cancer include pelvic or abdominal pain.",
      "Common symptoms of ovarian cancer include trouble eating or feeling full quickly.",
      "Common symptoms of ovarian cancer include urinary urgency or frequency.",
      "Common symptoms of ovarian cancer include pain during sex."
    ],
    "evidence_relations": "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex"
  },
  {
    "id": "Medical-40918a31",
    "source": "Medical",
    "question": "Who should receive genetic testing for BRCA and other syndromes in ovarian cancer?",
    "answer": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer."
    ],
    "evidence_relations": "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer"
  },
  {
    "id": "Medical-1043deff",
    "source": "Medical",
    "question": "What tumor biomarker tests are performed in ovarian cancer?",
    "answer": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor biomarker testing includes BRCA mutation.",
      "Tumor biomarker testing includes HRD status.",
      "Tumor biomarker testing includes MSI.",
      "Tumor biomarker testing includes MMR.",
      "Tumor biomarker testing includes HER2 expression.",
      "Tumor biomarker testing includes TMB.",
      "Tumor biomarker testing includes BRAF V600E.",
      "Tumor biomarker testing includes FR.",
      "Tumor biomarker testing includes RET mutations.",
      "Tumor biomarker testing includes NTRK gene fusion."
    ],
    "evidence_relations": "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutations, and NTRK gene fusion"
  },
  {
    "id": "Medical-2ca3a0ac",
    "source": "Medical",
    "question": "Which drug may be added to chemotherapy in some ovarian cancer cases?",
    "answer": "Bevacizumab may be added to chemotherapy in some cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Bevacizumab may be added to chemotherapy in some ovarian cancer cases."
    ],
    "evidence_relations": "Bevacizumab may be added to chemotherapy in some cases"
  },
  {
    "id": "Medical-0ce3e959",
    "source": "Medical",
    "question": "What are the treatment options for platinum-resistant ovarian cancer?",
    "answer": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy.",
      "Bevacizumab is a treatment option for platinum-resistant ovarian cancer.",
      "Targeted therapies are treatment options for platinum-resistant ovarian cancer.",
      "Mirvetuximab soravtansine-gynx is a targeted therapy for FR-positive tumors."
    ],
    "evidence_relations": "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FR-positive tumors"
  },
  {
    "id": "Medical-41491cb3",
    "source": "Medical",
    "question": "When are clinical trials recommended for ovarian cancer?",
    "answer": "Clinical trials are recommended for recurrent or persistent ovarian cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are recommended for recurrent ovarian cancer.",
      "Clinical trials are recommended for persistent ovarian cancer."
    ],
    "evidence_relations": "Clinical trials are recommended for recurrent or persistent ovarian cancer"
  },
  {
    "id": "Medical-fcbaf737",
    "source": "Medical",
    "question": "Which tumor markers are used in ovarian cancer diagnosis?",
    "answer": "Tumor markers include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, and HE4.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Tumor markers used in ovarian cancer diagnosis include CA-125.",
      "Tumor markers used in ovarian cancer diagnosis include Inhibin.",
      "Tumor markers used in ovarian cancer diagnosis include Beta-human chorionic gonadotropin (-hCG).",
      "Tumor markers used in ovarian cancer diagnosis include Alpha-fetoprotein (AFP).",
      "Tumor markers used in ovarian cancer diagnosis include Lactate dehydrogenase (LDH).",
      "Tumor markers used in ovarian cancer diagnosis include Carcinoembryonic antigen (CEA).",
      "Tumor markers used in ovarian cancer diagnosis include CA 19-9.",
      "Tumor markers used in ovarian cancer diagnosis include HE4."
    ],
    "evidence_relations": "Tumor marker tests include CA-125, Inhibin, Beta-human chorionic gonadotropin (-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, HE4"
  },
  {
    "id": "Medical-6b4b11a7",
    "source": "Medical",
    "question": "Which diagnostic procedures are available for ovarian cancer?",
    "answer": "Diagnostic methods include abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, FNA, core biopsy, paracentesis, colonoscopy, upper endoscopy, CBC, blood chemistry profile, and liver function tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for ovarian cancer include abdominal exams.",
      "Diagnostic methods for ovarian cancer include pelvic exams.",
      "Diagnostic methods for ovarian cancer include ultrasound.",
      "Diagnostic methods for ovarian cancer include CT scan.",
      "Diagnostic methods for ovarian cancer include MRI.",
      "Diagnostic methods for ovarian cancer include PET scan.",
      "Diagnostic methods for ovarian cancer include chest x-ray.",
      "Diagnostic methods for ovarian cancer include diagnostic laparoscopy.",
      "Diagnostic methods for ovarian cancer include biopsy.",
      "Diagnostic methods for ovarian cancer include FNA.",
      "Diagnostic methods for ovarian cancer include core biopsy.",
      "Diagnostic methods for ovarian cancer include paracentesis.",
      "Diagnostic methods for ovarian cancer include colonoscopy.",
      "Diagnostic methods for ovarian cancer include upper endoscopy.",
      "Diagnostic methods for ovarian cancer include CBC.",
      "Diagnostic methods for ovarian cancer include blood chemistry profile.",
      "Diagnostic methods for ovarian cancer include liver function tests."
    ],
    "evidence_relations": "Diagnostic Method includes abdominal and pelvic exam, ultrasound, CT scan, MRI, PET scan, chest x-ray, diagnostic laparoscopy, biopsy, fine-needle aspiration (FNA), core biopsy, paracentesis, colonoscopy, upper endoscopy, complete blood count (CBC), blood chemistry profile, liver function tests"
  },
  {
    "id": "Medical-476ca8b6",
    "source": "Medical",
    "question": "What surgical procedures are included in the treatment of ovarian cancer?",
    "answer": "Surgical procedures include hysterectomy, bilateral salpingo-oophorectomy, unilateral salpingo-oophorectomy, debulking surgery, cytoreductive surgery, interval cytoreductive surgery, laparotomy, laparoscopy, and peritoneal washing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgical procedures for ovarian cancer include hysterectomy.",
      "Surgical procedures for ovarian cancer include bilateral salpingo-oophorectomy.",
      "Surgical procedures for ovarian cancer include unilateral salpingo-oophorectomy.",
      "Surgical procedures for ovarian cancer include debulking surgery.",
      "Surgical procedures for ovarian cancer include cytoreductive surgery.",
      "Surgical procedures for ovarian cancer include interval cytoreductive surgery.",
      "Surgical procedures for ovarian cancer include laparotomy.",
      "Surgical procedures for ovarian cancer include laparoscopy.",
      "Surgical procedures for ovarian cancer include peritoneal washing."
    ],
    "evidence_relations": "Surgical Procedure includes hysterectomy, bilateral salpingo-oophorectomy (BSO), unilateral salpingo-oophorectomy (USO), debulking surgery, cytoreductive surgery, interval cytoreductive surgery (ICS), laparotomy, laparoscopy, peritoneal washing"
  },
  {
    "id": "Medical-181dd442",
    "source": "Medical",
    "question": "What genetic alterations are tested for in ovarian cancer?",
    "answer": "Genetic alterations tested include BRCA1 mutation, BRCA2 mutation, HRD, MSI, MMR, HER2 expression, TMB, BRAF V600E, FR, RET mutation, and NTRK gene fusion.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Genetic alterations tested for ovarian cancer include BRCA1 mutation.",
      "Genetic alterations tested for ovarian cancer include BRCA2 mutation.",
      "Genetic alterations tested for ovarian cancer include HRD.",
      "Genetic alterations tested for ovarian cancer include MSI.",
      "Genetic alterations tested for ovarian cancer include MMR.",
      "Genetic alterations tested for ovarian cancer include HER2 expression.",
      "Genetic alterations tested for ovarian cancer include TMB.",
      "Genetic alterations tested for ovarian cancer include BRAF V600E.",
      "Genetic alterations tested for ovarian cancer include FR.",
      "Genetic alterations tested for ovarian cancer include RET mutation.",
      "Genetic alterations tested for ovarian cancer include NTRK gene fusion."
    ],
    "evidence_relations": "Genetic Alteration includes BRCA1 mutation, BRCA2 mutation, homologous recombination deficiency (HRD), microsatellite instability (MSI), mismatch repair (MMR), HER2 expression, tumor mutational burden (TMB), BRAF V600E mutation, folate receptor alpha (FR), RET mutation, NTRK gene fusion"
  },
  {
    "id": "Medical-fbef0cd8",
    "source": "Medical",
    "question": "What are the main risk factors for ovarian cancer?",
    "answer": "Risk factors include BRCA1 mutation, BRCA2 mutation, Lynch syndrome, and family history.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Main risk factors for ovarian cancer include BRCA1 mutation.",
      "Main risk factors for ovarian cancer include BRCA2 mutation.",
      "Main risk factors for ovarian cancer include Lynch syndrome.",
      "Main risk factors for ovarian cancer include family history."
    ],
    "evidence_relations": "Risk Factor includes BRCA1 mutation, BRCA2 mutation, Lynch syndrome, Family history"
  },
  {
    "id": "Medical-adf818a2",
    "source": "Medical",
    "question": "What are common symptoms of ovarian cancer listed in the ontology?",
    "answer": "Common symptoms include persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, and constipation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of ovarian cancer include persistent bloating.",
      "Common symptoms of ovarian cancer include pelvic pain.",
      "Common symptoms of ovarian cancer include abdominal pain.",
      "Common symptoms of ovarian cancer include trouble eating.",
      "Common symptoms of ovarian cancer include feeling full quickly.",
      "Common symptoms of ovarian cancer include urinary urgency.",
      "Common symptoms of ovarian cancer include urinary frequency.",
      "Common symptoms of ovarian cancer include pain during sex.",
      "Common symptoms of ovarian cancer include fatigue.",
      "Common symptoms of ovarian cancer include unexplained weight loss.",
      "Common symptoms of ovarian cancer include constipation."
    ],
    "evidence_relations": "Symptom includes persistent bloating, pelvic pain, abdominal pain, trouble eating, feeling full quickly, urinary urgency, urinary frequency, pain during sex, fatigue, unexplained weight loss, constipation"
  },
  {
    "id": "Medical-0f6078ff",
    "source": "Medical",
    "question": "Which therapies are considered for recurrent ovarian cancer based on platinum sensitivity?",
    "answer": "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab and secondary cytoreductive surgery; platinum-resistant recurrence is treated with non-platinum chemotherapy, bevacizumab, mirvetuximab soravtansine-gynx, targeted therapy, or immunotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Platinum-sensitive recurrence of ovarian cancer is treated with platinum-based chemotherapy.",
      "Platinum-sensitive recurrence may be treated with bevacizumab.",
      "Platinum-sensitive recurrence may involve secondary cytoreductive surgery.",
      "Platinum-resistant recurrence of ovarian cancer is treated with non-platinum chemotherapy.",
      "Platinum-resistant recurrence may be treated with bevacizumab.",
      "Platinum-resistant recurrence may be treated with mirvetuximab soravtansine-gynx.",
      "Platinum-resistant recurrence may involve targeted therapy.",
      "Platinum-resistant recurrence may involve immunotherapy."
    ],
    "evidence_relations": "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment"
  },
  {
    "id": "Medical-e7671bff",
    "source": "Medical",
    "question": "What is the recommended management for recurrent or persistent ovarian cancer?",
    "answer": "Clinical trial enrollment is recommended for recurrent or persistent disease.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trial enrollment is recommended for recurrent ovarian cancer.",
      "Clinical trial enrollment is recommended for persistent ovarian cancer."
    ],
    "evidence_relations": "Clinical trial enrollment for recurrent or persistent disease"
  },
  {
    "id": "Medical-150e36b6",
    "source": "Medical",
    "question": "How is CLL/SLL diagnosed?",
    "answer": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CLL/SLL is diagnosed by a blood test.",
      "The blood test shows 5,000 monoclonal B lymphocytes per microliter."
    ],
    "evidence_relations": "CLL/SLL is diagnosed by blood test showing 5,000 monoclonal B lymphocytes per microliter"
  },
  {
    "id": "Medical-cdfc9ecd",
    "source": "Medical",
    "question": "What are common symptoms of CLL?",
    "answer": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of CLL include swollen glands.",
      "Common symptoms of CLL include fatigue.",
      "Common symptoms of CLL include night sweats.",
      "Common symptoms of CLL include fever.",
      "Common symptoms of CLL include recurrent infections.",
      "Common symptoms of CLL include early satiety.",
      "Common symptoms of CLL include unintentional weight loss."
    ],
    "evidence_relations": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-4f070485",
    "source": "Medical",
    "question": "What are risk factors for developing CLL?",
    "answer": "Risk factors for CLL include older age and family history of CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for developing CLL include older age.",
      "Risk factors for developing CLL include family history of CLL."
    ],
    "evidence_relations": "Risk factors for CLL include older age and family history of CLL"
  },
  {
    "id": "Medical-ae21e753",
    "source": "Medical",
    "question": "Which diagnostic methods are used to confirm CLL?",
    "answer": "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CLL is confirmed by a blood test.",
      "CLL is confirmed by flow cytometry.",
      "Confirming CLL may require a lymph node biopsy.",
      "Confirming CLL may require a bone marrow biopsy."
    ],
    "evidence_relations": "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy"
  },
  {
    "id": "Medical-e33e6d40",
    "source": "Medical",
    "question": "What surface proteins are identified in CLL cells by immunophenotyping?",
    "answer": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping identifies CLL cells by surface proteins.",
      "Surface proteins identified in CLL cells include CD20.",
      "Surface proteins identified in CLL cells include CD200.",
      "Surface proteins identified in CLL cells include LEF1."
    ],
    "evidence_relations": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1"
  },
  {
    "id": "Medical-9f0ba939",
    "source": "Medical",
    "question": "Which biomarker tests are performed in CLL?",
    "answer": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing for CLL includes FISH for 17p deletion.",
      "Biomarker testing for CLL includes DNA sequencing for TP53 mutations.",
      "Biomarker testing for CLL includes DNA sequencing for IGHV mutations.",
      "Biomarker testing for CLL includes karyotype analysis."
    ],
    "evidence_relations": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-e773a3cf",
    "source": "Medical",
    "question": "What are the treatment options for CLL/SLL?",
    "answer": "Treatment options include oral medications, IV infusions, and combination therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment options for CLL/SLL include oral medications.",
      "Treatment options for CLL/SLL include IV infusions.",
      "Treatment options for CLL/SLL include combination therapies."
    ],
    "evidence_relations": "Treatment options include oral medications, IV infusions, and combination therapies"
  },
  {
    "id": "Medical-b31acd9a",
    "source": "Medical",
    "question": "What factors are considered in CLL treatment planning?",
    "answer": "Performance status and comprehensive metabolic panel are used in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is considered in CLL treatment planning.",
      "Comprehensive metabolic panel is used in CLL treatment planning."
    ],
    "evidence_relations": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-7bc6693e",
    "source": "Medical",
    "question": "What considerations are needed before starting CLL treatment in women of reproductive age?",
    "answer": "Pregnancy testing and fertility preservation are considered before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pregnancy testing is considered before starting CLL treatment in women of reproductive age.",
      "Fertility preservation is considered before starting CLL treatment in women of reproductive age."
    ],
    "evidence_relations": "Pregnancy testing and fertility preservation are considered before starting treatment"
  },
  {
    "id": "Medical-92b44036",
    "source": "Medical",
    "question": "Which genetic alterations are relevant in CLL biomarker testing?",
    "answer": "Relevant genetic alterations include 17p deletion, TP53 mutation, and IGHV mutation.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "17p deletion is a relevant genetic alteration in CLL biomarker testing.",
      "TP53 mutation is a relevant genetic alteration in CLL biomarker testing.",
      "IGHV mutation is a relevant genetic alteration in CLL biomarker testing."
    ],
    "evidence_relations": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-7197a18d",
    "source": "Medical",
    "question": "What is the primary site of CLL?",
    "answer": "The primary site of CLL is the blood and bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary site of CLL is the blood.",
      "The primary site of CLL is the bone marrow."
    ],
    "evidence_relations": "The primary site of CLL is the blood and bone marrow"
  },
  {
    "id": "Medical-9f87cac2",
    "source": "Medical",
    "question": "What is the purpose of a comprehensive metabolic panel in CLL management?",
    "answer": "A comprehensive metabolic panel is used in treatment planning for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A comprehensive metabolic panel is used in treatment planning for CLL."
    ],
    "evidence_relations": "Performance status and comprehensive metabolic panel are used in treatment planning"
  },
  {
    "id": "Medical-f7b0cf01",
    "source": "Medical",
    "question": "What is the function of supportive care in CLL follow-up?",
    "answer": "Supportive care is part of follow-up strategies for CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care is part of follow-up strategies for CLL."
    ],
    "evidence_relations": "Follow-up strategies include watch and wait, regular monitoring, and supportive care"
  },
  {
    "id": "Medical-ccd3b472",
    "source": "Medical",
    "question": "What is the significance of complex karyotype in CLL?",
    "answer": "Complex karyotype is a biomarker assessed in CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Complex karyotype is a biomarker assessed in CLL."
    ],
    "evidence_relations": "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis"
  },
  {
    "id": "Medical-2621de32",
    "source": "Medical",
    "question": "Which symptoms may indicate advanced CLL?",
    "answer": "Symptoms such as early satiety and unintentional weight loss may indicate advanced CLL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms such as early satiety may indicate advanced CLL.",
      "Unintentional weight loss may indicate advanced CLL."
    ],
    "evidence_relations": "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss"
  },
  {
    "id": "Medical-1429a1d6",
    "source": "Medical",
    "question": "What is the most common type of throat cancer?",
    "answer": "Squamous cell carcinoma is the most common type of throat cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma is the most common type of throat cancer."
    ],
    "evidence_relations": "Squamous cell carcinoma is the most common type of throat cancer"
  },
  {
    "id": "Medical-93c00cfb",
    "source": "Medical",
    "question": "What is a major risk factor for oropharyngeal squamous cell carcinoma?",
    "answer": "HPV infection, especially HPV16, is a major risk factor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV infection is a major risk factor for oropharyngeal squamous cell carcinoma.",
      "HPV16 is a specific strain of HPV that is a major risk factor."
    ],
    "evidence_relations": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma"
  },
  {
    "id": "Medical-c99a29ae",
    "source": "Medical",
    "question": "Which symptoms may indicate throat cancer?",
    "answer": "Symptoms may include difficulty swallowing, sore throat, and changes in voice.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Difficulty swallowing may indicate throat cancer.",
      "Sore throat may indicate throat cancer.",
      "Changes in voice may indicate throat cancer."
    ],
    "evidence_relations": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-bfc7447f",
    "source": "Medical",
    "question": "What are the numbered stages of throat cancer according to the ontology?",
    "answer": "The numbered stages are Stage 0, Stage I, Stage II, Stage III, and Stage IV.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The numbered stages of throat cancer include Stage 0.",
      "The numbered stages of throat cancer include Stage I.",
      "The numbered stages of throat cancer include Stage II.",
      "The numbered stages of throat cancer include Stage III.",
      "The numbered stages of throat cancer include Stage IV."
    ],
    "evidence_relations": "Numbered stages: [\"Stage 0\", \"Stage I\", \"Stage II\", \"Stage III\", \"Stage IV\"]"
  },
  {
    "id": "Medical-4ba7ca1f",
    "source": "Medical",
    "question": "Which methods are used for tissue sampling in throat cancer diagnosis?",
    "answer": "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fine-needle aspiration (FNA) is used for tissue sampling in throat cancer diagnosis.",
      "Core needle biopsy (CNB) is used for tissue sampling in throat cancer diagnosis.",
      "Endoscopic biopsies are used for tissue sampling in throat cancer diagnosis."
    ],
    "evidence_relations": "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling"
  },
  {
    "id": "Medical-930c4439",
    "source": "Medical",
    "question": "Which biomarker tests are included in throat cancer biomarker testing?",
    "answer": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing in throat cancer includes p16 (HPV).",
      "Biomarker testing in throat cancer includes PD-L1.",
      "Biomarker testing in throat cancer includes MSI-H/dMMR.",
      "Biomarker testing in throat cancer includes tumor mutational burden."
    ],
    "evidence_relations": "Biomarker testing includes p16 (HPV), PD-L1, MSI-H/dMMR, and tumor mutational burden"
  },
  {
    "id": "Medical-49e7d093",
    "source": "Medical",
    "question": "What are the common sites of metastasis for throat cancer?",
    "answer": "Common sites of metastasis are the lungs, liver, or spine.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common sites of metastasis for throat cancer include the lungs.",
      "Common sites of metastasis for throat cancer include the liver.",
      "Common sites of metastasis for throat cancer include the spine."
    ],
    "evidence_relations": "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine"
  },
  {
    "id": "Medical-43965a1c",
    "source": "Medical",
    "question": "What is used to determine clinical stage before treatment in throat cancer?",
    "answer": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical stage of throat cancer is determined before treatment.",
      "Physical exam is used to determine clinical stage before treatment in throat cancer.",
      "Imaging is used to determine clinical stage before treatment in throat cancer.",
      "Biopsy is used to determine clinical stage before treatment in throat cancer."
    ],
    "evidence_relations": "Clinical stage is determined before treatment using physical exam, imaging, and biopsy"
  },
  {
    "id": "Medical-d8127f85",
    "source": "Medical",
    "question": "Which assessment is important before treatment of throat cancer?",
    "answer": "Dental health assessment is important before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Dental health assessment is important before treatment of throat cancer."
    ],
    "evidence_relations": "Dental health assessment is important before treatment"
  },
  {
    "id": "Medical-5e15bf0c",
    "source": "Medical",
    "question": "Which scoping procedures are used as diagnostic methods for throat cancer?",
    "answer": "Endoscopy, laryngoscopy, nasolaryngoscopy, esophagoscopy, bronchoscopy, and panendoscopy are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Endoscopy is used as a diagnostic method for throat cancer.",
      "Laryngoscopy is used as a diagnostic method for throat cancer.",
      "Nasolaryngoscopy is used as a diagnostic method for throat cancer.",
      "Esophagoscopy is used as a diagnostic method for throat cancer.",
      "Bronchoscopy is used as a diagnostic method for throat cancer.",
      "Panendoscopy is used as a diagnostic method for throat cancer."
    ],
    "evidence_relations": "Scoping procedures: [\"Endoscopy\", \"Laryngoscopy\", \"Nasolaryngoscopy\", \"Esophagoscopy\", \"Bronchoscopy\", \"Panendoscopy\"]"
  },
  {
    "id": "Medical-f5e27a80",
    "source": "Medical",
    "question": "Which genetic alterations are associated with squamous cell carcinoma of the throat?",
    "answer": "HPV-mediated, p16-positive, and p16-negative are associated genetic alterations.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV-mediated genetic alterations are associated with squamous cell carcinoma of the throat.",
      "p16-positive genetic alterations are associated with squamous cell carcinoma of the throat.",
      "p16-negative genetic alterations are associated with squamous cell carcinoma of the throat."
    ],
    "evidence_relations": "Genetic Alteration: [\"HPV-mediated\", \"p16-positive\", \"p16-negative\"]"
  },
  {
    "id": "Medical-75107d1d",
    "source": "Medical",
    "question": "What surveillance methods are used for patients after throat cancer treatment?",
    "answer": "Surveillance includes dental health assessment, imaging follow-up, and physical exam.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surveillance methods after throat cancer treatment include dental health assessment.",
      "Surveillance methods after throat cancer treatment include imaging follow-up.",
      "Surveillance methods after throat cancer treatment include physical exam."
    ],
    "evidence_relations": "Surveillance: [\"Dental health assessment\", \"Imaging follow-up\", \"Physical exam\"]"
  },
  {
    "id": "Medical-dd68e8b3",
    "source": "Medical",
    "question": "What symptoms are commonly associated with throat cancer?",
    "answer": "Difficulty swallowing, sore throat, and voice changes are common symptoms.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms associated with throat cancer include difficulty swallowing.",
      "Common symptoms associated with throat cancer include sore throat.",
      "Common symptoms associated with throat cancer include voice changes."
    ],
    "evidence_relations": "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice"
  },
  {
    "id": "Medical-fde1ce46",
    "source": "Medical",
    "question": "What are the main prognostic factors considered for squamous cell carcinoma of the throat?",
    "answer": "ECOG performance status, tumor grade, and HPV/p16 status are main prognostic factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ECOG performance status is a main prognostic factor for squamous cell carcinoma of the throat.",
      "Tumor grade is a main prognostic factor for squamous cell carcinoma of the throat.",
      "HPV/p16 status is a main prognostic factor for squamous cell carcinoma of the throat."
    ],
    "evidence_relations": "Prognostic Factor: [\"ECOG performance status\", \"Tumor grade\", \"HPV/p16 status\"]"
  },
  {
    "id": "Medical-d1271e37",
    "source": "Medical",
    "question": "What are common symptoms of cutaneous B-cell lymphoma?",
    "answer": "Symptoms include skin nodules and papules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of cutaneous B-cell lymphoma include skin nodules.",
      "Common symptoms of cutaneous B-cell lymphoma include papules."
    ],
    "evidence_relations": "Symptoms of CBCL include skin nodules and papules"
  },
  {
    "id": "Medical-500d2672",
    "source": "Medical",
    "question": "What are the typical clinical appearances of CBCL on the skin?",
    "answer": "CBCL appears as nodules or papules under the skin.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CBCL appears as nodules under the skin.",
      "CBCL appears as papules under the skin."
    ],
    "evidence_relations": "CBCL appears as nodules or papules under the skin"
  },
  {
    "id": "Medical-a40a55aa",
    "source": "Medical",
    "question": "Which subtypes are included under cutaneous B-cell lymphoma in the ontology?",
    "answer": "Primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type) are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Primary cutaneous marginal zone lymphoma (PCMZL) is included under cutaneous B-cell lymphoma.",
      "Primary cutaneous follicle center lymphoma (PCFCL) is included under cutaneous B-cell lymphoma.",
      "Primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type) is included under cutaneous B-cell lymphoma."
    ],
    "evidence_relations": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-b80836d6",
    "source": "Medical",
    "question": "Which lymphocyte subtype gives rise to cutaneous T-cell lymphoma?",
    "answer": "T lymphocytes give rise to cutaneous T-cell lymphoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T lymphocytes give rise to cutaneous T-cell lymphoma."
    ],
    "evidence_relations": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-c7d5764f",
    "source": "Medical",
    "question": "What are examples of diagnostic imaging tests for CBCL?",
    "answer": "Imaging tests are used for diagnosis of CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are used for the diagnosis of CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-1295f7a6",
    "source": "Medical",
    "question": "Which test is used to analyze cell surface proteins in CBCL diagnosis?",
    "answer": "Immunophenotyping is used to analyze cell surface proteins.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping is used to analyze cell surface proteins."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-6c304dfe",
    "source": "Medical",
    "question": "What laboratory test is commonly performed for CBCL diagnosis?",
    "answer": "Blood test is commonly performed for CBCL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A blood test is commonly performed for CBCL diagnosis."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-9b559ea7",
    "source": "Medical",
    "question": "What type of lymphoma is cutaneous T-cell lymphoma (CTCL)?",
    "answer": "CTCL is a cancer subtype of primary cutaneous lymphoma derived from T lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CTCL is a cancer subtype of primary cutaneous lymphoma.",
      "CTCL is derived from T lymphocytes."
    ],
    "evidence_relations": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
  },
  {
    "id": "Medical-145d27de",
    "source": "Medical",
    "question": "What are the characteristic skin lesions seen in CBCL?",
    "answer": "Nodules and papules are characteristic skin lesions in CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Nodules are characteristic skin lesions in CBCL.",
      "Papules are characteristic skin lesions in CBCL."
    ],
    "evidence_relations": "Symptoms of CBCL include skin nodules and papules"
  },
  {
    "id": "Medical-ed3b3141",
    "source": "Medical",
    "question": "Which white blood cell type can develop into lymphoma when growth is unregulated?",
    "answer": "Lymphocytes can develop into lymphoma when growth is unregulated.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lymphocytes can develop into lymphoma when growth is unregulated."
    ],
    "evidence_relations": "Unregulated growth of lymphocytes can develop into lymphoma"
  },
  {
    "id": "Medical-6a57de34",
    "source": "Medical",
    "question": "Which diagnostic method involves examining the skin for CBCL?",
    "answer": "Skin exam is a diagnostic method for CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A skin exam is a diagnostic method for CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-8bfc6705",
    "source": "Medical",
    "question": "Which categories of biomarkers are assessed in CBCL testing?",
    "answer": "Assessment includes both biomarkers and genetic changes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Assessment includes biomarkers.",
      "Assessment includes genetic changes."
    ],
    "evidence_relations": "Testing for CBCL includes assessment of biomarkers and genetic changes"
  },
  {
    "id": "Medical-4c444d45",
    "source": "Medical",
    "question": "Which diagnostic method is used to identify genetic changes in CBCL?",
    "answer": "Immunophenotyping is used to identify genetic changes in CBCL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Immunophenotyping is used to identify genetic changes in CBCL."
    ],
    "evidence_relations": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
  },
  {
    "id": "Medical-ca48819b",
    "source": "Medical",
    "question": "What are the three named subtypes of CBCL in the ontology?",
    "answer": "The three named subtypes are PCMZL, PCFCL, and PC-DLBCL, leg type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The three named subtypes of CBCL are PCMZL.",
      "The three named subtypes of CBCL are PCFCL.",
      "The three named subtypes of CBCL are PC-DLBCL, leg type."
    ],
    "evidence_relations": "The ontology lists PCMZL, PCFCL, and PC-DLBCL, leg type as subtypes of CBCL"
  },
  {
    "id": "Medical-960eb812",
    "source": "Medical",
    "question": "Which cell type is the origin of acute lymphoblastic leukemia (ALL)?",
    "answer": "ALL starts in lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute lymphoblastic leukemia (ALL) starts in lymphocytes."
    ],
    "evidence_relations": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-fe91b005",
    "source": "Medical",
    "question": "What rare subtype of B-ALL is treated differently?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL.",
      "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL."
    ],
    "evidence_relations": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-a413ecf5",
    "source": "Medical",
    "question": "What is B-cell lymphoblastic lymphoma also called?",
    "answer": "B-cell lymphoblastic lymphoma is also called B-LL or B-LBL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "B-cell lymphoblastic lymphoma is also called B-LL.",
      "B-cell lymphoblastic lymphoma is also called B-LBL."
    ],
    "evidence_relations": "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)"
  },
  {
    "id": "Medical-9ab2163c",
    "source": "Medical",
    "question": "What is T-cell lymphoblastic lymphoma also called?",
    "answer": "T-cell lymphoblastic lymphoma is also called T-LL or T-LBL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell lymphoblastic lymphoma is also called T-LL.",
      "T-cell lymphoblastic lymphoma is also called T-LBL."
    ],
    "evidence_relations": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)"
  },
  {
    "id": "Medical-5a825e05",
    "source": "Medical",
    "question": "What is the minimum percentage of lymphoblasts in bone marrow required for ALL diagnosis?",
    "answer": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow."
    ],
    "evidence_relations": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow"
  },
  {
    "id": "Medical-b3af6970",
    "source": "Medical",
    "question": "What are the possible disease sites for ALL?",
    "answer": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL can be found in bone marrow.",
      "ALL can be found in blood.",
      "ALL can be found in testicles.",
      "ALL can be found in the central nervous system (CNS)."
    ],
    "evidence_relations": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)"
  },
  {
    "id": "Medical-daac4d33",
    "source": "Medical",
    "question": "What symptom can T-ALL cause due to an enlarged thymus?",
    "answer": "T-ALL can cause breathing problems due to an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-ALL can cause breathing problems due to an enlarged thymus."
    ],
    "evidence_relations": "T-ALL can cause breathing problems due to an enlarged thymus"
  },
  {
    "id": "Medical-e31f34b7",
    "source": "Medical",
    "question": "What are the components of ALL treatment besides chemotherapy and steroids?",
    "answer": "Systemic therapy and supportive care are part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Systemic therapy is part of ALL treatment.",
      "Supportive care is part of ALL treatment."
    ],
    "evidence_relations": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-bff01916",
    "source": "Medical",
    "question": "Which subtype of B-ALL requires intensive systemic therapies?",
    "answer": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies."
    ],
    "evidence_relations": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
  },
  {
    "id": "Medical-b63d5b37",
    "source": "Medical",
    "question": "For which cases are clinical trials preferred in ALL?",
    "answer": "Clinical trials are preferred for certain B-ALL and T-ALL cases.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are preferred for certain B-ALL cases.",
      "Clinical trials are preferred for certain T-ALL cases."
    ],
    "evidence_relations": "Clinical trials are preferred for certain B-ALL and T-ALL cases"
  },
  {
    "id": "Medical-85d1a489",
    "source": "Medical",
    "question": "How is infant ALL (under 12 months) treated compared to other age groups?",
    "answer": "Infant ALL (under 12 months) is treated differently than other age groups.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Infant ALL (under 12 months) is treated differently than other age groups."
    ],
    "evidence_relations": "Infant ALL (under 12 months) is treated differently than other age groups"
  },
  {
    "id": "Medical-786c3df5",
    "source": "Medical",
    "question": "Which age groups are most often affected by ALL?",
    "answer": "ALL most often affects children, adolescents, and young adults (AYAs).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL most often affects children.",
      "ALL most often affects adolescents.",
      "ALL most often affects young adults (AYAs)."
    ],
    "evidence_relations": "ALL most often affects children, adolescents, and young adults (AYAs)"
  },
  {
    "id": "Medical-1d62116d",
    "source": "Medical",
    "question": "What is the purpose of a lumbar puncture in ALL diagnosis?",
    "answer": "A lumbar puncture is used as a diagnostic method for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A lumbar puncture is used as a diagnostic method for ALL."
    ],
    "evidence_relations": "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture"
  },
  {
    "id": "Medical-0c88cd2e",
    "source": "Medical",
    "question": "What is the standard supportive care for ALL?",
    "answer": "Supportive care is part of ALL treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care is part of ALL treatment."
    ],
    "evidence_relations": "Systemic therapy and supportive care are part of ALL treatment"
  },
  {
    "id": "Medical-efdf2abc",
    "source": "Medical",
    "question": "What cancer type is characterized by fast growth and origin in lymphocytes?",
    "answer": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer.",
      "ALL starts in lymphocytes."
    ],
    "evidence_relations": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-45dbe22b",
    "source": "Medical",
    "question": "Which site is affected in T-cell lymphoblastic lymphoma?",
    "answer": "T-cell lymphoblastic lymphoma involves the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell lymphoblastic lymphoma involves the thymus."
    ],
    "evidence_relations": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)"
  },
  {
    "id": "Medical-d579b469",
    "source": "Medical",
    "question": "What symptom may result from T-ALL affecting the thymus?",
    "answer": "Breathing problems may result from T-ALL affecting the thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Breathing problems may result from T-ALL affecting the thymus."
    ],
    "evidence_relations": "T-ALL can cause breathing problems due to an enlarged thymus"
  },
  {
    "id": "Medical-e0090b36",
    "source": "Medical",
    "question": "What type of cancer is rectal cancer classified as?",
    "answer": "Rectal cancer is a type of colorectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Rectal cancer is a type of colorectal cancer."
    ],
    "evidence_relations": "Rectal cancer is a type of colorectal cancer"
  },
  {
    "id": "Medical-2f6c215a",
    "source": "Medical",
    "question": "What is the most common subtype of rectal cancer?",
    "answer": "Adenocarcinoma is the most common subtype of rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenocarcinoma is the most common subtype of rectal cancer."
    ],
    "evidence_relations": "Adenocarcinoma is the most common subtype of rectal cancer"
  },
  {
    "id": "Medical-49bb5694",
    "source": "Medical",
    "question": "Which polyps rarely become cancerous in the rectum?",
    "answer": "Hyperplastic and inflammatory polyps rarely turn into cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hyperplastic polyps rarely turn into cancer.",
      "Inflammatory polyps rarely turn into cancer."
    ],
    "evidence_relations": "Hyperplastic and inflammatory polyps rarely turn into cancer"
  },
  {
    "id": "Medical-6b8d3af0",
    "source": "Medical",
    "question": "What are the recommended biomarkers to test in all rectal tumors?",
    "answer": "All rectal tumors should be tested for dMMR or MSI-H.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All rectal tumors should be tested for dMMR.",
      "All rectal tumors should be tested for MSI-H."
    ],
    "evidence_relations": "All rectal tumors should be tested for dMMR or MSI-H"
  },
  {
    "id": "Medical-63846367",
    "source": "Medical",
    "question": "Which biomarkers are associated with rectal cancer?",
    "answer": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mismatch repair deficiency (dMMR) is a biomarker in rectal cancer.",
      "Microsatellite instability-high (MSI-H) is a biomarker in rectal cancer."
    ],
    "evidence_relations": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer"
  },
  {
    "id": "Medical-7bd39a07",
    "source": "Medical",
    "question": "What genetic syndrome is a risk factor for rectal cancer?",
    "answer": "Lynch syndrome is a genetic risk factor for rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lynch syndrome is a genetic risk factor for rectal cancer."
    ],
    "evidence_relations": "Lynch syndrome is a genetic risk factor for rectal cancer"
  },
  {
    "id": "Medical-5025010a",
    "source": "Medical",
    "question": "Which genetic syndrome causes multiple polyps and increases rectal cancer risk?",
    "answer": "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Familial adenomatous polyposis (FAP) is a genetic syndrome.",
      "Familial adenomatous polyposis (FAP) causes multiple polyps.",
      "Familial adenomatous polyposis (FAP) increases rectal cancer risk."
    ],
    "evidence_relations": "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
  },
  {
    "id": "Medical-ebc00ba5",
    "source": "Medical",
    "question": "What blood test is used for monitoring rectal cancer?",
    "answer": "Blood tests such as CEA are used for monitoring rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Blood tests such as CEA are used for monitoring rectal cancer."
    ],
    "evidence_relations": "Blood tests such as CEA are used for monitoring rectal cancer"
  },
  {
    "id": "Medical-9a4b562a",
    "source": "Medical",
    "question": "Which imaging method is recommended for staging rectal cancer?",
    "answer": "MRI of the pelvis is recommended for staging rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MRI of the pelvis is recommended for staging rectal cancer."
    ],
    "evidence_relations": "MRI of the pelvis is recommended for staging rectal cancer"
  },
  {
    "id": "Medical-4418f730",
    "source": "Medical",
    "question": "Which scan is used to detect metastasis in rectal cancer?",
    "answer": "CT scan of chest and abdomen is used to detect metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CT scan of chest and abdomen is used to detect metastasis in rectal cancer."
    ],
    "evidence_relations": "CT scan of chest and abdomen is used to detect metastasis"
  },
  {
    "id": "Medical-58b16818",
    "source": "Medical",
    "question": "Which surgical procedure is an option for T1 tumors at the end of the rectum?",
    "answer": "Transanal local excision is an option for T1 tumors at the end of the rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Transanal local excision is an option for T1 tumors at the end of the rectum."
    ],
    "evidence_relations": "Transanal local excision is an option for T1 tumors at the end of the rectum"
  },
  {
    "id": "Medical-9fffc3b8",
    "source": "Medical",
    "question": "Which surgical procedure is used for tumors in the mid to upper rectum?",
    "answer": "Low anterior resection (LAR) is used for tumors in the mid to upper rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Low anterior resection (LAR) is used for tumors in the mid rectum.",
      "Low anterior resection (LAR) is used for tumors in the upper rectum."
    ],
    "evidence_relations": "Low anterior resection (LAR) is used for tumors in the mid to upper rectum"
  },
  {
    "id": "Medical-b73e21e2",
    "source": "Medical",
    "question": "What surgery is performed for tumors in the lower rectum?",
    "answer": "Abdominoperineal resection (APR) is used for tumors in the lower rectum.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Abdominoperineal resection (APR) is performed for tumors in the lower rectum."
    ],
    "evidence_relations": "Abdominoperineal resection (APR) is used for tumors in the lower rectum"
  },
  {
    "id": "Medical-bd4e8d31",
    "source": "Medical",
    "question": "What treatment is used for locally advanced rectal cancer?",
    "answer": "Chemoradiation is used for locally advanced rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemoradiation is used for locally advanced rectal cancer."
    ],
    "evidence_relations": "Chemoradiation is used for locally advanced rectal cancer"
  },
  {
    "id": "Medical-1537264f",
    "source": "Medical",
    "question": "Which chemotherapy drugs may be included in rectal cancer regimens?",
    "answer": "Chemotherapy regimens may include oxaliplatin or irinotecan.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy regimens for rectal cancer may include oxaliplatin.",
      "Chemotherapy regimens for rectal cancer may include irinotecan."
    ],
    "evidence_relations": "Chemotherapy regimens may include oxaliplatin or irinotecan"
  },
  {
    "id": "Medical-c02f01c8",
    "source": "Medical",
    "question": "Which procedure is recommended after surgery for surveillance of rectal cancer?",
    "answer": "Colonoscopy is recommended after surgery for surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Colonoscopy is recommended after surgery for surveillance of rectal cancer."
    ],
    "evidence_relations": "Colonoscopy is recommended after surgery for surveillance"
  },
  {
    "id": "Medical-3677b386",
    "source": "Medical",
    "question": "What are the fertility preservation options for rectal cancer patients?",
    "answer": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation options for rectal cancer patients include sperm banking.",
      "Fertility preservation options for rectal cancer patients include egg freezing.",
      "Fertility preservation options for rectal cancer patients include ovarian tissue banking.",
      "Fertility preservation options for rectal cancer patients include ovarian transposition."
    ],
    "evidence_relations": "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition"
  },
  {
    "id": "Medical-ce8744bd",
    "source": "Medical",
    "question": "What symptoms may indicate rectal cancer?",
    "answer": "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of rectal cancer may include changes in bowel habits.",
      "Symptoms of rectal cancer may include rectal bleeding.",
      "Symptoms of rectal cancer may include abdominal pain."
    ],
    "evidence_relations": "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain"
  },
  {
    "id": "Medical-f7e69032",
    "source": "Medical",
    "question": "Which genetic alterations are risk factors for rectal cancer?",
    "answer": "Lynch syndrome and familial adenomatous polyposis (FAP) are risk factors for rectal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Lynch syndrome is a risk factor for rectal cancer.",
      "Familial adenomatous polyposis (FAP) is a risk factor for rectal cancer."
    ],
    "evidence_relations": "Lynch syndrome is a genetic risk factor for rectal cancer; Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
  },
  {
    "id": "Medical-15f8d40a",
    "source": "Medical",
    "question": "Which surgical procedures are included in rectal cancer treatment?",
    "answer": "Surgical procedures include polypectomy, transanal local excision, transabdominal surgery, low anterior resection (LAR), and abdominoperineal resection (APR).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgical procedures for rectal cancer treatment include polypectomy.",
      "Surgical procedures for rectal cancer treatment include transanal local excision.",
      "Surgical procedures for rectal cancer treatment include transabdominal surgery.",
      "Surgical procedures for rectal cancer treatment include low anterior resection (LAR).",
      "Surgical procedures for rectal cancer treatment include abdominoperineal resection (APR)."
    ],
    "evidence_relations": "Surgical Procedure: Polypectomy, Transanal local excision, Transabdominal surgery, Low anterior resection (LAR), Abdominoperineal resection (APR)"
  },
  {
    "id": "Medical-3a64b795",
    "source": "Medical",
    "question": "What are the main symptoms of rectal cancer according to the ontology?",
    "answer": "The main symptoms are rectal bleeding, abdominal pain, and changes in bowel habits.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The main symptoms of rectal cancer include rectal bleeding.",
      "The main symptoms of rectal cancer include abdominal pain.",
      "The main symptoms of rectal cancer include changes in bowel habits."
    ],
    "evidence_relations": "Symptom: Rectal bleeding, Abdominal pain, Changes in bowel habits"
  },
  {
    "id": "Medical-9a4565c5",
    "source": "Medical",
    "question": "What is the recommended imaging for surveillance after local excision of rectal cancer?",
    "answer": "Imaging with EUS or MRI is recommended for surveillance after local excision.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging with EUS is recommended for surveillance after local excision of rectal cancer.",
      "Imaging with MRI is recommended for surveillance after local excision of rectal cancer."
    ],
    "evidence_relations": "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5"
  },
  {
    "id": "Medical-1118823b",
    "source": "Medical",
    "question": "What is the most common subtype of bladder cancer?",
    "answer": "Urothelial carcinoma is the most common subtype.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Urothelial carcinoma is the most common subtype of bladder cancer."
    ],
    "evidence_relations": "Urothelial carcinoma is the most common subtype of bladder cancer"
  },
  {
    "id": "Medical-b7f57756",
    "source": "Medical",
    "question": "Which cancer subtypes are less common in bladder cancer?",
    "answer": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Squamous cell carcinoma is a less common subtype of bladder cancer.",
      "Adenocarcinoma is a less common subtype of bladder cancer.",
      "Small cell carcinoma is a less common subtype of bladder cancer."
    ],
    "evidence_relations": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer"
  },
  {
    "id": "Medical-aeb19c82",
    "source": "Medical",
    "question": "What is the greatest risk factor for bladder cancer?",
    "answer": "Smoking is the greatest risk factor for bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Smoking is the greatest risk factor for bladder cancer."
    ],
    "evidence_relations": "Smoking is the greatest risk factor for bladder cancer"
  },
  {
    "id": "Medical-a14ecb5b",
    "source": "Medical",
    "question": "What is the role of biomarker tests in bladder cancer?",
    "answer": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer."
    ],
    "evidence_relations": "Biomarker tests may be used for surveillance in nonmuscle-invasive bladder cancer"
  },
  {
    "id": "Medical-7c3827b8",
    "source": "Medical",
    "question": "Which genetic alterations are associated with bladder cancer?",
    "answer": "Mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mutations in CDKN2A are associated with bladder cancer.",
      "Mutations in FGFR3 are associated with bladder cancer.",
      "Mutations in PIK3CA are associated with bladder cancer.",
      "Mutations in ERBB genes are associated with bladder cancer."
    ],
    "evidence_relations": "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer"
  },
  {
    "id": "Medical-d587c0c2",
    "source": "Medical",
    "question": "Which chemotherapy regimens are used for bladder cancer?",
    "answer": "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Chemotherapy regimens include cisplatin-based combinations.",
      "Chemotherapy regimens include ddMVAC."
    ],
    "evidence_relations": "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC"
  },
  {
    "id": "Medical-01f6cee9",
    "source": "Medical",
    "question": "What is trimodal therapy in bladder cancer?",
    "answer": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Trimodal therapy combines TURBT, chemotherapy, and radiation.",
      "Trimodal therapy is a bladder-preserving approach."
    ],
    "evidence_relations": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach"
  },
  {
    "id": "Medical-f14367b4",
    "source": "Medical",
    "question": "Are clinical trials available for bladder cancer patients?",
    "answer": "Clinical trials are available at all stages of bladder cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are available for bladder cancer patients.",
      "Clinical trials are available at all stages of bladder cancer."
    ],
    "evidence_relations": "Clinical trials are available at all stages of bladder cancer"
  },
  {
    "id": "Medical-5c1d4e51",
    "source": "Medical",
    "question": "What are common side effects of bladder cancer treatment?",
    "answer": "Common side effects include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common side effects of bladder cancer treatment include bleeding.",
      "Common side effects of bladder cancer treatment include infection.",
      "Common side effects of bladder cancer treatment include sexual dysfunction.",
      "Common side effects of bladder cancer treatment include urinary incontinence.",
      "Common side effects of bladder cancer treatment include fatigue.",
      "Common side effects of bladder cancer treatment include nausea.",
      "Common side effects of bladder cancer treatment include diarrhea."
    ],
    "evidence_relations": "Common side effects of treatment include bleeding, infection, sexual dysfunction, urinary incontinence, fatigue, nausea, and diarrhea"
  },
  {
    "id": "Medical-0a1eb649",
    "source": "Medical",
    "question": "Which procedures are included in follow-up and surveillance for bladder cancer?",
    "answer": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are included in follow-up and surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Regular cystoscopy is included in follow-up and surveillance for bladder cancer.",
      "Urine cytology is included in follow-up and surveillance for bladder cancer.",
      "Imaging is included in follow-up and surveillance for bladder cancer.",
      "Biomarker surveillance is included in follow-up and surveillance for bladder cancer."
    ],
    "evidence_relations": "Follow-up/Surveillance: [Regular cystoscopy, Urine cytology, Imaging, Biomarker surveillance]"
  },
  {
    "id": "Medical-10f571cf",
    "source": "Medical",
    "question": "Name two anatomical structures in the kidney where cancer can spread locally.",
    "answer": "Kidney cancer can spread locally to surrounding fat and blood vessels.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Kidney cancer can spread locally to surrounding fat.",
      "Kidney cancer can spread locally to blood vessels."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-b8dfd72f",
    "source": "Medical",
    "question": "Which factors determine the treatment approach for RCC?",
    "answer": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Treatment for RCC is based on histology.",
      "Treatment for RCC is based on tumor size.",
      "Treatment for RCC is based on tumor location.",
      "Treatment for RCC is based on presence of metastasis."
    ],
    "evidence_relations": "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis"
  },
  {
    "id": "Medical-1e2c5da7",
    "source": "Medical",
    "question": "How are multiple tumors in one or both kidneys classified?",
    "answer": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Multiple tumors in one kidney are treated as separate primary tumors.",
      "Multiple tumors in both kidneys are treated as separate primary tumors.",
      "Multiple tumors in one or both kidneys are not considered metastasis."
    ],
    "evidence_relations": "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis"
  },
  {
    "id": "Medical-a11058f1",
    "source": "Medical",
    "question": "Which anatomical structure is the origin of RCC according to the ontology?",
    "answer": "RCC originates from the renal tubules.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "RCC originates from the renal tubules."
    ],
    "evidence_relations": "RCC starts in the cells that line the renal tubules"
  },
  {
    "id": "Medical-e3a6570b",
    "source": "Medical",
    "question": "List three diagnostic tests for kidney cancer.",
    "answer": "Imaging tests, blood tests, and urine tests are diagnostic methods.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging tests are a diagnostic method for kidney cancer.",
      "Blood tests are a diagnostic method for kidney cancer.",
      "Urine tests are a diagnostic method for kidney cancer."
    ],
    "evidence_relations": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-a7da5e0d",
    "source": "Medical",
    "question": "What is a histological subtype of non-clear cell RCC?",
    "answer": "Papillary RCC is a histological subtype of non-clear cell RCC.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Papillary RCC is a histological subtype of non-clear cell RCC."
    ],
    "evidence_relations": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma"
  },
  {
    "id": "Medical-823c7c4f",
    "source": "Medical",
    "question": "Which anatomical structure surrounds the kidney and can be invaded by cancer?",
    "answer": "Gerotas fascia surrounds the kidney and can be invaded by cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Gerotas fascia surrounds the kidney.",
      "Gerotas fascia can be invaded by cancer."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-794ec19c",
    "source": "Medical",
    "question": "What is a potential local spread site for kidney cancer besides fat and vessels?",
    "answer": "Adrenal glands are a potential local spread site for kidney cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adrenal glands are a potential local spread site for kidney cancer."
    ],
    "evidence_relations": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerotas fascia"
  },
  {
    "id": "Medical-974e88ba",
    "source": "Medical",
    "question": "Which cancer subtype is called nephroblastoma?",
    "answer": "Wilms tumor is also known as nephroblastoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Wilms tumor is also known as nephroblastoma."
    ],
    "evidence_relations": "Wilms tumor (nephroblastoma) is listed in the ontology"
  },
  {
    "id": "Medical-10a38986",
    "source": "Medical",
    "question": "Which kidney cancer arises from the connective tissue?",
    "answer": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Renal sarcoma starts in the blood vessels of the kidney.",
      "Renal sarcoma starts in the connective tissue of the kidney."
    ],
    "evidence_relations": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
  },
  {
    "id": "Medical-b53a2a5a",
    "source": "Medical",
    "question": "Which subtypes are included in non-clear cell RCC according to the ontology?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC are included.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Papillary RCC is included in non-clear cell RCC.",
      "Chromophobe RCC is included in non-clear cell RCC.",
      "Collecting duct RCC is included in non-clear cell RCC.",
      "Renal medullary carcinoma is included in non-clear cell RCC.",
      "Clear cell papillary renal cell tumor is included in non-clear cell RCC.",
      "Fumarate hydratase-deficient RCC is included in non-clear cell RCC.",
      "ELOC-mutated RCC is included in non-clear cell RCC."
    ],
    "evidence_relations": "Non-clear cell RCC (nccRCC) includes Papillary RCC (PRCC), Chromophobe RCC, Collecting duct RCC (cdRCC), Renal medullary carcinoma (RMC), Clear cell papillary renal cell tumor, Fumarate hydratase-deficient RCC, and ELOC-mutated RCC"
  },
  {
    "id": "Medical-b821991a",
    "source": "Medical",
    "question": "Which test is used to evaluate biomarkers in kidney cancer?",
    "answer": "Biomarker testing is used to evaluate biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Biomarker testing is used to evaluate biomarkers in kidney cancer."
    ],
    "evidence_relations": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing"
  },
  {
    "id": "Medical-c87340df",
    "source": "Medical",
    "question": "Which high-risk HPV strain is associated with anal cancer?",
    "answer": "HPV16 is a high-risk strain associated with anal cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HPV16 is a high-risk strain.",
      "HPV16 is associated with anal cancer."
    ],
    "evidence_relations": "HPV16 is a high-risk strain associated with anal cancer"
  },
  {
    "id": "Medical-7dfa3ebe",
    "source": "Medical",
    "question": "What are common symptoms of anal cancer?",
    "answer": "Common symptoms include rectal bleeding, anal itching, pain, and a lump near the anus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of anal cancer include rectal bleeding.",
      "Common symptoms of anal cancer include anal itching.",
      "Common symptoms of anal cancer include pain.",
      "Common symptoms of anal cancer include a lump near the anus."
    ],
    "evidence_relations": "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus"
  },
  {
    "id": "Medical-0c7cb4ef",
    "source": "Medical",
    "question": "Which risk factor is shared by patients with a history of cervical, vulvar, or vaginal cancer or precancer?",
    "answer": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A history of cervical cancer increases anal cancer risk.",
      "A history of vulvar cancer increases anal cancer risk.",
      "A history of vaginal cancer increases anal cancer risk.",
      "A history of precancer increases anal cancer risk."
    ],
    "evidence_relations": "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk"
  },
  {
    "id": "Medical-5fed2a2c",
    "source": "Medical",
    "question": "What is the recommended follow-up for complete remission after anal cancer treatment?",
    "answer": "Follow-up includes DRE and inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years (stage II/III).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for complete remission after anal cancer treatment includes DRE every 3-6 months for 5 years.",
      "Follow-up for complete remission after anal cancer treatment includes inguinal lymph node exam every 3-6 months for 5 years.",
      "Follow-up for complete remission after anal cancer treatment includes anoscopy every 6-12 months for 3 years.",
      "Follow-up for complete remission after anal cancer treatment includes imaging yearly for 3 years for stage II/III."
    ],
    "evidence_relations": "Complete remission: DRE every 3-6 months for 5 years, inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, imaging yearly for 3 years (stage II/III)"
  },
  {
    "id": "Medical-506ba6ee",
    "source": "Medical",
    "question": "Which chemotherapy regimens are used for metastatic anal cancer?",
    "answer": "Carboplatin and paclitaxel, FOLFOX, FOLFCIS, modified DCF, and 5-FU and cisplatin are used.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Carboplatin and paclitaxel are used for metastatic anal cancer.",
      "FOLFOX is used for metastatic anal cancer.",
      "FOLFCIS is used for metastatic anal cancer.",
      "Modified DCF is used for metastatic anal cancer.",
      "5-FU and cisplatin are used for metastatic anal cancer."
    ],
    "evidence_relations": "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)"
  },
  {
    "id": "Medical-63d09604",
    "source": "Medical",
    "question": "What precancerous lesions are associated with anal squamous cell carcinoma?",
    "answer": "AIN, LSIL, HSIL, and Stage 0 are precancerous lesions.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "AIN is a precancerous lesion associated with anal squamous cell carcinoma.",
      "LSIL is a precancerous lesion associated with anal squamous cell carcinoma.",
      "HSIL is a precancerous lesion associated with anal squamous cell carcinoma.",
      "Stage 0 is a precancerous lesion associated with anal squamous cell carcinoma."
    ],
    "evidence_relations": "Anal squamous cell carcinoma: Precancerous Lesion: [AIN, LSIL, HSIL, Stage 0]"
  },
  {
    "id": "Medical-481c27a3",
    "source": "Medical",
    "question": "What are the consequences of abdominoperineal resection (APR)?",
    "answer": "APR results in a permanent colostomy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Abdominoperineal resection (APR) results in a permanent colostomy."
    ],
    "evidence_relations": "APR results in a permanent colostomy"
  },
  {
    "id": "Medical-73b1e8c2",
    "source": "Medical",
    "question": "What is the indication for groin dissection in anal cancer?",
    "answer": "Groin dissection is indicated for lymph node recurrence.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Groin dissection is indicated for lymph node recurrence in anal cancer."
    ],
    "evidence_relations": "Groin dissection: Indication: Lymph node recurrence"
  },
  {
    "id": "Medical-912613b8",
    "source": "Medical",
    "question": "Which supportive care measures are provided for anal cancer patients?",
    "answer": "Supportive care includes pelvic floor physical therapy, dietary counseling, vaginal dilator therapy, ostomy care, mental health support, and peer-to-peer support.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Supportive care for anal cancer patients includes pelvic floor physical therapy.",
      "Supportive care for anal cancer patients includes dietary counseling.",
      "Supportive care for anal cancer patients includes vaginal dilator therapy.",
      "Supportive care for anal cancer patients includes ostomy care.",
      "Supportive care for anal cancer patients includes mental health support.",
      "Supportive care for anal cancer patients includes peer-to-peer support."
    ],
    "evidence_relations": "Supportive Care: [Pelvic floor physical therapy, Dietary counseling, Vaginal dilator therapy, Ostomy care, Mental health support, Peer-to-peer support]"
  },
  {
    "id": "Medical-ea7aec7d",
    "source": "Medical",
    "question": "What are common side effects of anal cancer treatment?",
    "answer": "Common side effects include infertility, bowel dysfunction, urinary incontinence, sexual dysfunction, hand-foot syndrome, nausea, vomiting, diarrhea, fatigue, skin irritation, mucositis, low blood cell counts, hearing loss (cisplatin), and neuropathy (oxaliplatin).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common side effects of anal cancer treatment include infertility.",
      "Common side effects of anal cancer treatment include bowel dysfunction.",
      "Common side effects of anal cancer treatment include urinary incontinence.",
      "Common side effects of anal cancer treatment include sexual dysfunction.",
      "Common side effects of anal cancer treatment include hand-foot syndrome.",
      "Common side effects of anal cancer treatment include nausea.",
      "Common side effects of anal cancer treatment include vomiting.",
      "Common side effects of anal cancer treatment include diarrhea.",
      "Common side effects of anal cancer treatment include fatigue.",
      "Common side effects of anal cancer treatment include skin irritation.",
      "Common side effects of anal cancer treatment include mucositis.",
      "Common side effects of anal cancer treatment include low blood cell counts.",
      "Common side effects of anal cancer treatment include hearing loss due to cisplatin.",
      "Common side effects of anal cancer treatment include neuropathy due to oxaliplatin."
    ],
    "evidence_relations": "Side Effect: [Infertility, Bowel dysfunction, Urinary incontinence, Sexual dysfunction, Hand-foot syndrome, Nausea, Vomiting, Diarrhea, Fatigue, Skin irritation, Mucositis, Low blood cell counts, Hearing loss (cisplatin), Neuropathy (oxaliplatin)]"
  },
  {
    "id": "Medical-4c1f9dd4",
    "source": "Medical",
    "question": "Which patients are eligible for clinical trials in anal cancer?",
    "answer": "All patients are encouraged to consider enrollment in clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "All patients are encouraged to consider enrollment in clinical trials for anal cancer."
    ],
    "evidence_relations": "Clinical trials are recommended for all patients if available"
  },
  {
    "id": "Medical-0eed4fb2",
    "source": "Medical",
    "question": "What is the primary cancer type described in this context?",
    "answer": "Acute lymphoblastic leukemia (ALL) is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "The primary cancer type described is acute lymphoblastic leukemia (ALL)."
    ],
    "evidence_relations": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
  },
  {
    "id": "Medical-abe5fc71",
    "source": "Medical",
    "question": "Which cells are the origin of ALL?",
    "answer": "ALL arises from lymphoid progenitor cells.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Acute lymphoblastic leukemia (ALL) arises from lymphoid progenitor cells."
    ],
    "evidence_relations": "ALL arises from lymphoid progenitor cells"
  },
  {
    "id": "Medical-b2e840c7",
    "source": "Medical",
    "question": "Which ALL subtype can cause an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) can cause an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell ALL (T-ALL) can cause an enlarged thymus."
    ],
    "evidence_relations": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-ce4f84f0",
    "source": "Medical",
    "question": "What is mature B-cell ALL also called?",
    "answer": "Mature B-cell ALL is also called Burkitt leukemia.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mature B-cell ALL is also called Burkitt leukemia."
    ],
    "evidence_relations": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-ea9eb2d8",
    "source": "Medical",
    "question": "What is the main difference in treatment for mature B-cell ALL compared to B-ALL?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Mature B-cell ALL is also known as Burkitt leukemia.",
      "Mature B-cell ALL is treated differently from B-ALL."
    ],
    "evidence_relations": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL"
  },
  {
    "id": "Medical-1b8db6c8",
    "source": "Medical",
    "question": "What are the main treatment modalities for ALL?",
    "answer": "Everyone with ALL is treated with steroids and multiagent chemotherapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Everyone with ALL is treated with steroids.",
      "Everyone with ALL is treated with multiagent chemotherapy."
    ],
    "evidence_relations": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-99cee2d0",
    "source": "Medical",
    "question": "Which ALL subtype is treated with therapies targeting the BCR::ABL protein?",
    "answer": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein."
    ],
    "evidence_relations": "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
  },
  {
    "id": "Medical-dfc549c9",
    "source": "Medical",
    "question": "What is the preferred treatment approach for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL?",
    "answer": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are preferred for certain subtypes of ALL.",
      "Certain subtypes include BCR::ABL1-negative or BCR::ABL1-like B-ALL."
    ],
    "evidence_relations": "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL"
  },
  {
    "id": "Medical-0b9d8142",
    "source": "Medical",
    "question": "What are the treatment options for T-ALL?",
    "answer": "T-ALL treatment options include chemotherapy and clinical trials.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-ALL treatment options include chemotherapy.",
      "T-ALL treatment options include clinical trials."
    ],
    "evidence_relations": "T-ALL treatment options include chemotherapy and clinical trials"
  },
  {
    "id": "Medical-3c195424",
    "source": "Medical",
    "question": "What are common symptoms of ALL?",
    "answer": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Symptoms of ALL may include anemia.",
      "Symptoms of ALL may include infections.",
      "Symptoms of ALL may include bleeding.",
      "Symptoms of ALL may include enlarged lymph nodes.",
      "Symptoms of ALL may include organ involvement."
    ],
    "evidence_relations": "Symptoms of ALL may include anemia, infections, bleeding, enlarged lymph nodes, and organ involvement"
  },
  {
    "id": "Medical-06ecb1df",
    "source": "Medical",
    "question": "What are some risk factors for developing ALL?",
    "answer": "Risk factors for ALL include certain genetic syndromes and family history.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for developing ALL include certain genetic syndromes.",
      "Risk factors for developing ALL include family history."
    ],
    "evidence_relations": "Risk factors for ALL include certain genetic syndromes and family history"
  },
  {
    "id": "Medical-fcfc4ee8",
    "source": "Medical",
    "question": "Which patient populations are most commonly affected by ALL?",
    "answer": "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL is more common in children.",
      "ALL also occurs in adolescents and young adults (AYAs).",
      "ALL occurs in adults."
    ],
    "evidence_relations": "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults"
  },
  {
    "id": "Medical-612b302a",
    "source": "Medical",
    "question": "What supportive care should be considered before ALL treatment?",
    "answer": "Fertility preservation should be considered before treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation should be considered before ALL treatment."
    ],
    "evidence_relations": "Fertility preservation should be considered before treatment"
  },
  {
    "id": "Medical-5496bd62",
    "source": "Medical",
    "question": "What is included in follow-up for ALL patients?",
    "answer": "Follow-up includes regular blood tests and surveillance for relapse.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for ALL patients includes regular blood tests.",
      "Follow-up for ALL patients includes surveillance for relapse."
    ],
    "evidence_relations": "Follow-up includes regular blood tests and surveillance for relapse"
  },
  {
    "id": "Medical-c3fbbeb8",
    "source": "Medical",
    "question": "What laboratory method is essential for immunophenotyping in ALL diagnosis?",
    "answer": "Flow cytometry is essential for immunophenotyping in ALL diagnosis.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Flow cytometry is essential for immunophenotyping in ALL diagnosis."
    ],
    "evidence_relations": "Diagnosis of ALL involves flow cytometry, immunophenotyping"
  },
  {
    "id": "Medical-30093110",
    "source": "Medical",
    "question": "Which organs may show involvement in ALL besides bone marrow?",
    "answer": "ALL may involve blood, lymph nodes, thymus, testicles, and central nervous system.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ALL may involve blood.",
      "ALL may involve lymph nodes.",
      "ALL may involve thymus.",
      "ALL may involve testicles.",
      "ALL may involve central nervous system."
    ],
    "evidence_relations": "ALL can be found in bone marrow, blood, testicles, and central nervous system"
  },
  {
    "id": "Medical-a06b41f4",
    "source": "Medical",
    "question": "Which subtype of ALL is associated with an enlarged thymus?",
    "answer": "T-cell ALL (T-ALL) is associated with an enlarged thymus.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "T-cell ALL (T-ALL) is associated with an enlarged thymus."
    ],
    "evidence_relations": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus"
  },
  {
    "id": "Medical-277e2774",
    "source": "Medical",
    "question": "What is the role of steroids in ALL treatment?",
    "answer": "Steroids are part of the standard multiagent chemotherapy for ALL.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Steroids are part of the standard multiagent chemotherapy for ALL."
    ],
    "evidence_relations": "Everyone with ALL is treated with steroids and multiagent chemotherapy"
  },
  {
    "id": "Medical-69adc0f1",
    "source": "Medical",
    "question": "How is Stage II pancreatic cancer defined?",
    "answer": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Stage II pancreatic cancer is defined by a tumor larger than 4 cm.",
      "Stage II pancreatic cancer may have spread to 1-3 nearby lymph nodes."
    ],
    "evidence_relations": "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes"
  },
  {
    "id": "Medical-62915cf3",
    "source": "Medical",
    "question": "Which hereditary syndromes increase the risk of pancreatic cancer?",
    "answer": "HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "HBOC increases the risk of pancreatic cancer.",
      "Peutz-Jeghers syndrome increases the risk of pancreatic cancer.",
      "Lynch syndrome increases the risk of pancreatic cancer.",
      "Li-Fraumeni syndrome increases the risk of pancreatic cancer.",
      "FAMMM syndrome increases the risk of pancreatic cancer.",
      "Hereditary pancreatitis increases the risk of pancreatic cancer."
    ],
    "evidence_relations": "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer"
  },
  {
    "id": "Medical-5d1e33ba",
    "source": "Medical",
    "question": "What diagnostic methods are used for pancreatic cancer?",
    "answer": "Diagnostic methods include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging is a diagnostic method for pancreatic cancer.",
      "Endoscopic tests are a diagnostic method for pancreatic cancer.",
      "Biopsy is a diagnostic method for pancreatic cancer.",
      "Blood tests are a diagnostic method for pancreatic cancer.",
      "Genetic tests are a diagnostic method for pancreatic cancer.",
      "Biomarker tests are a diagnostic method for pancreatic cancer."
    ],
    "evidence_relations": "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests"
  },
  {
    "id": "Medical-bbe2b0d9",
    "source": "Medical",
    "question": "What is the role of imaging in pancreatic cancer diagnosis?",
    "answer": "Imaging is used for staging and determining surgical eligibility in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Imaging is used for staging in pancreatic cancer.",
      "Imaging is used for determining surgical eligibility in pancreatic cancer."
    ],
    "evidence_relations": "Imaging is used for staging and determining surgical eligibility in pancreatic cancer"
  },
  {
    "id": "Medical-73631aaa",
    "source": "Medical",
    "question": "What symptom may indicate pancreatic cancer?",
    "answer": "Jaundice (yellowed skin or eyes) may indicate pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Jaundice may indicate pancreatic cancer.",
      "Jaundice is characterized by yellowed skin or eyes."
    ],
    "evidence_relations": "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)"
  },
  {
    "id": "Medical-3785154c",
    "source": "Medical",
    "question": "What treatment is an option for some patients with stage I, II, or III pancreatic cancer?",
    "answer": "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Surgery is a treatment option for some patients with stage I pancreatic cancer.",
      "Surgery is a treatment option for some patients with stage II pancreatic cancer.",
      "Surgery is a treatment option for some patients with stage III pancreatic cancer."
    ],
    "evidence_relations": "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer"
  },
  {
    "id": "Medical-f5dd3419",
    "source": "Medical",
    "question": "What is the main purpose of drug treatment in pancreatic cancer?",
    "answer": "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Drug treatment is most often used to control growth in pancreatic cancer.",
      "Drug treatment is most often used to reduce symptoms in pancreatic cancer."
    ],
    "evidence_relations": "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer"
  },
  {
    "id": "Medical-ba2d6fae",
    "source": "Medical",
    "question": "Are clinical trials available for pancreatic cancer patients?",
    "answer": "Yes, clinical trials are available for pancreatic cancer patients.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Clinical trials are available for pancreatic cancer patients."
    ],
    "evidence_relations": "Clinical trials are available for pancreatic cancer patients"
  },
  {
    "id": "Medical-c6d4a32e",
    "source": "Medical",
    "question": "Which care team member is responsible for performing biopsies?",
    "answer": "A pathologist is responsible for performing biopsies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A pathologist is responsible for performing biopsies."
    ],
    "evidence_relations": "Pathologist is listed as a Care Team Role in the ontology"
  },
  {
    "id": "Medical-5a1326ab",
    "source": "Medical",
    "question": "What is a common genetic syndrome associated with increased pancreatic cancer risk?",
    "answer": "Hereditary breast-ovarian cancer syndrome (HBOC) is associated with increased pancreatic cancer risk.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hereditary breast-ovarian cancer syndrome (HBOC) is associated with increased pancreatic cancer risk."
    ],
    "evidence_relations": "Hereditary breast-ovarian cancer syndrome, HBOC, is listed under Genetic Syndrome increasing risk of pancreatic cancer"
  },
  {
    "id": "Medical-33142c97",
    "source": "Medical",
    "question": "Which syndrome is characterized by increased risk of both melanoma and pancreatic cancer?",
    "answer": "Familial malignant melanoma syndrome (FAMMM syndrome) is associated with increased risk of both.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Familial malignant melanoma syndrome is associated with increased risk of melanoma.",
      "Familial malignant melanoma syndrome is associated with increased risk of pancreatic cancer."
    ],
    "evidence_relations": "Familial malignant melanoma syndrome, FAMMM syndrome, is listed under Genetic Syndrome increasing risk of pancreatic cancer"
  },
  {
    "id": "Medical-f7ffe25a",
    "source": "Medical",
    "question": "What is the primary cancer type discussed in this dataset?",
    "answer": "Prostate cancer is the primary cancer type.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Prostate cancer is the primary cancer type discussed in this dataset."
    ],
    "evidence_relations": "Prostate cancer is a disease where cells in the prostate gland grow out of control"
  },
  {
    "id": "Medical-9fbd09c4",
    "source": "Medical",
    "question": "Which subtype of prostate cancer is confined to the prostate gland?",
    "answer": "Localized prostate cancer is confined to the prostate.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Localized prostate cancer is confined to the prostate gland."
    ],
    "evidence_relations": "Localized prostate cancer is early-stage and confined to the prostate"
  },
  {
    "id": "Medical-83e047ca",
    "source": "Medical",
    "question": "What stage is regional prostate cancer classified as?",
    "answer": "Regional prostate cancer is classified as advanced-stage.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Regional prostate cancer is classified as advanced-stage."
    ],
    "evidence_relations": "Regional prostate cancer has spread to nearby lymph nodes"
  },
  {
    "id": "Medical-c6d69844",
    "source": "Medical",
    "question": "For which patients is germline genetic testing recommended in prostate cancer?",
    "answer": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Germline genetic testing is recommended for patients with high-risk prostate cancer.",
      "Germline genetic testing is recommended for patients with very-high-risk prostate cancer.",
      "Germline genetic testing is recommended for patients with regional prostate cancer.",
      "Germline genetic testing is recommended for patients with metastatic prostate cancer."
    ],
    "evidence_relations": "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer"
  },
  {
    "id": "Medical-c9348a2d",
    "source": "Medical",
    "question": "What is the mainstay of advanced prostate cancer treatment?",
    "answer": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment."
    ],
    "evidence_relations": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
  },
  {
    "id": "Medical-e22e810e",
    "source": "Medical",
    "question": "What is included in follow-up for prostate cancer patients?",
    "answer": "Follow-up includes regular PSA testing, imaging, and biopsies as needed.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Follow-up for prostate cancer patients includes regular PSA testing.",
      "Follow-up for prostate cancer patients includes imaging.",
      "Follow-up for prostate cancer patients includes biopsies as needed."
    ],
    "evidence_relations": "Follow-up includes regular PSA testing, imaging, and biopsies as needed"
  },
  {
    "id": "Medical-ff590b8b",
    "source": "Medical",
    "question": "Which treatments are available for metastatic prostate cancer?",
    "answer": "Metastatic prostate cancer treatments include ADT, LHRH agonist/antagonist, chemotherapy, immunotherapy, targeted therapy, radiation therapy, and radiopharmaceuticals.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "ADT is a treatment for metastatic prostate cancer.",
      "LHRH agonist/antagonist is a treatment for metastatic prostate cancer.",
      "Chemotherapy is a treatment for metastatic prostate cancer.",
      "Immunotherapy is a treatment for metastatic prostate cancer.",
      "Targeted therapy is a treatment for metastatic prostate cancer.",
      "Radiation therapy is a treatment for metastatic prostate cancer.",
      "Radiopharmaceuticals are a treatment for metastatic prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Treatment: Androgen deprivation therapy (ADT), LHRH agonist, LHRH antagonist, Leuprolide, Goserelin, Triptorelin, Degarelix, Relugolix, Bicalutamide, Flutamide, Nilutamide, Orchiectomy, Chemotherapy, Immunotherapy, Targeted therapy, Radiation therapy, Radiopharmaceuticals"
  },
  {
    "id": "Medical-f9135c63",
    "source": "Medical",
    "question": "Which genetic alterations are associated with metastatic prostate cancer?",
    "answer": "BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, and FANCA are associated with metastatic prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "BRCA1 is associated with metastatic prostate cancer.",
      "BRCA2 is associated with metastatic prostate cancer.",
      "ATM is associated with metastatic prostate cancer.",
      "CHEK2 is associated with metastatic prostate cancer.",
      "MLH1 is associated with metastatic prostate cancer.",
      "MSH2 is associated with metastatic prostate cancer.",
      "MSH6 is associated with metastatic prostate cancer.",
      "PALB2 is associated with metastatic prostate cancer.",
      "PMS2 is associated with metastatic prostate cancer.",
      "FANCA is associated with metastatic prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA"
  },
  {
    "id": "Medical-1ad52a4e",
    "source": "Medical",
    "question": "What are common urinary symptoms of prostate cancer?",
    "answer": "Common urinary symptoms include frequent urination, weak urine stream, and trouble urinating.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Frequent urination is a common urinary symptom of prostate cancer.",
      "A weak urine stream is a common urinary symptom of prostate cancer.",
      "Trouble urinating is a common urinary symptom of prostate cancer."
    ],
    "evidence_relations": "Symptom: Frequent urination, Weak urine stream, Trouble urinating"
  },
  {
    "id": "Medical-677867c1",
    "source": "Medical",
    "question": "Which blood and urine biomarker tests are used in prostate cancer diagnosis?",
    "answer": "4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, and SelectMDx are used for biomarker testing.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "4Kscore is used for biomarker testing in prostate cancer diagnosis.",
      "PHI is used for biomarker testing in prostate cancer diagnosis.",
      "IsoPSA is used for biomarker testing in prostate cancer diagnosis.",
      "ExoDx is used for biomarker testing in prostate cancer diagnosis.",
      "miR Sentinel is used for biomarker testing in prostate cancer diagnosis.",
      "MPS is used for biomarker testing in prostate cancer diagnosis.",
      "PCA3 is used for biomarker testing in prostate cancer diagnosis.",
      "SelectMDx is used for biomarker testing in prostate cancer diagnosis."
    ],
    "evidence_relations": "Blood and urine biomarker tests (4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, SelectMDx)"
  },
  {
    "id": "Medical-babba8f2",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy for patients on active surveillance?",
    "answer": "Repeat biopsy and regular PSA testing are recommended for active surveillance.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Repeat biopsy is recommended for patients on active surveillance.",
      "Regular PSA testing is recommended for patients on active surveillance."
    ],
    "evidence_relations": "Follow-up Strategy: Repeat biopsy for active surveillance, Regular PSA testing"
  },
  {
    "id": "Medical-a45d778d",
    "source": "Medical",
    "question": "Which risk group classification guides prognosis and treatment decisions?",
    "answer": "Very low, low, intermediate, high, and very high risk groups guide prognosis and treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Very low risk group guides prognosis and treatment decisions.",
      "Low risk group guides prognosis and treatment decisions.",
      "Intermediate risk group guides prognosis and treatment decisions.",
      "High risk group guides prognosis and treatment decisions.",
      "Very high risk group guides prognosis and treatment decisions."
    ],
    "evidence_relations": "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment"
  },
  {
    "id": "Medical-a0e852ec",
    "source": "Medical",
    "question": "Which treatment is a surgical option for advanced prostate cancer?",
    "answer": "Orchiectomy is a surgical option for advanced prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Orchiectomy is a surgical option for advanced prostate cancer."
    ],
    "evidence_relations": "Metastatic prostate cancer: Treatment: Orchiectomy"
  },
  {
    "id": "Medical-8a3d6beb",
    "source": "Medical",
    "question": "What is a common symptom of prostate cancer that affects sexual function?",
    "answer": "Erectile dysfunction is a common symptom affecting sexual function.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Erectile dysfunction is a common symptom of prostate cancer.",
      "Erectile dysfunction affects sexual function."
    ],
    "evidence_relations": "Symptom: Erectile dysfunction"
  },
  {
    "id": "Medical-bbe1e6e4",
    "source": "Medical",
    "question": "Which demographic factor increases prostate cancer risk?",
    "answer": "Black race increases the risk of prostate cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Black race increases the risk of prostate cancer."
    ],
    "evidence_relations": "Risk Factor: Black race"
  },
  {
    "id": "Medical-fec61a48",
    "source": "Medical",
    "question": "Which dietary habits are considered risk factors for prostate cancer?",
    "answer": "High-fat diet and low fruit and vegetable intake are risk factors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "A high-fat diet is a risk factor for prostate cancer.",
      "Low fruit and vegetable intake is a risk factor for prostate cancer."
    ],
    "evidence_relations": "Risk Factor: High-fat diet, Low fruit and vegetable intake"
  },
  {
    "id": "Medical-2eb79e75",
    "source": "Medical",
    "question": "What is the main hormonal therapy for advanced prostate cancer?",
    "answer": "Androgen deprivation therapy (ADT) is the main hormonal therapy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Androgen deprivation therapy (ADT) is the main hormonal therapy for advanced prostate cancer."
    ],
    "evidence_relations": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment"
  },
  {
    "id": "Medical-338ef222",
    "source": "Medical",
    "question": "What is the most common type of adrenal gland tumor?",
    "answer": "Adenoma is the most common type of adrenal gland tumor.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma is the most common type of adrenal gland tumor."
    ],
    "evidence_relations": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-bfb768d9",
    "source": "Medical",
    "question": "What hormone is produced in excess by aldosteronoma?",
    "answer": "Aldosteronoma produces excess aldosterone.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Aldosteronoma produces excess aldosterone."
    ],
    "evidence_relations": "Aldosteronoma produces excess aldosterone"
  },
  {
    "id": "Medical-d909a766",
    "source": "Medical",
    "question": "Which adrenal tumor is associated with Cushing syndrome?",
    "answer": "Adenoma producing excess cortisol causes Cushing syndrome.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma producing excess cortisol causes Cushing syndrome."
    ],
    "evidence_relations": "Adenoma producing excess cortisol causes Cushing syndrome"
  },
  {
    "id": "Medical-10fa6b86",
    "source": "Medical",
    "question": "Which hereditary syndromes are risk factors for adrenocortical carcinoma?",
    "answer": "Risk factors for adrenocortical carcinoma include Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau syndrome (VHL).",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for adrenocortical carcinoma include Beckwith-Wiedemann syndrome.",
      "Risk factors for adrenocortical carcinoma include Carney complex.",
      "Risk factors for adrenocortical carcinoma include Familial adenomatous polyposis (FAP).",
      "Risk factors for adrenocortical carcinoma include Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome.",
      "Risk factors for adrenocortical carcinoma include Li-Fraumeni syndrome.",
      "Risk factors for adrenocortical carcinoma include Lynch syndrome.",
      "Risk factors for adrenocortical carcinoma include Multiple endocrine neoplasia type 1 (MEN 1).",
      "Risk factors for adrenocortical carcinoma include Multiple endocrine neoplasia type 2 (MEN 2).",
      "Risk factors for adrenocortical carcinoma include Neurofibromatosis type 1 (NF1).",
      "Risk factors for adrenocortical carcinoma include Von Hippel-Lindau syndrome (VHL)."
    ],
    "evidence_relations": "Risk Factor for Adrenocortical Carcinoma (ACC) includes Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), Von Hippel-Lindau syndrome (VHL)"
  },
  {
    "id": "Medical-189210ec",
    "source": "Medical",
    "question": "Which adrenal tumor originates from the adrenal medulla?",
    "answer": "Pheochromocytoma originates from the adrenal medulla.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Pheochromocytoma originates from the adrenal medulla."
    ],
    "evidence_relations": "Origin of Pheochromocytoma is Adrenal medulla"
  },
  {
    "id": "Medical-df3d2ccc",
    "source": "Medical",
    "question": "What are common symptoms of adrenocortical carcinoma?",
    "answer": "Symptoms of adrenocortical carcinoma include weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of adrenocortical carcinoma include weight gain.",
      "Common symptoms of adrenocortical carcinoma include muscle weakness.",
      "Common symptoms of adrenocortical carcinoma include pink or purple stretch marks.",
      "Common symptoms of adrenocortical carcinoma include excess facial hair.",
      "Common symptoms of adrenocortical carcinoma include hair loss on the head.",
      "Common symptoms of adrenocortical carcinoma include irregular periods.",
      "Common symptoms of adrenocortical carcinoma include enlarged breast tissue.",
      "Common symptoms of adrenocortical carcinoma include shrinking testicles.",
      "Common symptoms of adrenocortical carcinoma include nausea.",
      "Common symptoms of adrenocortical carcinoma include vomiting.",
      "Common symptoms of adrenocortical carcinoma include abdominal bloating.",
      "Common symptoms of adrenocortical carcinoma include back pain.",
      "Common symptoms of adrenocortical carcinoma include fever.",
      "Common symptoms of adrenocortical carcinoma include loss of appetite.",
      "Common symptoms of adrenocortical carcinoma include loss of weight without trying."
    ],
    "evidence_relations": "Symptom of Adrenocortical Carcinoma (ACC) includes weight gain, muscle weakness, pink or purple stretch marks, excess facial hair, hair loss on the head, irregular periods, enlarged breast tissue, shrinking testicles, nausea, vomiting, abdominal bloating, back pain, fever, loss of appetite, and loss of weight without trying"
  },
  {
    "id": "Medical-32b97819",
    "source": "Medical",
    "question": "What is the main population at risk for adrenocortical carcinoma?",
    "answer": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adrenocortical carcinoma can occur at any age.",
      "Adrenocortical carcinoma is most likely in children under 5.",
      "Adrenocortical carcinoma is most likely in adults in their 40s and 50s."
    ],
    "evidence_relations": "Adrenocortical carcinoma can occur at any age but is most likely in children under 5 and adults in their 40s and 50s"
  },
  {
    "id": "Medical-c78a374e",
    "source": "Medical",
    "question": "Which adrenal tumor may metastasize to bones?",
    "answer": "Neuroblastoma may metastasize to bones.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Neuroblastoma may metastasize to bones."
    ],
    "evidence_relations": "Spread of Neuroblastoma: May metastasize to bones"
  },
  {
    "id": "Medical-bfcfdc70",
    "source": "Medical",
    "question": "Which imaging methods are included in the diagnosis of adrenocortical carcinoma?",
    "answer": "Diagnostic methods for adrenocortical carcinoma include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for adrenocortical carcinoma include CT scan.",
      "Diagnostic methods for adrenocortical carcinoma include MRI scan.",
      "Diagnostic methods for adrenocortical carcinoma include PET scan.",
      "Diagnostic methods for adrenocortical carcinoma include FDG-PET/CT.",
      "Diagnostic methods for adrenocortical carcinoma include SSTR-PET/CT.",
      "Diagnostic methods for adrenocortical carcinoma include blood test.",
      "Diagnostic methods for adrenocortical carcinoma include biochemical test.",
      "Diagnostic methods for adrenocortical carcinoma include genetic test.",
      "Diagnostic methods for adrenocortical carcinoma include biopsy."
    ],
    "evidence_relations": "Diagnostic Method of Adrenocortical Carcinoma (ACC) includes CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy"
  },
  {
    "id": "Medical-dfca353c",
    "source": "Medical",
    "question": "What percentage of adrenal cancer patients have symptoms due to hormone excess?",
    "answer": "Half of adrenal cancer patients have symptoms due to hormone excess.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Half of adrenal cancer patients have symptoms due to hormone excess."
    ],
    "evidence_relations": "Half of adrenal cancer patients have symptoms due to hormone excess"
  },
  {
    "id": "Medical-7f86e4c5",
    "source": "Medical",
    "question": "What are the two functional categories of adenoma in the adrenal gland?",
    "answer": "Adenoma can be functioning or nonfunctioning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Adenoma can be functioning.",
      "Adenoma can be nonfunctioning."
    ],
    "evidence_relations": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning"
  },
  {
    "id": "Medical-539448fd",
    "source": "Medical",
    "question": "What is the biomarker for aldosteronoma?",
    "answer": "Aldosterone is the biomarker for aldosteronoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Aldosterone is the biomarker for aldosteronoma."
    ],
    "evidence_relations": "Biomarker of Aldosteronoma: Aldosterone"
  },
  {
    "id": "Medical-77bf9d25",
    "source": "Medical",
    "question": "What is the biomarker for cortisol-producing adenoma?",
    "answer": "Cortisol is the biomarker for cortisol-producing adenoma.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Cortisol is the biomarker for cortisol-producing adenoma."
    ],
    "evidence_relations": "Biomarker of Cortisol-producing Adenoma: Cortisol"
  },
  {
    "id": "Medical-28728520",
    "source": "Medical",
    "question": "Which diagnostic methods are used for neuroblastoma?",
    "answer": "Diagnostic methods for neuroblastoma include imaging tests and biochemical test.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Diagnostic methods for neuroblastoma include imaging tests.",
      "Diagnostic methods for neuroblastoma include biochemical test."
    ],
    "evidence_relations": "Diagnostic Method of Neuroblastoma includes Imaging tests, Biochemical test"
  },
  {
    "id": "Medical-2085b009",
    "source": "Medical",
    "question": "What are some risk factors for adrenal tumors in general?",
    "answer": "Certain hereditary syndromes and family history increase the risk of adrenal tumors.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Certain hereditary syndromes increase the risk of adrenal tumors.",
      "Family history increases the risk of adrenal tumors."
    ],
    "evidence_relations": "Risk Factor for Adrenal Tumor includes Hereditary syndromes, Family history"
  },
  {
    "id": "Medical-57129a04",
    "source": "Medical",
    "question": "What subtype of breast cancer is characterized by cancer cells blocking lymph vessels in the skin?",
    "answer": "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels in the skin.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels.",
      "Inflammatory breast cancer (IBC) affects the skin."
    ],
    "evidence_relations": "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin"
  },
  {
    "id": "Medical-d47d0c68",
    "source": "Medical",
    "question": "Which biomarkers are key for breast cancer?",
    "answer": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Hormone receptor status (ER, PR) is a key biomarker for breast cancer.",
      "HER2 status is a key biomarker for breast cancer."
    ],
    "evidence_relations": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer"
  },
  {
    "id": "Medical-3e184ed2",
    "source": "Medical",
    "question": "Which mutation can be targeted with specific therapies in breast cancer?",
    "answer": "PIK3CA mutation can be targeted with specific therapies.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PIK3CA mutation can be targeted with specific therapies in breast cancer."
    ],
    "evidence_relations": "PIK3CA mutation can be targeted with specific therapies"
  },
  {
    "id": "Medical-dd137889",
    "source": "Medical",
    "question": "Which biomarker status may influence immunotherapy options in breast cancer?",
    "answer": "MSI-H/dMMR status may influence immunotherapy options.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "MSI-H/dMMR status may influence immunotherapy options in breast cancer."
    ],
    "evidence_relations": "MSI-H/dMMR status may influence immunotherapy options"
  },
  {
    "id": "Medical-03388322",
    "source": "Medical",
    "question": "Which biomarker may guide immunotherapy use in breast cancer?",
    "answer": "PD-L1 expression may guide immunotherapy use.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PD-L1 expression may guide immunotherapy use in breast cancer."
    ],
    "evidence_relations": "PD-L1 expression may guide immunotherapy use"
  },
  {
    "id": "Medical-1560f6ac",
    "source": "Medical",
    "question": "How is lymph node involvement assessed in breast cancer?",
    "answer": "Sentinel lymph node biopsy is used to assess lymph node involvement.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Sentinel lymph node biopsy is used to assess lymph node involvement in breast cancer."
    ],
    "evidence_relations": "Sentinel lymph node biopsy is used to assess lymph node involvement"
  },
  {
    "id": "Medical-6c8055a7",
    "source": "Medical",
    "question": "Which therapy is used for hormone receptor-positive breast cancer?",
    "answer": "Endocrine therapy is used for hormone receptor-positive breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Endocrine therapy is used for hormone receptor-positive breast cancer."
    ],
    "evidence_relations": "Endocrine therapy is used for hormone receptor-positive breast cancer"
  },
  {
    "id": "Medical-6f086f1b",
    "source": "Medical",
    "question": "Which therapy is used for BRCA-mutated, HER2-negative breast cancer?",
    "answer": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer."
    ],
    "evidence_relations": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer"
  },
  {
    "id": "Medical-85ed509e",
    "source": "Medical",
    "question": "Which inhibitors are used for hormone receptor-positive, HER2-negative breast cancer?",
    "answer": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer."
    ],
    "evidence_relations": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer"
  },
  {
    "id": "Medical-869c8d57",
    "source": "Medical",
    "question": "What are common symptoms of breast cancer?",
    "answer": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Common symptoms of breast cancer include breast lump.",
      "Common symptoms of breast cancer include pain.",
      "Common symptoms of breast cancer include nipple discharge.",
      "Common symptoms of breast cancer include skin changes.",
      "Common symptoms of breast cancer include redness.",
      "Common symptoms of breast cancer include swelling.",
      "Common symptoms of breast cancer include peau dorange."
    ],
    "evidence_relations": "Common symptoms include breast lump, pain, nipple discharge, skin changes, redness, swelling, and peau dorange"
  },
  {
    "id": "Medical-69eae99e",
    "source": "Medical",
    "question": "What are risk factors for breast cancer?",
    "answer": "Risk factors include family history, BRCA mutations, and being assigned female at birth.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Risk factors for breast cancer include family history.",
      "Risk factors for breast cancer include BRCA mutations.",
      "Risk factors for breast cancer include being assigned female at birth."
    ],
    "evidence_relations": "Risk factors include family history, BRCA mutations, and being assigned female at birth"
  },
  {
    "id": "Medical-329de573",
    "source": "Medical",
    "question": "What should be discussed before starting breast cancer treatment regarding reproductive health?",
    "answer": "Fertility preservation should be discussed before starting treatment.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Fertility preservation should be discussed before starting breast cancer treatment."
    ],
    "evidence_relations": "Fertility preservation should be discussed before starting treatment"
  },
  {
    "id": "Medical-e79a7e61",
    "source": "Medical",
    "question": "What patient factor is considered in treatment planning for breast cancer?",
    "answer": "Performance status is considered in treatment planning.",
    "question_type": "Fact Retrieval",
    "evidence": [
      "Performance status is considered in treatment planning for breast cancer."
    ],
    "evidence_relations": "Performance status is considered in treatment planning"
  }
]